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ABSTRACT OF THE DISSERTATION 
 
Structural and Biochemical Studies of the Amyloid-Forming Proteins  
Tar DNA Binding Protein 43, Superoxide Dismutase 1, and Alpha-Synuclein 
 
 by 
 
Elizabeth Lynn Guenther 
Doctor of Philosophy in Biochemistry and Molecular Biology 
University of California, Los Angeles, 2017 
Professor David S. Eisenberg, Chair 
 
 
 
The formation of elongated, unbranched fibrillar protein aggregates, termed 
amyloid, has been linked to neurodegenerative diseases including Alzheimer’s Disease, 
Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS). For decades, scientists have 
sought to determine the structures and polymorphic features of these aggregates to better 
understand their complex assembly and role in disease.  Here, we show structures from 
three amyloid proteins, TAR DNA Binding Protein 43 (TDP-43), Superoxide Dismutase 1 
(SOD1), and α-synuclein, offering insight into amyloid and protein aggregation in general. 
 First, we investigated TDP-43 as a model for the polymorphic capabilities of pathological 
amyloid aggregation. From x-ray diffraction, electron diffraction and cryoEM, we show that the 
segment, 247DLIIKGISVHI257, from the second RNA recognition motif forms an array of amyloid 
polymorphs. These associations include seven distinct interfaces displaying five different 
symmetry classes of steric zippers.  The polymorphic nature of this segment illustrates at the 
molecular level how amyloid proteins can form diverse fibril structures. 
 iii 
 In the second section, we investigated the role of the low complexity domain (LCD) of 
TDP-43 in reversible stress granule aggregation and irreversible pathogenic aggregation.  We 
determined six atomic resolution segment structures from the LCD of TDP-43 that offer insight 
into regions of the protein responsible for aggregation.  We illustrate how three of these 
structures, 300GNNQGSN306, 370GNNSYS375, and 396GFNGGFG402 form fibrils and exhibit 
characteristic steric zippers, indicative of pathogenic aggregation.  We present an atomic 
structure for segment 312NFGAFS317, which reveals a fibril with a kinked interface that is 
reversible and may play a role in stress granule assembly.  We present a model that combines 
previous literature with our new structural findings, to illustrate how stress granule assembly 
can lead to pathogenic aggregation. 
 Third, we structurally characterized peptide segments from SOD1 because pathological 
deposition of mutated SOD1 accounts for ~20% of the familial ALS (fALS) cases. We used a 
computational approach to discover four segments from the protein that form fibril-like 
aggregates and subsequently solved the structure of three of those segments: 101DSVISLS107, 
147GVIGIAQ153 and 147GVTGIAQ153. We found, through the use of proline mutations, that two of 
these 101DSVISLS107 and 147GVIGIAQ153 are likely to trigger the aggregation of full-length SOD1, 
suggesting common molecular determinants of fALS and sALS.   
 In the fourth section, we investigated whether amyloid oligomers or fibrils were 
responsible for SOD1 toxicity in ALS.  We determined the corkscrew-like structure of a cytotoxic 
segment of SOD1 in its oligomeric state.  Through time course cytotoxicity assays, we 
demonstrated that the toxicity is likely a property of soluble oligomers and not large insoluble 
aggregates. Our work adds to evidence that the toxic oligomeric entities in protein aggregation 
diseases contain antiparallel, out-of-register β-sheet structures and identifies a target for 
structure-based therapeutics in ALS. 
 In the final section, we characterized the amyloidogenic core of  α-synuclein, the main 
component of Lewy bodies, the neuron-associated aggregates seen in Parkinson’s disease. We 
 iv 
utilized a new technique known as Micro-electron diffraction (MicroED) to solve the structure of 
crystals of an 11-residue segment we term NACore that are invisible by optical microscopy. The 
structure reveals protofibrils built of pairs of face-to-face β-sheets that exhibit a fiber diffraction 
pattern similar to full-length α-synuclein.  We present a model of the toxic, full-length α-
synuclein fibril, incorporating the NACore and an additional segment. 
 En masse, the structures in this dissertation offer broad insights into pathological and 
reversible protein aggregation. The structures provide a starting point for additional studies 
aimed at developing therapeutics for amyloid formation in neurodegenerative disease. 
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CHAPTER 1 
 
Molecular Structures of a Key Segment of Amyloid-forming Protein TDP-43 
Reveal Prodigious Packing Polymorphism 
 
INTRODUCTION 
The formation of elongated, unbranched fibrillar protein aggregates, termed amyloid, 
has been linked to neurodegenerative diseases including Alzheimer’s Diseases, Parkinson’s 
Disease, prion diseases and Amyotrophic Lateral Sclerosis (ALS) among others (1-4). For 
decades scientists have sought molecular structures for amyloid aggregates and have attempted 
to understand the range of polymorphic fibrillar structures formed by proteins in the amyloid 
state (5-7). Contributions to understanding amyloid structure have come in recent years from 
diffraction methods (8-10), solid-state NMR (11-14), and electron cryo-microscopy (15-17). 
These studies have shown that amyloid fibrils consist of packed β-sheets that run parallel or 
roughly parallel to the fibril axes.  Each β-sheet adheres to its neighboring sheets because the 
sidechains of each β-strand project roughly perpendicular to the fibril axis, toward the 
neighboring sheet.  Because the sidechains of mating sheets can interdigitate like the teeth of a 
zipper, this interaction has been called a steric zipper (8).  Steric zippers can form between 
identical or non-identical β-sheets.  A common property of β-sheets in the amyloid state is that 
they can pack in a variety of ways to form several different fibril structures. Such polymorphic 
amyloid assemblies are well known. Research on amyloid-β has demonstrated how 
conformational variations can lead to distinct assemblies of amyloid aggregates (5, 6). Different 
polymorphs of the same amyloid protein can exhibit different biophysical or biomedical 
properties. In the case of prion protein, distinct strains can confer different toxic effects as well 
as transmission capabilities based on the fibrillar structure the protein has adopted (18). Since 
2 
polymorphs can determine transmission and severity of disease, understanding polymorph 
structure has medical implications. 
Structural studies of amyloid at the atomic level have offered evidence for two basic 
models to explain the frequent observation that a single protein produces amyloid fibrils of 
varying morphologies or polymorphs. In the first model, termed segmental polymorphism, the 
segment forming the zipper spine differs between amyloid fibrils (19, 20). Segmental 
polymorphism has been observed in a number of proteins to date, including islet amyloid 
polypeptide (IAPP), in which various six- and eleven-residue segments of IAPP are each capable 
of forming zippers, independently (21,22). In a second model, termed packing polymorphism, a 
single zipper-forming segment packs differently in different amyloid fibrils(19, 20). Outside of 
amyloid research, this type of packing is commonly referred to as modal polymorphism. We 
have observed this polymorphism by the amyloid-β segment, 16KLVFFA21, in which three 
distinct zipper interfaces were revealed by three crystal forms (23). Both of these types of 
polymorphism presume homotypic zipper interfaces: two mated sheets both composed of the 
same segment. However, analogous polymorphisms are likely also to exist for heterotypic 
zippers, where the two mated sheets are derived from sequentially distant segments (19, 20) as 
in solid-state NMR structures of α-synuclein and amyloid-β (11-13). The abundance of examples 
of segmental and packing variations observed between distinct fibrils raises the question of 
whether these same variations play a role within a single fibril, a phenomenon termed positional 
polymorphism. If so, to what extent does positional polymorphism expand the repertoire of 
amyloid polymorphs accessible to a given sequence? 
Currently, one of the proteins in the forefront of research on amyloid disease is TAR 
DNA Binding Protein 43 (TDP-43) owing to the presence of its aggregates in patients with ALS 
and Frontotemporal Lobar Degeneration (FTLD) (24, 25). Recent findings have shown that 
aggregates of TDP-43 are also found in patients with Alzheimer’s, Parkinson’s and Huntington’s 
Diseases (26-29). Distinct from other amyloid and amyloid-like proteins, TDP-43 is viewed as 
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an essential protein for cellular homeostasis. It has been shown that knockdown of the 
expression of TDP-43 in mice results in embryonic lethality (30-32). In addition, other studies 
have demonstrated that changes in TDP-43 expression levels leads to motor deficits and loss of 
body fat in mouse models (30, 33). This has led to the hypothesis that TDP-43 aggregation can 
confer toxicity through a loss of function mechanism. In this case, TDP-43 is redistributed from 
the nucleus to the cytoplasm as seen in neuronal cell culture experiments (34, 35). The effects of 
the nuclear clearance of TDP-43 is still being investigated, however research has shown that loss 
of TDP-43 function results in the inclusion of cryptic exons in transcripts, improper regulation 
of microprocessing and dysregulation of Rho family GTPases (33, 36, 37). These findings have 
made understanding the mechanism by which TDP-43 aggregates an essential focus of research 
in ALS and other neurodegenerative diseases. By understanding how the protein aggregates, 
inhibitors against the aggregation can be developed and protein function can be restored, as 
demonstrated with p53 in ovarian carcinomas (38). 
Here, we apply three structural methods, x-ray diffraction, electron diffraction, and 
cryoEM, to determine three different assemblies of a key segment in the second RNA 
Recognition Motif (RRM2) of TDP-43.  In addition to segmental and packing polymorphisms, 
we reveal that positional polymorphism contributes an important alternative route to amyloid 
fibril assembly. We propose such positional polymorphism is not limited to TDP-43, but a 
widespread phenomenon among amyloid proteins in general. 
 
RESULTS 
Segments from the RRM2 of TDP-43 exhibit characteristic amyloid properties 
We decided to target the RRM2 of TDP-43 for structural studies based on three previous 
findings. First, researchers have shown that patients with ALS and FTLD have aggregates in the 
brain and spinal cord that are primarily composed of C-terminal fragments ranging in size from 
15-35kDa (35, 39, 40).  The longer fragments include part of the first RNA Recognition Motif 
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(RRM1), the RRM2 and the C-terminal tail while the shorter segments include only part of the 
RRM2 and the C-terminal tail.  Second, a study showed that inclusion of a truncated RRM2 at 
residue 208 increased the number of TDP-43 aggregates present in cells and also increased 
cellular death (41).  Finally, a study illustrated that the RRM2 of TDP-43 adopts an intermediate 
state during folding and that the presence of the RRM1 aids the RRM2 in folding into its final 
conformation (42).  These findings together indicated that the unfolding or destabilization of the 
RRM2 by cleavage could expose an aggregation prone region that was previously protected and 
thus facilitate amyloid aggregation of TDP-43. 
Since amyloid spines are typically composed of segments ranging from 6-11 residues, we 
used the 3D Profile Method, ZipperDB, to narrow our region of focus in the RRM2 to a 13-
residue segment 247DLIIKGISVHISN259(Figure 1.1A) (43). Within this region, 4 of the top 10 
potential zipper forming segments of TDP-43 are located based on Rosetta energy. This is 
significant as there are 408 possible 6-residue zippers that the 3D Profile Method evaluates for 
the 414 residue TDP-43. We decided to characterize biochemically 11 segments within this 
region, ranging from 6 to 11 residues in length with average of hydropathicity values ranging 
from 0.07 to 2.17 (Figure 1.1A, Supplementary Table 1.1) (44). 
To determine if these segments exhibit amyloid properties, we tested their propensity to 
aggregate, their stability under denaturing conditions, and their fibril diffraction pattern.  We 
find that all 11 segments form fibrils when shaken for one week (Figure 1.1B). Based on previous 
studies demonstrating that amyloid fibrils are stable when incubated with SDS and heat, we 
subjected the fibrils to a 2% SDS solution at 70°C for 15 minutes (45).  We find that under these 
extremely harsh denaturing conditions, the fibrils exhibit moderate to high stability.  Segments 
247DLIIKGISV255, 247DLIIKGISVH256, 248LIIKGISVHI257, and 252GISVHI257 all exhibit the highest 
stability illustrating almost no dissociation of fibrils (Figure 1.1C and Supplementary Figure 1.1).  
Finally, we checked whether the dried fibril samples exhibit the characteristic cross-β diffraction 
pattern indicative of amyloid fibrils (46).  For the nine samples on which we were able to study 
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diffraction, we found that all exhibit reflections at spacings of 4.6-4.7Å and 8.8-11.5Å, which 
supports the presence of a typical steric-zipper-based amyloid fibril (Supplementary Figure 1.2). 
Segments 248LIIKGI253 and 247DLIIKGISVHI257 form two distinct steric zipper 
structures. 
Following biochemical characterization of peptide segments from the 13-residue range 
within the RRM2 we attempted crystallization of all 11 segments. We successfully determined 
the structures of two constructs, 248LIIKGI253 and 247DLIIKGISVHI257, through the use of two 
methods: x-ray diffraction and microelectron diffraction (MicroED) respectively. 
Crystals of 248LIIKGI253 were grown in hanging drop 96-well trays and were visible by 
light microscopy (Figure 1.2A).  Fibril diffraction pattern revealed rings at 4.6Å and 11.5Å, which 
are consistent with amyloid structure (Figure 1.2B). Initial processing of the diffraction data 
from a micro-focus x-ray beamline provided unit cell dimensions of 11.54Å, 9.59Å, and 21.18 Å 
indicating an antiparallel β-sheet. Molecular replacement and refinement revealed a face=back, 
up-up, in-register antiparallel Class 7 steric zipper (Figure 1.2C, Table 1.1) (9).  The hydrogen 
bonding network is such that the sheet comprises only the first four residues, LIIK (Figure 
1.2D), thus leaving two-residue overhangs and a ragged appearance to the sheet edges. Due to its 
ragged edges, the buried surface area is relatively low at 117Å2, however the shape 
complementarity is high at 0.78. 
In contrast to the microcrystals formed by segment 248LIIKGI253, crystals of 
247DLIIKGISVHI257 were not visible by light microscopy owing to their small size.  The 
nanocrystals of 247DLIIKGISVHI257, which we term the RRMcore, were formed by shaking in pH 
8.5 buffer, and at ~100nm in width were visible only by electron microscopy (Figure 1.2E). We 
decided to use the cryoEM method, MicroED, on the basis of its previous success in determining 
key structures from three other amyloid proteins, α-synuclein, tau and IAPP (21, 47-49).  With 
this technique, an electron microscope is used to collect data in diffraction mode. The structure 
of 247DLIIKGISVHI257 was determined to be a parallel, face-to-back Class 2 steric zipper (Figure 
6 
1.2G and 1.2H and Table 1.2) (9).  The steric zipper interface is formed by the inter-digitation of 
residues DLIIKGIS from one strand with KGISVHI from the mating strand.  The tight interface 
results in 350 Å2 buried surface area and a shape complementarity of 0.67.  Fibril diffraction of 
the sample illustrated characteristic amyloid reflections at spacings of 4.72Å and 10.4Å (Figure 
1.2F). 
The structures of 248LIIKGI253 and 247DLIIKGISVHI257 reveal two possible ways that 
segments from the RRMcore can associate to form an amyloid spine.  The heterotypic nature of 
the two structures suggests that the RRMcore can form polymorphic assemblies. 
CryoEM Structure of 247DLIIKGISVHI257Fibril Reveals a 27-Filament Helical Fibril 
During biochemical characterization of segments within the RRMcore we noticed that 
aggregates of 247DLIIKGISVHI257 grown at pH 8.5 differed in morphology from those grown at 
pH 7.5. The crystals formed at pH 8.5 revealed the parallel Class 2 zipper described above, while 
the aggregates grown at pH 7.5 displayed fibrillar morphology, but not crystalline. Fibril 
diffraction of this sample revealed cross-β diffraction at 4.65Å and 10.5Å, indicating the 
presence of steric zipper interfaces formed by parallel β-sheets (Figure 1.3B). By electron 
microscopy, the fibrils exhibited a regular helical twist (Figure 1.3A and Supplementary Figure 
1.3).  Following studies that used cryoEM to determine structures of helical fibrils of amyloid-β 
and light chain amyloid (15, 16), we applied this method to our fibrils 
CryoEM experiments on the 247DLIIKGISVHI257 sample revealed 8 classes of fibrils 
including cylinders, twists, sheets and a 3-start helix (Supplementary Figure 1.4). The most 
dominant species, comprising ~60% of the sample, was the 3-start helix, a common 
organization pattern of biological fibrils (50). Subsequent class averaging of the 3 start-helix 
allowed us to visualize multiple faces of the fibril, generating enough data for single particle 
reconstruction (Supplementary Figure 1.5).  
Using single particle reconstruction and accounting for helical symmetry, a model of the 
structure was determined at 3.7Å resolution (Figure 1.3C and Supplementary Figure 1.6). The 
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247DLIIKGISVHI257 3-start helix appears as a many-filament parallel β-sheet fibril, exhibiting 3-
fold screw symmetry. A single layer cross-section of the fibril comprises 27 peptide strands, with 
nine strands in the asymmetric unit (Figure 1.3D).  Each of the nine strands displays a kinked, 
straight, or curved conformation, contributing to the complex polymorphism of the structure 
(Supplementary Figure 1.7). The asymmetric units are related by a left handed three-fold screw 
with a rise of 1.60Å and a rotation of 120.4° per step. The individual protofilament β-sheets, 27 
in total, exhibit a left-handed twist, as is common for β-sheets. The density map indicates that 
the β-sheets at the center and outer perimeter of the fibril have disordered termini (Figures 1.3E 
and 1.3F).  Thus, we have modeled only the six ordered residues for these. 
This complex helical fibril structure illustrates a tight packing of the 247DLIIKGISVHI257 
segment into a polymorphic structure, the first amyloid molecular structure of its kind. The 
packing offers insight into how the RRMcore of TDP-43, and amyloid proteins in general, can 
use the flexibility of their peptide backbones to adopt multiple conformations and form diverse 
steric zipper interfaces, even in a single structure. This expanded repertoire of geometric shapes 
reveals the capacity of protofilaments to fit together to fill space, exclude water, and bury 
hydrophobic surfaces, as discussed below (Supplementary Figure 1.8). 
Structures from the RRMcore Offer Insight into Polymorphic Features of Amyloid 
Formation 
Our detailed analysis of the RRMcore polymorphs reveals that there are seven distinct 
interfaces that are formed among the three structures (Figure 1.4 and Supplementary Table 1.2).  
For the cryoEM structure we considered only interfaces that have at least 3 inter-digitating side 
chains.  Each distinct steric zipper interface features different interacting amino acid sidechains. 
Some of the interfaces feature homotypic interactions, whereas others feature heterotypic 
interactions. This creates interfaces that have varying values of buried surface area and shape 
complementarity, as well as different symmetries. These seven interfaces can belong to five 
classes of steric zippers. Two of these classes were revealed by the x-ray and electron diffraction 
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structures.  The 248LIIKGI253 x-ray structure is an antiparallel Class 7 zipper (the two outer faces 
of the pair of β-sheet are equivalent, and both β-sheets have the same strand edge facing up) 
(Figure 1.4A). The 247DLIIKGISVHI257 microED structure is a parallel Class 2 zipper (the two b-
sheets are face to back, again with the same strand edge facing up) (Figure 1.4B).  This steric 
zipper has the greatest surface area buried at 350Å2 (Figure 1.4B). The cryoEM structure 
accounts for the other five distinct interfaces that belong to three classes of zippers: 1, 3 and 4 
(Figure 1.4C-E). Class 3 zippers had been postulated (sheets face-to-face, with the strand edge 
facing up in one sheet and down in its mate), but not previously observed; now we find them in 
our cryoEM structure at the interfaces of ISVHI/LIIKGIS and DLIIKG/KGISVH (Figure 1.4C). 
These various distinct interfaces are achieved due to the flexibility of the RRMcore backbone, 
which is displayed as an overlay (Figure 1.4F).  
Within the cryoEM structure we see that the β-sheet interfaces exhibit both up-up and 
up-down backbone directionality (51). This is achieved by a kinked peptide flipping the direction 
of its backbone at the central isoleucine, amino acid eight of the 11 residue segment 
(Supplementary Figure 1.9). That is, the carbonyl of the glycine residue faces down, and at the 
kink, the carbonyl of the adjacent isoleucine also faces down. This creates a strand in which half 
of the segment exhibits “up” directionality and the other half exhibits “down” directionality. 
Here, the 247DLIIKGISVHI257 strand can have both an up-up interface on one side and an up-
down interface on the other side. Because the RRMcore can bend back on itself, the interactions 
of strands 6’, 2 and 5 illustrate how only three copies of the peptide segment are needed to 
create two entirely distinct interfaces (Figures 1.5A and 1.5B). This enables lateral growth of the 
fibril, perpendicular to the fibril axis and suggests how a propagating fibril could be composed of 
two distinct steric zipper cores within a localized region. 
We also analyzed the flexibility of the 247DLIIKGISVHI257 backbone. To do this we 
applied the LSQ superimposition feature from the program COOT on eight distinctly different b-
strands of RRMcore in two of our structures (52).  We compared the backbone conformations of 
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the seven full length strands from the cryoEM structure, strands 1-7, and the backbone of the 
microED structure, strand 10 (Figure 1.4F). When analyzing RMSD values we find that none of 
the strands perfectly overlay (Supplementary Table 1.3). In the cryoEM structure, we see four 
kinked segments in the asymmetric unit, all of which have distinct backbones and RMSD values 
ranging from 0.41 to 0.72 Å. The other four strands of 247DLIIKGISVHI257 are more linear in 
conformation but also all have distinctive backbone angles, with RMSD values ranging from 
0.59 to 2.34 Å. We find that the eight strands can be divided into three subclasses: kink, 
straight, and curve. We represent the eight strands as a pseudo-phylogenic tree to show the 
structural relationships of the distinct backbones (Figure 1.5C). 
The last features we investigated were the possible modes of formation of this complex 
fibril from 27 distinct strands. To do this we first computed the solvation energies of the surfaces 
of three possible protofibrils, each of 9 protofilaments, to determine the asymmetric unit that 
best represents the protofibril (Supplementary Figure 1.10) (53). From three potential 
collections of nine protofilaments, we found the lowest solvation energy to be 3,460 cal/mol, 
corresponding to the asymmetric unit displayed in Figure 3 (Supplementary Figure 1.11). A 
pseudo two-fold axis runs between strands 1, 2, 5 and 8 and 3, 4, 6 and 9 (Supplementary Figure 
1.12). To visualize this we have displayed all kinked strands as red, straight strands as blue, 
partial strands as yellow and curved strands as green (Figure 1.5D). In this representation, one 
can see how two red strands associate with a blue and a yellow strand to form a core component 
of the asymmetric unit that is then repeated through two fold symmetry. The green, curved 
strands serve to stabilize the asymmetric unit or protofibril, resulting in three-fold symmetry of 
the mature fibril. 
The data from all three structures provide us with information for how the RRMcore can 
initiate aggregation. The 247DLIIKGISVHI257 backbone can adopt at least eight different 
conformations. This allows the segment to associate with seven unique interfaces comprising 
five different classes of steric zippers. Ultimately the polymorphic features of this region can 
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offer insight into how core segments of other amyloid proteins may initiate and accelerate fibril 
formation. 
 
DISCUSSION 
Nucleation of complex amyloid fibrils 
The combination of the diverse interfaces and the flexibility of the 247DLIIKGISVHI257 
backbone offers the opportunity to formulate models for the nucleation of amyloid fibrils. We 
have designed four alternative mechanistic models, supported by the structures in this paper, to 
explain the seeding and propagation of amyloid fibrils (Figures 1.5E-H). In the first two 
mechanisms we focus on growth of a single fibril, while the last two mechanisms display both 
lateral extension and secondary nucleation, respectively. In the first mechanism, two individual 
β-sheets form independently (Figure 1.5E). They subsequently mate together to form the steric 
zipper interface. Elongation follows, allowing for growth of the fibril. This is likely how the 
microED structure and the kinked interfaces of the cryoEM structure associate. In the second 
mechanism, an individual β-sheet forms first and serves as a seed or template for the additional 
sheet (Figure 1.5F). This forces a specific backbone conformation on the mating peptide strand 
and dictates the type of interface that forms. Elongation subsequently follows the initial 
templating of the new strand. We expect this process to occur in the cryoEM structure. The 
presence of nine distinct strands makes it unlikely that they all form independently and come 
together in a perfectly symmetrical manner.  Rather, we envision that the most common 
interface, the kinked interface, forms independently and dictates new interfaces and backbone 
conformations for additional strands, such as the blue, yellow and green strands. This is 
explained further below through the lateral growth and secondary nucleation models. 
In a third model, we propose how a fibril could grow laterally with two different 
interfaces (Figure 1.5G). The first fibril forms and serves as a template for an additional sheet on 
the back side, or non-zipper side, of the templating sheet. This arrangement is found in our fibril 
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structure at the interactions of strands 2, 5 and 6’. Here, the prime symbol represents the 
corresponding strand on the adjacent asymmetric unit. Strand 2 could form the initial fibril with 
strand 5 and then serve as a seed for the growth of strand 6’ (Figure 1.5A). In the fourth model, 
we illustrate how this lateral growth could lead to secondary nucleation (Figure 1.5H). Once 
lateral fibril growth has occurred, it is possible for one of the sheets to dissociate and create a 
new steric zipper interface with a different strand. This is represented by the orange and green 
arrows. From our cryoEM structure, one can envision strand 6’ dissociating from the 
protofilament of strand 2 and forming a new interface with strand 9’ (Supplementary Figure 
1.11). This creates two independent filaments that were nucleated by one.  Each of these models 
offers one explanation of how amyloid proteins might form polymorphic assemblies in distinct 
cellular environments. 
Packing polymorphism of RRMcore 
Understanding how amyloid proteins form polymorphic assemblies is a critical aspect of 
neurodegenerative research. Here, we present evidence that an amyloid-forming segment can 
display two distinct types of packing polymorphism: positional and modal, concepts introduced 
by Caspar and Cohen (54).  Positional polymorphism is defined as the different disposition of 
identical parts within a single assembly.  In contrast, modal polymorphism is defined the 
different dispositions of identical parts in different modes of assembly-the customary usage of 
the term packing polymorphism in amyloid structures.  The structures of RRMcore reported 
here show both Positional Polymorphism and Modal Polymorphism.  Positional Polymorphism, 
for the first time in amyloid structure research, is evident in the 27-β-sheet fibril, where the 
seven β-sheets composed of RRMcore assume several distinctly different structures, as 
discussed above. An additional different RRMcore β-sheet is the straight polymorph of the 
microED structure (Figure 1.5C,D) which qualifies RRMcore also as exhibiting Modal 
Polymorphism.  This remarkable variation in conformation of the β-sheets formed by RRMcore 
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leads to prodigious packing polymorphism, which now includes positional, in additional to 
modal polymorphism. 
Although the entire TDP-43 protein cannot be modeled into the 27- sheet fibril 
determined here by cryoEM, the structure offers an example at the molecular scale of the 
prodigous polymorphism of which amyloid assemblies are capable, and the great range of 
structures that amyloid fibrils can form.  This extreme polymorphism has implications for 
research in neurodegeneration.  Distinct amyloid polymorphs may seed distinct “strains” of 
amyloid, which in a disease context can lead to different clinical conditions.  Each polymorph 
may require its own drug.  Previous work from our lab has shown that fibril inhibition of one 
specific amyloid polymorph can inhibit fibril formation, and in some cases toxicity (38, 55, 56). 
In cases where multiple polymorphs form, inhibiting one structure may not be sufficient to 
inhibit disease formation or progression.  Thus, understanding amyloid polymorphism is likely 
to be important in the process of drug development against amyloid diseases.  We suggest that 
the structures presented in this paper offer insight not only about TDP-43 aggregation, but also 
about the challenges presented by amyloid aggregation in general. 
 
MATERIALS AND METHODS 
Selection and Generation of TDP-43 Peptide Targets 
All targeted peptide segments were chosen based on the Rosetta Energy 3D Profile 
Method, Zipper DB (43).  Following selection of peptide targets ranging in size from 6-11 
residues, all peptides were purchased from Genscript at a purity of 95% or higher. 
Peptide Fibril Formation 
For initial biochemical characterization, all peptide segments were dissolved in 
phosphate buffered saline (PBS) at pH 7.5.  Peptide segments 247DLIIKG252,   247DLIIKGISV255, 
247DLIIKGISVH256, 248LIIKGISVH256, 248LIIKGISVHI257, 250KGISVHISN259, 252GISVHI257 and 
252ISVHISN259 were dissolved) to a final concentration of 20mM.  Peptide segments 248LIIKGI253 
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and 253SVHISN259 were dissolved to a final concentration of 40mM due to their high solubility.  
The last peptide segment, 247DLIIKGISVHI257, was dissolved to a final concentration of 1mM due 
to its low solubility.  All peptides were then incubated at 37°C in a Torrey Pine Scientific shaker 
at level 9 for 1 week.  Samples were examined by TEM following fibril formation. 
Negative Stain Transmission Electron Microscopy (TEM) 
 Negatively stained samples for TEM were prepared by applying 5 L of sample on 
hydrophilic 400 mesh carbon-coated formvar support films mounted on copper grids (Ted 
Pella, Inc.). The fibrils were allowed to adhere for 4 min and washed once with 2% uranyl 
acetate.  The samples were then stained for 2 min with 2% uranyl acetate, leaving a few 
nanoliters of stain on the grid.  Grids were allowed to dry for 5 minutes before storage.  Each 
grid was inspected on a T12 (FEI) microscope. 
Fibril Denaturation Studies 
 Peptide fibrils were generated as described above.  Untreated and treated samples were 
then prepared.  For untreated samples, 6µL of water was added to 54µL of fibril preparation. For 
treated samples, 6µL of 20% SDS solution were added to 54µL of fibril preparation for a final 2% 
SDS concentration.  The treated samples were then quiescently incubated at 70°C for 15 
minutes. Turbidity experiments were subsequently performed as untreated and treated samples 
were aliquoted into black 384-well plates (Nunc, Rochester, NY) covered with optical tape.  
Values were recorded at a wavelength of 340nm in a Spectramax M5 (Molecular Devices, 
Sunnyvale, CA). Experiments were performed in triplicate. Data was normalized against 
untreated fibril samples so the starting value was 1.00.  Error bars represent standard deviation. 
Fibril Diffraction 
 Fibrils prepared in PBS were spun down at 15,000 rpm for 30 minutes in a tabletop 
micro-centrifuge  and washed with water a total of three times. Fibrils of 247DLIIKGISVHI257 
prepared in water did not undergo this step. Concentrated fibrils were diluted in 20µL of water. 
3 µL of fibril sample was applied to the middle of two glass capillaries for alignment and allowed 
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to dry overnight. For data collection, the glass capillaries, with fibril sample, were mounted on 
brass pins.  Diffraction was collected at beamline 24-ID-E of the Advanced Photon Source, 
Argonne National Laboratory, Argonne, IL, USA with a wavelength of 0.9792 Å.  All patterns 
were collected at a distance of 300 mm and analyzed using the Adxv software package (57). 
Crystallization  
 248LIIKGI253 was dissolved in 10mM LiOH to a final concentration of 18.7 mg/mL.  
Crystals were grown by hanging drop vapor diffusion over a reservoir containing 0.1M CHES, 
pH 9.5 and 20% w/v PEG 8000. Each hanging drop contained 1µL of peptide solution mixed 
with 1µL of reservoir solution.  Crystals were mounted in loops and stored in liquid nitrogen 
before data collection. 
 247DLIIKGISVHI257 was dissolved in CHES buffer at pH 8.5 to a final concentration of 
1mM.  Crystals were formed by shaking the peptide at 37°C for 1 week in a Torey Pine Scientific 
Shaker at level 9. 
Xray Data Collection and Structure Determination 
The x-ray diffraction data for segment 248LIIKGI253 was collected at beamline 24-ID-E of 
the Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA. Detector ADSC 
HF -4M was used. Data was collected at a wavelength of 0.9792Å, temperature of 100K, at 5° 
oscillations and 175mm detector distance. Indexing was done using XDS, integration was done 
with DENZO and data sets from two crystals were merged in P1 and scaled with SCALEPACK to 
1.4Å resolution (58). The data was imported using the CCP4 suite (59). Molecular replacement 
was done using Phaser (60). Initial models of different idealized polyalanine β-strands did not 
pack correctly in the cell. The final model used was a sheet composed of two anti-parallel 
strands with the sequence, AIIAGI, based on the structure of VEAVYL. The model was manually 
adjusted over 13 cycles to the correct sequence and rotamer orientation in Coot (52). The atomic 
model was refined by Refmac with a final Rfactor/Rfree of 20.7/22.6 (61). 
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MicroED Data Collection and Structure Determination 
The microED data for segment 247DLIIKGISVHI257 was collected using the same protocol 
as Rodriguez et al. with minor differences detailed below (49, 62, 63). Data was collected at 
HHMI Janelia Research Campus using the Tecnai F20 TEM operating at 200 kV recorded using 
a bottom mount TVIPS F416 CMOS camera. Individual image frames were exposed for 3s per 
image. During each exposure, crystals were continuously rotated within the beam at a rate of 
0.3° per second. Diffraction data was collected on 41 individual crystals, but only 13 were used 
for data processing. Indexing and integration was done using XDS and data sets from 13 crystals 
were merged in P1 and scaled with SCALEPACK to 1.4Å resolution (64). The data was imported 
using the CCP4 suite (59). Molecular replacement was done using Phaser (59). An idealized 11 
residue β-strand model of DLIIKGISVHI was used for molecular replacement. The model was 
further refined in refmac, accounting for twinning operations and adjusting rotamer 
orientations in Coot (52, 61). The twinning operator is –H, K, K-L with a fraction of 0.5. The 
final model had an Rfactor/Rfree of 26.2/30.6 
Cryo electron microscopy (cryoEM) and reconstruction.  
 247DLIIKGISVHI257 peptide was dissolved in water to a final concentration of 1mM.  The 
sample was shaken for 1 week at 37°C in a Torrey Pine shaker on level 9.  The fibril sample was 
subsequently spun down at 15,000 rpm for 30 min.  The supernatant, with contaminant 
monomer, was disposed of and the fibril sample was resuspended in 20µL of water. 
Each aliquot of 2.5 µL of the fibril sample was applied onto a “baked” (65) Quantifoil 1.2/1.3 μm, 
200 mesh grid, blotted for 4 seconds at force 1, then vitrified in liquid ethane at liquid nitrogen 
temperature in a Vitrobot Mark IV (FEI).  CryoEM data were collected in an FEI Titan Krios 
microscope equipped with a Gatan Quantum LS / K2 Summit direct electron camera system 
(operated with a 300kV acceleration voltage and a slit width 20 eV). Data collection was in 
counting mode driven by Leginon automation software package (66). Defocus values were 
controlled with Leginon by applying a single 3.0 μm target defocus. Dose-fractionation movies 
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were recorded at a frame duration of 200 ms and total duration of 10 s. The total dosage was 60 
e/A-2, with each frame 1.2 e/A-2 (6 e/A-2s) [measured on Digital Micrograph (Gatan) software]. 
Frames were aligned as described (67), except that an iterative alignment scheme as previously 
described (68) was implemented after the original alignment method. We used the summary of 
all frames to determine defocus and particle locations, and 3rd to 20th frames for data 
processing. The focal parameters of the data were determined by CTFFIND4 (69). We selectively 
included images within a defocus range of 2.5 – 4 μm. 
D11I fibrils were manually marked in EMAN (70) helixboxer. A total of 1,904 individual 
filaments were selected. These filaments were segmented by 90% overlap scheme into 33,758 
boxes of 288x288 pixels. A series of Relion (71) 2D classifications were done to the dataset for 
the following purposes: 1. all boxes were subjected to a general (tau_fudge = 2) 2D 
classifications to eliminate bad particles, and to separate different morphologies (See Text for 
morphological distributions). We chose the group of fibrils with the most abundant morphology 
(20,138 boxes) for the next run (2. tau_fudge = 4) which was to further eliminate bad particles 
and misclassified particles. The second 2D classification resulted in 18,887 boxes. 3. We used a 
last 2D classification with a very high tau_fudge factor (16) to extend the working resolution to 
beyond 4.8 Å, making it possible to catch the layer line corresponding to the helical arrangement 
of β-strands.  
A total of 18,818 boxes were included in the 3D analyses. We use EMAN based IHRSR72 
to reconstruct the 3D structure of the fibril. The resolution was slightly better than 4 Å, making 
it possible to trace the backbone and register the 11-peptide sequence. We built an atomic model 
for an asymmetric unit (with 9 strands) with Coot (52). We built 18 helically related copies of the 
asymmetric unit to account for the helix. We did a preliminary Fourier space pseudo-
crystallographic model refinement (72). We then carried out another model refinement with the 
phenix.real_space_refine command of the Phenix package (73) using default settings.  
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We further refined the 3D model of the fibril in Relion (with IHRSR implementation (74) by 
Class3D with one class. (Due to the fine feature of the β-strands, Refine3D was unable to 
adequately regulate working resolution to refine with high enough resolution factors.) We tested 
the resolution by even-odd division of the dataset according to movie numbers. The FSC crosses 
0.5 at 3.8 Å and 0.143 at 3.2 Å. The local resolution was also accessed by ResMap (75) to be 3.5 
Å. The side chain features of the map is consistent with a resolution of 3.5-3.6 Å. We further 
refined the atomic model in Phenix with phenix.real_space_refine command with 30 
asymmetric units. 
Analysis of Structural Features 
 All images  displaying the interfaces of the RRM2 structures were created in Pymol (76). 
Area buried and shape complementarity were calculated based on established protocols (77, 78). 
Backbone RMSD values were determined using the LSQ superimpose feature in COOT (52).  
The pseudo-phylogeny tree comparing these RMSD value was generated using the T-REX 
interface (79) at URL: http://www.trex.uqam.ca/. 
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Figure 1.1: Segments from the RRM2 domain of TDP-43 exhibit characteristic 
amyloid properties. (A) Schematic of TDP-43 domains showing the sequence of RRM2 and 
amyloid-promoting segments predicted by ZipperDB (red histogram bars) (43). Four of the top 
ten potential zipper-forming peptide segments lie between residues 247-259, the RRMcore. The 
eleven segments chosen for further characterization are displayed below the ZipperDB 
predictions.  (B) Negative stain EM images of 5mM fibril samples of segments in the 
247DLIIKGISVHISN259 region grown in PBS. Segments range in length from six to eleven 
residues and span the entire 13-residue RRMcore. Fibril morphology differs for many of the 
segments, indicating the potential for polymorphic assembly in this region. (C) Segments from 
the RRM2 exhibit moderate to high stability under heat and SDS denaturation. Fibril samples 
were first grown by shaking at 37°C at 20mM concentration in PBS, pH 7.5. Following fibril 
formation, samples were treated with 2% SDS and heated to 70°C for 15 minutes.  The data are 
normalized with untreated samples at an initial value of 1.  Error bars represent standard 
deviation. 
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Figure 1.2: Atomic structures of 248LIIKGI253 and 247DLIIKGISVHI257, determined 
by diffraction methods, illustrate different steric zipper interfaces (A) Microcrystals 
of 248LIIKGI253 were grown in hanging drop experiments at a pH of 8.5. Crystals were visible by 
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light microscopy. (B) Fibril diffraction of the 248LIIKGI253 sample exhibits reflections consisted 
with the characteristic cross-β pattern with 4.6Å and 11.5Å diffraction rings.  (C) The structure 
of 248LIIKGI253 was determined from x-ray diffraction data taken at the Advanced Photon 
Source. The segment forms an anti-parallel, face=back (Class 7) steric zipper interface (Sawaya 
et al. 2007), viewed here down the fibril axis.  (D) View of 248LIIKGI253, perpendicular to the 
fibril axis, illustrates the anti-parallel stacking of the strands. (E) Nanorystals of the 
247DLIIKGISVHI257 were grown in a shaker at 37°C at a pH of 8.5. Crystals were invisible by light 
microscopy and successfully visualized using an electron microscope. (F) Fibril diffraction of the 
247DLIIKGISVHI257 segment exhibits reflections consistent with the characteristic cross-β 
pattern with 4.7Å and 10.4Å diffraction rings.  (G) The structure of 247DLIIKGISVHI257 was 
determined by micro-electron diffraction at HHMI Janelia Research Campus. The segments 
form a parallel face-to-back Class 2 steric zipper interface viewed here down the fibril axis. (H) 
Orthogonal view of the 247DLIIKGISVHI257 structure illustrates the stacking of β-strands. 
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Figure 1.3: Cryo EM Structure of the 247DLIIKGISVHI257 fibril illustrates a 27-
filament, polymorphic 3-start helix. (A) CryoEM image of the 247DLIIKGISVHI257 fibril 
sample grown in water at 1mM. Sample was frozen in liquid ethane.  Scale bar is 60nm. (B) X-
24 
ray fibril diffraction of the 247DLIIKGISVHI257 sample grown in water exhibits a characteristic 
cross-β pattern with 4.65Å and 10.9Å reflections. (C) The structure of the 247DLIIKGISVHI257 
fibril is described as a 3-start helix with a left-handed twist. The fibril is composed of 27 β-sheets 
running the full length of the fibril, with 9 β-sheets per asymmetric unit, related by three-fold 
symmetry. This model displays the fibril looking down the fibril axis, through the center pore of 
the helical fibril. The three asymmetric units are colored gray, blue and red.  The three fold 
screw axis is represented by the triangle.  (D) The asymmetric unit of this structure is composed 
of nine β-sheets, each exhibiting a left-handed twist moving down the fibril axis. Each sheet is 
labelled by a number 1-9. The β-sheets are classified by their relative conformation; kinked = 
red, straight = blue, curve = green and partial = yellow. Each strand is represented by a unique 
color within its designated family with the first and last amino acid residues indicated by 
number in corresponding color.  Two of the β-sheets, at the center and on the periphery of the 
helix, show density for only the first six residues: 247DLIIKG252. (E) Top view of the density of the 
3-start helix viewed down the fibril axis. (F)  Density of the fibril, viewed perpendicular to the 
fibril axis. 
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Figure 1.4: The three atomic structures reported here display seven unique sheet-
to-sheet interfaces, representing five classes of amyloid steric zippers (9) The buried  
solvent-accessible surface area (Ab) and steric complementarity (Sc) are shown for each 
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interface.  (A) The 248LIIKGI253 structure, determined by x-ray diffraction, is the only example 
from all seven interfaces of an anti-parallel zipper. This Class 7 structure exhibits the highest 
shape complementarity at 0.78. (B) The 247DLIIKGISVHI257 electron diffraction structure 
illustrates a Class 2 steric-zipper interface. This structure exhibits the tightest packing of all 
DLIIKGISSVHI interfaces, with a buried surface area of 350Å2. (C) Two interfaces from the 
247DLIIKGISVHI257 cryoEM structure exhibit Class 3 morphology. These are the first two 
examples of Class 3 zippers determined at atomic resolution. (D) The third interface in the 
247DLIIKGISVHI257 cryoEM structure is a Class 4 steric zipper formed at the periphery of the 3-
start helix. (E) Two interfaces from the 247DLIIKGISVHI257 cryoEM structure exhibit Class 1 
morphology. The kinked interface is one of the most distorted interfaces found to date for 
amyloid steric zippers. The segment β-strand appears to pack against itself as well as against a 
mating sheet. The DLIIKG/DLIIKG interface represents the weakest interface with the smallest 
area buried 97Å2 and the poorest shape complementarity at 0.17. (F) The backbones of all full 
RRMcore strands have been superimposed for residues LIIK to illustrate their differences.  Only 
the 7 sheets formed from full length 247DLIIKGISVHI257 strands of the cryoEM structure are 
assigned numbers. Strand 10 is from the microED structure.  
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Figure 1.5: The conformational flexibility of the 247DLIIKGISVHI257 backbone 
provides insight into amyloid fibril formation and polymorphism (A) Enlargement 
looking down the fibril of two distinct steric-zipper interfaces formed by β-sheets 2, 5 and 6’ (left 
to right). Here the ‘ symbol indicates the corresponding strand on the adjacent asymmetric unit 
(i.e 6’ is strand 6 on the adjacent asymmetric unit moving counterclockwise, or up the fibril 
axis). This arrangement of DLIIKG/DLIIKG and ISVHI/LIIKGIS interfaces is possible because 
the 247DLIIKGISVHI257 segment kinks on itself. The N- and C- termini of the segment are 
marked by the numbers 1 and 11 respectively. (B) View perpendicular to the fibril axis of the 
arrangement of Panel A, showing 6 of the 15,000+ layers of the fibril (C) The structural 
relationships of the eight distinct β-sheet backbones illustrated by a pseudo-phylogenetic tree. 
The two principal branches are kinked and linear sheets. The linear branch forks into two sub-
branches: straight and curve. (D) A view down the fibril axis of one layer of the fibril represented 
by sticks and spheres. The strands are colored by relative conformation: kink = red, straight = 
blue, curve = green and partial = yellow. (E) A model of fibril nucleation in which individual 
sheets form before mating to form a fibril. Each sheet is represented by blue or red. The 
schematic illustrates that the monomer of the amyloid protein is added along the hydrogen 
bonding axis followed by the mating of two distinct sheets. Elongation of the fibril follows the 
mating step. (F) A second model of fibril formation in which one sheet nucleates the second 
sheet. This schematic illustrates how one sheet may form first and then dictates the 
conformation a monomer of the amyloid protein will nucleate the mating sheet. The mating 
sheet continues to grow and the fibril is elongated. (G) A third model of fibril formation in which 
lateral extension of the fibril is shown. The schematic illustrates that an additional, distinct fibril 
interface (red/orange) can form off of a preexisting fibril (red/blue). (H) A fourth model in 
which secondary nucleation is displayed. The schematic illustrates how once the lateral 
extension occurs from model 3, the orange strand can dissociate and form a distinct and 
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independent filament with a new strand, green. Now two independent filaments exist from the 
seed of one fibril. 
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Table 1.1: Statistics of x-ray diffraction data collection and atomic refinement 
Sample LIIKGI 
Data Collection  
Beam Line APS NECAT 24-ID-E 
Detector ADSC HF-4M 
Date 3/6/15 
PDB accession code  
Space group P1 
Unit cell dimensions  
a,b,c (Å) 11.54, 9.59, 21.18  
α,β,γ() 95.63, 98.21, 76.50 
Reflections observed 7208 
Unique reflections 1561 
Wavelength (Å) 0.9792 
Resolution (Å) a 20.91-1.40(1.45-1.40) 
Rsym (%) b 12.7(36.1) 
CC(1/2) 0.979 (0.879) 
I/σ 11.5(5.05) 
Completeness (%) 94.5(94.6) 
        Wilson B value (Å2) 9.57 
Refinement  
Resolution (Å) 20.91 – 1.40 
Resolution (Å) last shell 1.43-1.40 
Reflections in Working Set 1241 
Reflections in Test Set 160 
Rwork(%)/Rfree(%)c 20.7(27.2)/22.6(37.1) 
Protein Molecules in Asymmetric Unit 2 
Number of non-H atoms  
Protein 92 
Non-protein 6 
RMS deviations  
Bond lengths (Å) 0.006 
Bond angles (°) 2.087 
Average B-factor (Å2) 9.95 
Protein atoms 9.55 
Non-protein atoms 16.14 
Ramachandran plot regions d  
Favored 100 
Allowed 0 
Outliers 0 
 
a Highest resolution shell shown in parenthesis. 
b   22 /))((100 ImeanIIxRsym  
where I is the observed intensity of the reflection HKL and the sum is taken over all reflections 
HKL. 
c   obscalcobs FFFxRfactor /100  
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 Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.  Rwork  
refers to the Rfactor for the data utilized in the refinement and Rfree refers to the Rfactor for 5% of 
the reflections randomly chosen that were excluded from the refinement 
dPercentage of residues in Ramachandran plot regions were determined using Molprobity 
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Table 1.2: Statistics of microED data collection and atomic refinement 
Sample DLIIKGISVHI 
Excitation Voltage (kV) 200 
Wavelength (Å) 0.0251 
Total dose per crystal (e/ Å2) 3.4 
Frame rate (frame/s) 0.265 
Rotation rate (°/s) 0.3 
# crystals used 13 
Total angular rotation collected (°) 38.4-77.6* 
Merging Statistics  
Space group P1 
Unit cell dimensions  
a, b, c (A° ) 24.81, 4.73, 15.83 
α, β, γ (°) 80.88, 86.37, 89.78 
Resolution (Å) a 15.60-1.39 (1.43-1.39) 
Rmergeb  20.3 (145.1) 
# of reflections 9353 
Unique reflections 1037 
Completeness 73.4 (62.1) 
Multiplicity 9.0 (6.7) 
I/sigma 3.34 (0.92) 
CC1/2 (Diederichs, 2013) 99.2 (33.3) 
Refinement Statistics  
Reflections in working set 944 
Reflections in test set 92 
Rwork 26.2 (40.9) 
Rfree 30.6 (53.5) 
RMSD bonds (Å) 0.009 
RMSD angles (°) 1.211 
Ramachandran (%)d  
Favored 100 
Allowed 0 
Outliers 0 
PDB ID code  
EMDB ID code  
a Highest resolution shell shown in parenthesis. 
b   22 /))((100 ImeanIIxRsym  
where I is the observed intensity of the reflection HKL and the sum is taken over all reflections 
HKL. 
c   obscalcobs FFFxRfactor /100  
 Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.  Rwork  
refers to the Rfactor for the data utilized in the refinement and Rfree refers to the Rfactor for 5% of 
the reflections randomly chosen that were excluded from the refinement 
dPercentage of residues in Ramachandran plot regions were determined using Molprobity 
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Supplementary Figure 1.1: RRM2 segments demonstrate high to moderate stability 
against treatment with SDS and heat.  Fibril samples were first grown by shaking at 37°C 
at 20mM concentration in PBS, pH 7.5. Following fibril formation, samples were treated with 
2% SDS and heated to 70°C for 15 minutes.  The data shows the raw absorbance values as 
monitored by the Spectramax. 
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Supplementary Figure 1.2: Fibril diffraction of the RRM2 fibril segments shows 
classic amyloid diffraction. Fibril diffraction was collected at the 5um beam at the Advanced 
Photon Source. All nine samples exhibit the classic 4.6-4.8Å ring indicative of the stacking of β-
strands and the 8-12Å ring indicative of mating sheets. 
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Supplementary Figure 1.3:  Negative stain EM image of  247DLIIKGISVHI257 cryo-EM 
sample. 247DLIIKGISVHI257 fibrils were grown by shaking for one week at 1mM in water. Sample 
was stained with 2% uranyl acetate and visualized on the FEI T12 transmission electron 
microscope. Fibril samples illustrate multiple morphologies, including twisted helical 
assemblies. 
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Supplementary Figure 1.4:  Eight unique fibril morphologies are observed in the 
247DLIIKGISVHI257 cryo-EM sample. (A) Illustration of the eight different types of fibrils 
observed by cryo-EM. The eight fibrils demonstrate four different conformations of amyloid 
fibrils: helices, twists, cylinders, and sheets. (B) The relative abundance of the eight unique 
fibrils are displayed as a table. The 3-start helix represents the most abundant species, 
comprising approximately 60% of the sample. 
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Supplementary Figure 1.5:  Classification of images for the 247DLIIKGISVHI257 
cryo-EM sample. (A) Round 1 classification illustrates the polymorphic assemblies observed 
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in the fibril sample. (B and C) Round 2 and 3 class averages focus on fibrils exhibiting the 3-start 
helix morphology. Each panel illustrates a unique face of the fibril as it twists along the EM grid. 
5-7Å features of the structure become apparent during these rounds of class averaging. 
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Supplementary Figure 1.6: 2D Projection of the final 3D model of the 247DLIIKGISVHI257 
cryo-EM fibril structure. The panels illustrate a side view of the fibril, perpendicular to the fibril 
axis. Each panel represents an 8° azimuthal rotation of the fibril.  The hydrogen bonding 
network is visualized by the stacking of β-strands. 
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Supplementary Figure 1.7:The asymmetric unit of the 3-start helix is composed of 
9 strands (A)  The electron density of the asymmetric unit is displayed.  Here, the N-terminus 
is displayed in red and the C-terminus is displayed in blue.  (B,C)  The peptide strands are 
displayed within the electron density.  The β-sheets are classified by their relative conformation; 
kinked = red, straight = blue, curve = green and partial = yellow. Each strand is represented by a 
unique color within its designated family. 
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Supplementary Figure 1.8:  The protofilaments of the 3-start helix fill space, 
exclude water, and bury hydrophobic surfaces.  Here, glycines and apolar residues are 
white, polar residues are green, positively charged residues are blue, and negatively charged 
residues are red.  The three fold screw axis is indicated by the triangle. 
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Supplementary Figure 1.9: The 247DLIIKGISVHI257 kinked backbone illustrates the 
flipping of the backbone orientation. The figure below illustrates the kinking of the 
247DLIIKGISVHI257 backbone allows for the carbonyl of the glycine and isoleucine to both face 
down. The glycine and isoleucine residues have been marked by one letter abbreviations. 
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Supplementary Figure 1.10: Solvation energies of all unique interfaces. (A) One layer 
of the 27 strand fibril is illustrated with 12 strands labelled. The interactions of these strands 
account for all interfaces in the full fibril structure. (B) The solvation energy values in cal/mol 
are included for all 19 distinct interactions that occur in this structure. Not all interactions are 
steric zippers. 
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Supplementary Figure 1.11: Solvation energies for three possible asymmetric units. 
(A-C) The figure displays the solvation energies in cal/mol for the three possible combinations 
of the nine strands in an asymmetric unit. The organization in Panel A resulted in the lowest 
solvation energy, 3,463 cal/mol. 
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Supplementary Figure1.12: Pseudo-two fold symmetry is observed in the 
asymmetric unit (A-B) Strands 1, 2, 5 and 8 form a complex which exhibits two fold 
symmetry with strands 3, 4, 6 and 9.  The oval shape indicates two fold symmetry. 
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Supplementary Table 1.1: Charge and hydropathicity values for the RRM2 
segments.  Total number of charges and net charges are displayed for fibrils prepared in PBS 
at pH 7.5.  GRAVY value represents the average of hydropathy values as calculated with EXPASY 
Protparam. 
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Supplementary Table 1.2: Area buried and shape complementarity values for the 5 
interfaces formed in the cryo-EM, 3-start helix structure.  Area buried is represented 
by Ab and shape complementarity is represented by Sc. 
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Supplementary Table 1.3: RMSD values the 247DLIIKGISVHI257 backbone illustrates 
that all strands are unique. The RMSD values in Å2illustrate that none of the backbones 
overlay perfectly. Strands 1-4 represent the kinked morphologies while strands 5-8 represent the 
linear morphologies. 
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CHAPTER 2 
 
Atomic Structures of segments within the Low Complexity Domain of TDP-43 
Offer Insight into its Dual Functions of Reversible and Pathogenic Aggregation 
 
INTRODUCTION 
Over the last several decades, there has been immense interest in understanding the role 
of low complexity domains (LCDs) in proteins linked to neurodegenerative diseases.  These 
LCDs are regions of proteins that exhibit biased compositions of amino acids and frequently 
exhibit no secondary structure (1-3).  In some cases the LCDs are the result of nucleotide 
expansions that cause duplications of short sequences, as in Huntington’s Disease (4-6). In 
other cases the LCDs are intrinsic to the protein and believed to have a functional role as in the 
RNA binding proteins: TAR DNA binding protein 43 (TDP-43), Fused in sarcoma (FUS) and 
hnRNPA1 (7).  Recent findings have illustrated that the LCDs of these RNA-binding proteins 
play a critical role in a process known as stress granule formation (8-11). 
Stress granules (SGs) are aggregates of RNA and RNA binding proteins that form in the 
cytoplasm when the cell is experiencing some sort of stress, whether it is physical, mechanical or 
chemical (12-14).  This process is often initiated by a halt in translation and puts the cell in a 
hibernating state until the stress can be remedied (15).  These aggregates are reversible, 
meaning that when the stress is relieved, phosphorylation of SG-proteins result in 
disaggregation (10, 16, 17).  The proteins and RNA are then free to perform their normal 
functions in the cell.  Over the last decade, researchers have studied how this process occurs and 
what biophysical properties these aggregates exhibit. Recent findings have demonstrated that 
these SGs exist in a liquid-like state, although their mechanism of assembly and the role of RNA 
are still being investigated (10, 18-20). Studies on FUS and hnRNPA1 have demonstrated that 
the LCDs are sufficient for liquid-liquid phase separation (LLPS) (10, 18).  Other studies 
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involving the stress granule protein, G3BP-1, have shown that the SGs exist in a biphasic state 
with the mRNA packed at the center and the RNA-binding proteins on the periphery (21). 
Because this research is in its infancy, questions remain about the structures of the aggregates 
and the structural aspects of stress granule assembly. 
In addition to studies aimed at determining the structure of stress granule assemblies, 
researchers have focused on the role of SG-associated proteins in neurodegenerative diseases.  
One of the major hallmarks of neurodegenerative diseases, is the deposition of proteinaceous 
fibrils, or amyloids, in cells (22-24).  Different from stress granule assembly, aggregation of 
these proteins into the amyloid state in disease seems a virtually irreversible process (25, 26).  
Variants found in TDP-43, FUS and hnRNPA-1 have all been linked to Amyotrophic Lateral 
Sclerosis, ALS, among other diseases (27). Of these proteins, TDP-43 stands out for four key 
reasons. First, TDP-43 has over 40 variants that are linked to ALS and other neurodegenerative 
diseases (27-29). Second, the majority of the variants that cause disease are localized to the LCD 
(30, 31). Third, the majority of the aggregates found in the cytoplasm of cells of patients are 
cleavage products inclusive of the LCD (32-34).  Finally, TDP-43 is found to aggregate in 97% of 
sporadic cases and 45% of familial case of ALS (35, 36).  This makes TDP-43 an intriguing 
candidate for understanding how the LCD participates in both reversible, stress granule 
assembly and irreversible, pathogenic assembly. 
TAR DNA Binding Protein (TDP-43) is 43kD protein composed of four domains: an N-
terminal domain, two RNA recognition motifs and a C-terminal low complexity domain (LCD) 
(37-39).  This protein is involved in a number of cellular functions including mRNA shuttling, 
transcription, miRNA processing and alternative splicing among others (35, 40-42).  Over the 
past decade, research into TDP-43 has found aggregates of the protein in patients with ALS, 
Alzheimer’s Disease, Parkinson’s Disease, Frontotemporal Lobar Degeneration and 
Huntington’s Disease(43-46).  These aggregates are irreversible, ubiquitinated, hyper-
phosporylated, C-terminal cleavage products ranging in size from 25-35kD (47).  Thus it is 
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hypothesized that the LCD of TDP-43 plays a role in both this irreversible disease aggregation 
and the reversible stress granule aggregation. 
Through structure determination, we can learn which segments of TDP-43 may drive 
aggregation and how familial variants affect this process. Here we use x-ray diffraction and 
micro-electron diffraction (microED) to determine the atomic resolution structures of six 
peptide segments, four in the reference sequence and two variants, from the C-terminus, or 
LCD, of TDP-43.  We show that the LCD is capable of forming typical steric-zipper β-sheet 
structures characteristic of pathogenic aggregation. However, we also show that a key segment, 
312-317, forms a kinked, reversible structure characteristic of proteins in stress granules that is 
perturbed by the familial mutants A315T/E. 
 
RESULTS 
Three segments from the LCD of TDP-43 form steric zippers 
We targeted segments throughout the entire C-terminus because there is not a consensus 
of which region is the amyloidogenic core. The LCD of TDP-43 is an unstructured domain 
composed of approximately 140 amino acid residues.  Researchers have demonstrated that this 
region plays a role in aberrant mislocalization and aggregation of TDP-43 to the cytoplasm in 
mice and neuroblastoma cell lines (48-50).  It was initially suggested that the entire LCD, 
residues 277-414, served as a prion like domain and was the minimum fragment required for 
aggregation (51).  However, additional studies suggested smaller regions within the LCD are 
sufficient for aggregation and neurodegeneration.  In the first study, segment 286-331 was 
identified and shown to form amyloid fibrils and confer neurotoxicity on primary cortical 
neurons (52).  A second study identified residues 311-360, illustrating through NMR and CD 
studies that this segment undergoes a helix to β-sheet transition that initiates aggregation and 
cytoplasmic inclusion (53, 54).  A third study suggested that segment 342-366 is the minimum 
toxic core that transitions from a random coil to a β-sheet (55).  Ultimately, these studies 
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illustrated that there are several regions of the LCD that can be responsible for amyloid-like 
aggregation. 
Previous findings have demonstrated that steric-zipper adhesive segments of amyloid 
fibrils, are composed of segments ranging from 6-11 residues (56, 57).  For this reason we 
decided to target such peptide segments in the C-terminus for structural determination.  
Because the C-terminus of TDP-43 is a prion-like sequence we focused our efforts on regions of 
the LCD that contain glutamine and asparagine residues which are found to be important for 
prion aggregation (58, 59).  We applied  ZipperDB, (URL: 
https://services.mbi.ucla.edu/zipperdb) to identify segments with adhesive energies more than 
22 kcal/mol-per segment (60).  With these criteria, we targeted over ten, 6-11 residue segments 
in the C-terminus and were able to determine the structure of three segments: 300GNNQGSN306, 
370GNNSYS375, and 396GFNGGFG402 (Fig. 1A-D, Table 1).  All three structures form steric zippers 
which are composed of parallel, in-register β-sheets. Segments 300GNNQGSN306 and 
370GNNSYS375 both form Class 1 steric zippers in which the β-sheets are face-to-face with the 
same edges of the sheet oriented up the fibril (Fig. 1B) (57).  Both structures have two distinct 
interfaces, as commonly observed in steric zippers structures.  Segment 300GNNQGSN306 has a 
hydrated interface with a buried surface area of 212Å2 and a dry interface with a buried surface 
area of 184Å2 (Fig. 1B).  The interfaces of segment 370GNNSYS375 are both dry with buried 
surface areas of 253Å2 and 166Å2 (Fig. 1C).  Segment 396GFNGGFG402 forms a Class 4 steric 
zipper with face-to-back β-sheets and up-down orientation (Fig. 1D) (57).  Because the structure 
is face-to-back there is only one unique interface which has a buried surface area of 222Å2. 
In addition to determining the structure of these segments, we also wanted to confirm 
that they exhibit typical amyloid characteristics.  We aggregated the samples by shaking and 
observed as expected that all three segments form fibrils by electron microscopy (Fig. 1F). 
Because amyloid fibrils have been shown to be resistant to treatment with heat and SDS, we also 
subjected the fibrils to a 2% SDS solution at 70°C for 15 minutes (17).  We found that fibrils of 
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370GNNSYS375 and 396GFNGGFG402 were both resistant to this treatment as determined by 
turbidity.  This indicates a strong steric zipper interaction (Fig. 1E).  The biochemical properties 
of these segments, along with the structures that we determined provide the first atomic 
resolution information on segments of the LCD of TDP-43 that may be responsible for 
pathogenic aggregation of the protein. 
Segment 312-317 of the LCD forms a kinked structure that is disrupted by the 
A315T/E familial mutants 
To further explore the role of the LCD in the aggregation of TDP-43, we focused on 
segments that have the potential to contribute to stress granule formation. The McKnight 
laboratory discovered that  glycine residues flanked by aromatic side chains are features of 
hydrogel formation of the LCD of the protein FUS (17).  The hydrogels formed by the LCD of 
FUS were re-solubilized by treatment with SDS and heat, unlike pathogenic amyloid fibrils. 
Deletion of tyrosine residues in the LCD disrupted hydrogel formation.  This led to the 
hypothesis that aromatic residues play a role in phase separation and can be important for the 
LLPS found during stress granule assembly.  For this reason we focused our structural and 
biochemical studies on a segment of the LCD, 312NFGAFS317, that contains a glycine residue and 
two proximal aromatic phenylalanines.  Of additional interest is that two ALS familial variants 
are located in this region: A315T and A315E (52, 61).  Both of these variants have been shown to 
increase redistribution of TDP-43 to the cytoplasm and increase neuronal death as compared to 
the reference sequence (62-65).  We proceeded to biochemically and structurally characterize 
segments 312NFGAFS317, 312NFGTFS317, and 312NFGEFS317. 
For biochemical characterization we first investigated the segments’ ability to form fibrils 
and the stability of those fibrils under denaturing conditions.  All three peptide segments formed 
fibrils when shaken in phosphate-buffered saline (PBS) as observed by electron microscopy (Fig. 
2A).  Next we tested the stability of the fibrils when treated with 2% SDS at 70°C for 15 minutes 
(Fig. 2B).  We found that the reference sequence, 312NFGAFS317, was sensitive to this treatment 
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and that the fibrils dissociated as observed by turbidity.  Because we targeted this sequence due 
to its potential role in LLPS and reversible aggregation, this finding provided initial support for 
our hypothesis that this sequence and aromatics may be important for reversible aggregation of 
TDP-43.  The mutant segment 312NFGTFS317 was also sensitive to the treatment and resulted in 
fibril dissociation, however the 312NFGEFS317 segment was stable under denaturing conditions 
(Fig. 2B).  This shows that the A315E variant changed the native structure and biochemical 
properties of the reference 312NFGAFS317 segment. 
Following biochemical characterization, we determined the structures of all three 
segments, revealing that each sequence forms a distinct structure.  The reference 312NFGAFS317 
segment forms a kinked structure, similar to conformations from the LCDs of FUS and 
hnRNPA1 (Fig. 3B, Table 2) (66).  Phenylalanine-5, the residue at the kink, has Ramachandran 
angles of a left-handed α-helix.  The kink places phenylalanine at position 5 on the same side of 
the sheet as phenylalanine at position 2. In contrast, a canonical β-sheet places the odd 
numbered sidechains on one face and the even numbered sidechains on the opposite face (56).  
In the 312NFGAFS317 structure, residues 2, 4, and 5 are all on the same face.  The subsequent 
packing of mating strands creates two different interfaces.  Here we see that all of the aromatic 
residues pack near each other creating a hydrophobic, aromatic interface.  The other interface is 
held together by the interactions of the asparagine side chains.  This novel kinked structure 
provides us with an atomic-resolution insight into how aromatics can create a stable, but also 
labile fibril.  We have termed structures that adopt similar kinked backbones, LARKS (Low 
complexity, Amyloid-like, Reversible, Kinked Segments). 
Following structural characterization of the 312NFGAFS317 segment, we determined the 
structure of the 312NFGTFS317 variant, which exhibits similar susceptibility to denaturation as 
312NFGAFS317 (Fig. 3C).  The 312NFGTFS317 structure is similar to the 312NFGAFS317 structure in 
having an aromatic, hydrophobic interface, however there are three significant differences 
(Table 2).  First, the 312NFGTFS317 segment is kinked in a different manner.  In 312NFGTFS317 the 
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peptide kinks at the central glycine, residue 3, which has Ramachandran angles of a left-handed 
α-helix similar to the phenylalanine in the 312NFGAFS317 structure.  The phenylalanine 
sidechains are again on the same side of the β-sheet, however this is because residues 2, 3, and 5 
face the same direction. The second difference is the hydration of the 312NFGTFS317 structure.  In 
the 312NFGAFS317 structure there are no water molecules, however, in the 312NFGTFS317 structure 
the non-aromatic, second interface is heavily hydrated (Fig. 3B).  Lastly, the buried surface area 
differs greatly between the structures.  While 312NFGAFS317 and 312NFGTFS317 have an aromatic 
interface with similar buried surface area values (185Å2 and 190Å2 respectively), the buried 
surface area of interface 2 is very different.  Interface 2 in the 312NFGAFS317 structure has an area 
buried of 233 Å2, while the area buried in 312NFGTFS317 interface 2 is 169Å2 (Fig. 3B, C).  The 
different manner in which 312NFGTFS317 kinks creates a less tight interface that is hydrated, 
likely making a fibril that is more labile than the 312NFGAFS317 fibril.  Therefore, the A315T 
variant may induce TDP-43 aggregation through destabilization of the LARKS structure. 
The third such structure we determined was the 312NFGEFS317 segment, which, unlike 
312NFGAFS317 demonstrated high stability against denaturing conditions. The backbone of 
312NFGEFS317 also kinks, however in this case the kink is at the glutamate, residue 4 (Fig. 4D, 
Table 3).  This kink again positions phenylalanines 2 and 5  on the same face of the β-strand. 
However, despite the presence of a kink, the packing of the strands is significantly different than 
in 312NFGAFS317.  Here the aromatic residues of adjacent strands do not pack together.  Instead, 
there is a face-to-back packing that creates one interface with a buried surface area of 243Å2.  
This buried surface area offers some insight into why the 312NFGEFS317 fibril is more stable than 
312NFGAFS317 and 312NFGTFS317 fibrils.  Considering the two interfaces that form, the buried 
surface area of 312NFGAFS317 is 418Å2, while it is 359Å2 for 312NFGTFS317. Because 312NFGEFS317 
is composed of only one unique interface, the buried surface area is a doubling of that value, 
486Å2. This illustrates that the packing of 312NFGEFS317 is significantly tighter than the 
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312NFGAFS317 segment, which may explain its stability against denaturing conditions and offer 
insight into how the A315E variant induces TDP-43 aggregation. 
In summary we find that the 312NFGAFS317 segment of TDP-43 forms a kinked β-sheet 
structure that is amyloid-like, but reversible. We find that the familial variants within this 
segment, A315T and A315E, perturb the reference sequence structure in different ways.  The 
A315T mutant creates a less stable kinked structure, whereas the A315E variant creates a more 
stable, steric-zipper-like structure.  It is important to note that we believe it is likely that there 
are other LARKS throughout the C-terminus that have yet to be identified, as evidenced by the 
fact that 3D Profiling indicates the presence of 14 putative LARKS in TDP-43 (Fig. S1).  Our 
structures offer a starting point for better understanding the regions of TDP-43 responsible for 
reversible amyloid-like aggregation. 
 
DISCUSSION 
The structures determined in this paper suggest how the LCD of TDP-43 can drive 
aggregation of the protein in either of two directions: into intracellular bodies such as stress 
granules and also into pathogenic amyloid fibrils.  In Figure 4 we present three models that 
incorporate our findings to explain how LLPS or stress granule assembly can lead to pathogenic 
assembly.  In Fig. 4A we illustrate how the wildtype protein can form pathogenic amyloid 
assemblies.  The soluble protein begins the process of stress granule assembly, LLPS(states 1 to 
2).  The LARKS of the LCD, such as 312NFGAFS317, can stabilize the stress granule (States 2 to 3).  
Because we have shown that the C-terminus contains denaturing-resistant, steric-zipper 
segments (300GNNQGSN306, 370GNNSYS375, and 396GFNGGFG402), it is then possible for the 
LARKS-mediated liquid to progress to pathogenic amyloid assembly (States 2 to 4 and 3 to 4).  
Our models do not clarify what prevents LARKS and steric zippers from spontaneously 
assembling in other cellular conditions.  However, it is clear that nucleation of either structure is 
stochastic and rare.  Higher concentrations and longer times favor formation of both 
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intracellular bodies such as stress granules and pathogenic aggregation because the elements of 
both LARKS and steric zippers are present in the LCD. 
The models of Figures 4B and C are variations of the first model that illustrate how 
familial variants in the LCD can contribute to pathogenic amyloid formation.  Fig. 4B illustrates 
how the A315T variant destabilizes LARKS assembly and pushes the equilibrium towards 
pathogenic assembly.  The interface of 312NFGTFS317 is smaller than the 312NFGAFS317 interface.  
This weakens the LARKS assembly and suggests that the protein will spend less time in State 3, 
pushing the protein back to State 2 LLPS or into pathogenic amyloid assembly.  Figure 4C 
illustrates how the A315E variant creates a new steric-zipper forming segment which pushes the 
protein into pathogenic amyloid assembly.  Here the 312NFGEFS317 segment no longer forms a 
reversible LARKS, but instead forms a steric zipper.  By creating this new zipper, the mutation 
removes a stable reversible segment and increases the likelihood that an irreversible steric 
zipper will form. 
These structure-based models suggest how LLPS and stress granule assembly may 
contribute to pathogenic amyloid formation.  We have structurally characterized two familial 
variants in this paper, but it is our hypothesis that the other 40+variants found in the TDP-43 
LCD may operate by similar mechanisms: either destabilizing LARKS assemblies or creating 
new steric zipper segments.  We suggest these structural concepts can apply to other RNA 
binding stress granule proteins such as FUS and hnRNPA1. In conclusion, we believe this study 
offers the first atomic-level insight into how the LCD of TDP-43 functions in both reversible 
stress granule and irreversible pathogenic assemblies. 
 
MATERIALS AND METHODS 
Selection and Generation of TDP-43 Peptide Targets 
 Putative steric zipper forming segments were selected based on the presence of 
glutamine and asparagine residues (58, 59). Targets were narrowed down using the 3D Profile 
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Method, ZipperDB, selecting for segments with energies below -22 kcal/mol (67). 312NFGAFS317 
was selected based on the presence of aromatic residues and familial variants located within the 
segment (17). 
Peptide Fibril Formation 
 All peptide segments were dissolved in phosphate buffered saline (PBS) at pH 7.5 to a 
final concentration of 20mM.  Samples were then incubated at 37°C in a Torrey Pine Scientific 
shaker at level 9 for 80 hours.  Samples were examined by TEM following fibril formation. 
Negative Stain Transmission Electron Microscopy (TEM) 
 Samples for TEM were prepared by applying 5 L of sample on hydrophilic 400 mesh 
carbon-coated formvar support films mounted on copper grids (Ted Pella, Inc.). The fibrils were 
allowed to adhere for 4 min and washed twice with water.  The samples were then stained for 2 
min with 2% uranyl acetate, leaving a few nanoliters of stain on the grid.  Grids were allowed to 
dry for 1 minute before storage.  Each grid was inspected on a T12 (FEI) microscope. 
Fibril Denaturation Studies 
 Peptide fibrils were generated as described above.  Untreated and treated samples were 
then prepared.  For untreated samples, 6µL of water was added to 54µL of fibril preparation. For 
treated samples, 6µL of 20% SDS solution were added to 54µL of fibril preparation for a final 2% 
SDS concentration.  The treated samples were then quiescently incubated at 70°C for 15 
minutes. Turbidity experiments were subsequently performed as untreated and treated samples 
were aliquoted into black 384-well plates (Nunc, Rochester, NY) covered with optical tape.  
Values were recorded at a wavelength of 340nm in a Spectramax M5 (Molecular Devices, 
Sunnyvale, CA).  Experiments were performed in triplicate. Data was normalized against 
untreated fibril samples so the starting value was 1.00.  Error bars represent standard deviation. 
Crystallization 
 All crystals, except 312NFGEFS317, were grown by hanging drop vapor diffusion. 
300GNNQGSN306 was dissolved in water to a final concentration of 10 mg/mL.  The reservoir 
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solution was optimized around the initial hit of 0.2M sodium sulfate, 0.1M Bis tris propane pH 
7.5, and 20% (w/v) PEG 3350.  Hanging drops contained a 2:1 solution of protein: reservoir. 
370GNNSYS375 was dissolved in water to a final concentration of 10mg/mL.  Crystals were 
grown over a reservoir solution containing 0.2M sodium nitrate, 0.1M Bis tris propane pH 8.5, 
and 20% (w/v) PEG 3350.  Hanging drops contained a 2:1  solution of protein: reservoir. 
396GFNGGFG402 was dissolved in water to a final concentration of 12 mg/mL.  Crystals 
formed with the reservoir solution: 800 mM Sodium phosphate monobasic/ 1200 mM 
Potassium phosphate dibasic, 100 mM Sodium acetate/ Acetic acid pH 4.5. Hanging drops 
contained a 2:1 solution of protein: reservoir. 
312NFGAFS317 was dissolved in water to a final concentration of 11mg/mL. Crystals 
formed with a reservoir solution of 0.1M phosphate/citrate pH 4.2, 40% w/v ethanol and 5% 
w/v PEG 1,000. The drops contained a 2:1 ratio of protein solution: reservoir. 
312NFGTFS317 was dissolved in water to a final concentration of 11mg/mL.  Crystals 
formed with a reservoir solution of 0.2M ammonium acetate, 0.1M sodium acetate pH 4.6, and 
30% w/v PEG 4,000.  The drops contained a 2:1 ratio of protein solution: reservoir. 
312NFGEFS317 was dissolved in PBS (pH 7.5) to a final concentration of 20mM. The 
peptide solution was shaken at 37°C in a Torrey Pines shaker at level 9 for 80 hours. 
X-ray Diffraction Data Collection and Processing 
All x-ray diffraction data was collected at beamline 24-ID-E of the Advanced Photon 
Source, Argonne National Laboratory, Argonne, IL, USA. Detector ADSC Q315 was used. For 
NFGAFS, data was collected at a wavelength of 0.9791Å, temperature of 100K, at 5° oscillations 
and 130mm detector distance. Indexing and integration was done using XDS in P212121 and 
scaled with SCALEPACK to 1.1Å resolution (68). The data was imported using the CCP4 suite 
(69). Molecular replacement was done using Phaser (70). Initial models of different idealized 
polyalanine β-strands did not yield a structure. The final model used was a kinked strand with 
the sequence NFGAAS, which was based on the truncated structure of NNFGAIL (71). The 
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model was manually adjusted over 3 cycles to the correct sequence and rotamer orientation in 
COOT (72). The atomic model was refined by Phenix with a final Rfactor/Rfree of 13.3/16.0 
(73). 
For NFGTFS, data was collected at a wavelength of 0.9791Å, temperature of 100K, at 5° 
oscillations and 125mm detector distance. Indexing and integration was done using XDS in P21 
and scaled with SCALEPACK to 1.0Å resolution (68). The data was imported using the CCP4 
suite (69). The structure was solved by direct methods using the program SHELX (74). The 
model was manually adjusted over 3 cycles to the correct sequence and rotamer orientation in 
COOT (72). The atomic model was refined by Refmac with a final Rfactor/Rfree of 8.7/9.3 (75). 
For GNNQGSN, data was collected at a wavelength of 0.9791Å, temperature of 100K, at 
5° oscillations and 125mm detector distance. Indexing and integration was done using XDS in 
C2 and scaled with SCALEPACK to 1.8Å resolution (68). The data was imported using the CCP4 
suite (69). Molecular replacement was done using Phaser with an idealized β-strand of the 
sequence GNNAGA (70). The model was manually adjusted over 38 cycles to the correct 7 
residue sequence and rotamer orientation in COOT (72). The atomic model was refined by 
Refmac with a final Rfactor/Rfree of 26.0/26.0 (75). 
For GFNGGFG, data was collected at a wavelength of 0.9791Å, temperature of 100K, at 
5° oscillations and 150mm detector distance. Indexing and integration was done using Denzo in 
P1 and scaled with SCALEPACK to 1.25Å resolution (76). The data was imported using the CCP4 
suite69. Molecular replacement was done using Phaser (70).  Initial models of different idealized 
polyalanine β-strands did not yield a structure. The final model used was two kinked strands 
with the sequence GFAGG, which was based on the truncated structure of SYSGYS (66). The 
model was manually refined using Phenix over 4 cycles to the correct 7 residue sequence and 
rotamer orientation in COOT (72, 73). The atomic model has a final Rfactor/Rfree of 14.4/16.1. 
For GNNSYS, data was collected at a wavelength of 0.9791Å, temperature of 100K, at 3° 
oscillations and 125mm detector distance. Indexing and integration was done using Denzo in 
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P212121 and scaled with SCALEPACK to 1.00Å resolution (76). The data was imported using the 
CCP4 suite (69). Molecular replacement was done using Phaser with an idealized 5 residue 
polyalanine β-strand (70). The model was manually refined using Phenix over 2 cycles to the 
correct 6 residue sequence and rotamer orientation in COOT (72, 73). The atomic model has a 
final Rfactor/Rfree of 15.5/18.1. 
MicroED Data Collection and Processing 
The microED data for segment NFGEFS was collected using the same protocol as 
Rodriguez et al. with minor differences detailed below (77-79). Data was collected at HHMI 
Janelia Research Campus using the Tecnai F20 TEM operating at 200 kV recorded using a 
bottom mount TVIPS F416 CMOS camera. Individual image frames were exposed for 3s per 
image. During each exposure, crystals were continuously rotated within the beam at a rate of 
0.2° per second. Diffraction data was collected on 15 individual crystals, but only 4 were used for 
data processing. 
Indexing and integration was done using XDS and data sets from 4 crystals were merged 
in P21212 and scaled with SCALEPACK to 1.0Å resolution (68). The data was imported using the 
CCP4 suite (69). The structure was solved by direct methods using the program SHELX (74). 
The model was manually adjusted over 4 cycles to the correct sequence and rotamer orientation 
in COOT (72). The atomic model was refined by Refmac with a final Rfactor/Rfree of 23.7/28.6 
(75). 
Structure Analysis 
 All images of crystallographic structures were generated in Pymol.  Area buried and 
shape complementarity values were calculated based on previous literature (80, 81). 
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Figure 2.1:  Segments from the C-terminus form steric zippers and exhibit high 
stability against heat denaturation. (A) The sequence of the LCD C-terminus of TDP-43.  
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The three segments that form steric zippers are highlighted in red, while the LARKS segment, 
312NFGAFS317 is highlighted in blue.  The position of familial variants A315T and A315E are 
indicated in red font. (B) The structure of 300GNNQGSN306 was determined from x-ray 
diffraction data taken at the Advanced Photon Source. The segment forms a parallel, face-to-
face, Class 1 steric zipper interface, viewed here down the fibril axis. (C) The structure of 
370GNNSYS375 was determined from x-ray diffraction data taken at the Advanced Photon Source. 
The segment also forms a parallel, face-to-face, Class 1 steric zipper interface, viewed here down 
the fibril axis.  (D) The structure of 396GFNGGFG402 was determined from x-ray diffraction data 
taken at the Advanced Photon Source. The segment also forms a parallel, face-to-back, Class 4 
steric zipper interface, viewed here down the fibril axis. (E) Segments, 370GNNSYS375 and 
396GFNGGFG402 exhibit high stability under heat and SDS denaturation consistent with their 
steric-zipper structures. Fibril samples were first grown by shaking at 37°C at 20mM 
concentration. Following fibril formation, samples were treated with 2% SDS and heated to 70°C 
for 15 minutes. 
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Figure 2.2: The 312NFGAFS317 segment of TDP-43 forms labile fibrils that are 
stabilized by the familial variant A315E and destabilized by A315T.  (A) Negatively 
stained EM images of 20mM fibril samples of the reference and familial variant sequences.  
Notice that these fibrils resemble fibrils formed by characteristic amyloid proteins.  (B) 
312NFGAFS317 and 312NFGTFS317 dissociate under denaturing conditions, while 312NFGEFS317 
exhibits stability comparable to that of steric zippers.  Fibril samples were first grown by shaking 
at 37°C at 20mM concentration. Following fibril formation, samples were treated with 2% SDS 
and heated to 70°C for 15 minutes. 
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Figure 2.3: The 312NFGAFS317 segments forms a kinked β-sheet that is disrupted by 
familial variants A315T/E (A) The structure of 312NFGAFS317 was determined from x-ray 
diffraction taken at the Advanced Photon Source.  The segment forms a kinked structure which 
places residues 2, 4 and 5 on the same face of the β-sheet.  An aromatic, hydrophobic interface 1 
mediates the interaction of mating sheets.  Here we view the structure down the fibril axis. (B) 
The structure of 312NFGTFS317 was determined from x-ray diffraction taken at the Advanced 
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Photon Source.  The segment also kinks, but at the central glycine, placing residues 2, 3, and 5 
on the same face of the β-sheet.  The structure packs less tightly than 312NFGAFS317 and is 
hydrated.  The structure is displayed looking down the fibril axis. (C) The structure of 
312NFGEFS317 was determined by electron diffraction at Janelia Research Campus.  This segment 
kinks at the glutamate, placing residues 2 and 5 on the same face of the β-sheet.  The mating 
sheets pack face-to-back and do not have the aromatic interface observed in 312NFGAFS317 and 
312NFGTFS317.  The area buried for this structure is the largest of all three structures, all of which 
are viewed down the fibril axis. 
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Figure 2.4: Models illustrating how the LCD of TDP-43 can participate in dynamic 
intracellular bodies such as stress granules through LARKS ( ) and in pathogenic 
amyloid fibrils through steric zippers ( ) (A) By concentration, LLPS of  protein can 
promote pathogenic amyloid aggregation.  The soluble protein begins LLPS (states 1 to 2).  
LARKS can then associate and stabilize the stress granule (states 2 to 3).  High concentration of 
protein favors association of steric zipper-forming segments leading to pathogenic aggregates 
(states 2 to 4 and 3 to 4).  (B) A variant sequence such as A315T can destabilize the LARKS 
association, pushing the aggregate towards irreversible, pathogenic fibril assembly.  Here, 
because state 3 is destabilized, the protein will move back to LLPS (state 2) or pathogenic fibrils 
(state 4).  (C) A familial variant sequence such as A3115E can convert a LARKS into a new steric-
zipper interface.  In this case, the new interface promotes pathogenic aggregation and pulls the 
protein into an irreversible amyloid fibril. 
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Table 2.1: Statistics of x-ray diffraction data collection and atomic refinement for 
300GNNQGSN306, 370GNNSYS375, and 396GFNGGFG402 
 GNNQGSN GFNGGFG GNNSYS 
Data Collection    
Beam Line APS NECAT 24-ID-E APS NECAT 24-ID-E APS NECAT 24-ID-E 
Detector ADSC Q315 ADSC Q315 ADSC Q315 
Date 8/13/2014 6/19/2014 4/18/2015 
PDB accession code    
Space group C2 P1 P212121 
Unit cell 
dimensions 
   
a,b,c (Å) 49.67, 4.77, 14.99 4.81, 16.44, 22.67 4.79, 15.62,40.68 
α,β,γ() 90, 101.66, 90 90.63, 86.37, 91.26 90, 90, 90 
Reflections 
observed 
1,177 7,394 9,975 
Unique reflections 385 1,802 1,837 
Wavelength (Å) 0.9791 0.9791 0.9791 
Resolution (Å) 24.32-1.80 22.53-1.24 20.34-1.00 
Highest Resolution 
Shell (Å) a 
2.08-1.80 1.29-1.25 1.06-1.00 
Rsym (%) b 32.5(57.1) 16.1(40.6) 16.1(50.0) 
CC(1/2) 95.5(86.3) 98.5(69.0) 99.2(66.8) 
I/σ 2.75(1.71) 7.10(1.95) 9.2(2.1) 
Completeness (%) 94.1(97.8) 94.4(95.4) 95.4(70.0) 
        Wilson B value (Å2) 6.22 2.43 2.69 
Refinement    
Resolution (Å) 24.32-1.80 22.53-1.24 20.34-1.00 
Resolution (Å) last 
shell 
1.85-1.80 1.29-1.24 1.04-1.00 
Reflections in 
Working Set 
345 1,614 1,667 
Reflections in Test 
Set 
39 180 169 
Rwork(%)/Rfree(%)c 26.0(36.6)/26.0(61.0) 14.4(26.2)/16.1(39.0) 15.5(28.9)/18.1(28.4) 
Protein Molecules 
in Asymmetric Unit 
1 2 1 
Number of non-H 
atoms 
   
Protein 49 94 45 
Non-protein 2 8 1 
RMS deviations    
Bond lengths (Å) 0.019 0.006 0.005 
Bond angles (°) 1.70 1.04 1.18 
Average B-factor (Å2)    
Protein atoms 15.42 3.3 3.46 
Non-protein atoms 22.59 7.4 15.34 
76 
Ramachandran plot 
regions d 
   
Favored 100 100 100 
Allowed 0 0 0 
Outliers 0 0 0 
 
a Highest resolution shell shown in parenthesis. 
b   22 /))((100 ImeanIIxRsym  
where I is the observed intensity of the reflection HKL and the sum is taken over all reflections 
HKL. 
c   obscalcobs FFFxRfactor /100  
 Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.  Rwork  
refers to the Rfactor for the data utilized in the refinement and Rfree refers to the Rfactor for 5% of 
the reflections randomly chosen that were excluded from the refinement 
dPercentage of residues in Ramachandran plot regions were determined using Molprobity 
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Table 2.2: Statistics of x-ray diffraction data collection and atomic refinement 
312NFGAFS317 and 312NFGTFS317 
 NFGAFS NFGTFS 
Data Collection   
Beam Line APS NECAT 24-ID-E APS NECAT 24-ID-
E 
Detector ADSC Q315 ADSC Q315 
PDB accession code   
Space group P212121 P21 
Unit cell dimensions   
a,b,c (Å) 13.82, 4.85, 46.74  15.33, 4.84, 23.57 
α,β,γ() 90, 90, 90 90.00, 96.91, 90.00 
Reflections observed 12,008  
Unique reflections 1,447  
Wavelength (Å) 0.9791  
Resolution (Å) 13.25-1.10  
Highest Resolution Shell (Å) a 1.14-1.10  
Rsym (%) b 17.2 (72.6)  
CC(1/2) 99.1 (82.3)  
I/σ 9.65 (2.52)  
Completeness (%) 94(75.9) 87.6(39.2) 
        Wilson B value (Å2) 4.55 2.54 
Refinement   
Resolution (Å) 13.25-1.10 13.52-1.00 
Resolution (Å) last shell 1.14-1.10 1.04-1.00 
Reflections in Working Set 1,300 1,635 
Reflections in Test Set 145 183 
Rwork(%)/Rfree(%)c 13.3(21.9)/16.0(18.3)  
Protein Molecules in Asymmetric Unit 1  
Number of non-H atoms   
Protein 50 48 
Non-protein 0 3 
RMS deviations   
Bond lengths (Å) 0.006 0.020 
Bond angles (°) 0.95 1.73 
Average B-factor (Å2)   
Protein atoms 4.55 2.39 
Non-protein atoms 0 14.75 
Ramachandran plot regions d   
Favored 100 100 
Allowed 0 0 
Outliers 0 0 
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a Highest resolution shell shown in parenthesis. 
b   22 /))((100 ImeanIIxRsym  
where I is the observed intensity of the reflection HKL and the sum is taken over all reflections 
HKL. 
c   obscalcobs FFFxRfactor /100  
 Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.  Rwork  
refers to the Rfactor for the data utilized in the refinement and Rfree refers to the Rfactor for 5% of 
the reflections randomly chosen that were excluded from the refinement 
dPercentage of residues in Ramachandran plot regions were determined using Molprobity 
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Table 2.3: Statistics of microED data collection and atomic refinement for 
312NFGEFS317 
Sample NFGEFS 
Excitation Voltage (kV) 200 
Wavelength (Å) 0.0251 
Total dose per crystal (e/ Å2) 3.4 
Frame rate (frame/s) 0.3-0.5 
Rotation rate (°/s) 0.2 
# crystals used 4 
Total angular rotation collected (°) 72 
Merging Statistics  
Space group P21212 
Unit cell dimensions  
a, b, c (A° ) 42.77, 17.42, 4.90 
α, β, γ (°) 90, 90, 90 
Resolution (Å) a 13.54-1.00 
Rmerge  1.03-1.00 
# of reflections 28.3(99.3) 
Unique reflections 18,942 
Completeness 2,004 
Multiplicity 88.7(78.0) 
I/sigma 9.45(4.81) 
CC1/2 (Diederichs, 2013) 4.64(1.07) 
Refinement Statistics 99.2(36.0) 
Reflections in working set  
Reflections in test set 1,851 
Rwork 206 
Rfree 23.7 
RMSD bonds (Å) 28.6 
RMSD angles (°) 0.008 
Ramachandran (%)d 0.69 
Favored  
Allowed 75 
Outliers 25 
PDB ID code 0 
EMDB ID code  
 
a Highest resolution shell shown in parenthesis. 
b   22 /))((100 ImeanIIxRsym  
where I is the observed intensity of the reflection HKL and the sum is taken over all reflections 
HKL. 
c   obscalcobs FFFxRfactor /100  
 Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.  Rwork  
refers to the Rfactor for the data utilized in the refinement and Rfree refers to the Rfactor for 5% of 
the reflections randomly chosen that were excluded from the refinement 
dPercentage of residues in Ramachandran plot regions were determined using Molprobity 
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Supplementary Figure 2.1: 14 putative LARKS are found in the LCD of TDP-43. The 
graph illustrates the number of proteins in the human proteome that contain putative LARKS 
and the respective number of LARKS.  The data were generated by a 3D Profiling algorithm 
developed in our lab that predicts the likelihood of a peptide segment adopting a kinked 
backbone conformation.  TDP-43 is predicted to have 14 LARKS, which is on the high end of 
predictions. 
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CHAPTER 3 
 
Aggregation-triggering segments of SOD1 fibril formation support a common  
pathway for familial and sporadic ALS 
 
INTRODUCTION 
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that 
affects motor neurons, often causing death within two to five years. 90% of ALS cases are 
‘sporadic’ (sALS) and their cause is unknown (1). However, the remaining 10% of ALS cases are 
inherited ‘familial’ ALS (fALS) and approximately 20% of which are linked to mutations in the 
SOD1 gene.  
Mature SOD1 is a 32 kDa homodimeric metalloenzyme, in which each monomer 
contains a copper ion, zinc ion, and one intra-subunit disulfide bond (2) (Fig. 1A). SOD1 is one 
of the most abundant proteins in cells, serving to protect organisms against oxidative damage. 
The loss of protein function does not necessarily lead to disease because SOD1-deficient mice 
develop mild impairments that are not observed in ALS (3). Instead, the mutated SOD1 seems to 
have a toxic gain of function that leads to the pathologies of disease. To date, more than 140 
dominant disease-related mutations that span nearly the whole protein sequence have been 
described (http://alsod.iop.kcl.ac.uk/Als/).  
Several studies suggest sALS and fALS have common mechanisms of pathogenesis 
associated with accumulation of misfolded SOD1 (4). Evidence to support this has shown that 
insoluble protein aggregates found in both fALS (5) and sALS (6) patients were SOD1 
immunoreactive. Scientists have created transgenic mice that express human SOD1 mutations 
found in fALS. The mice exhibit behavioral and cellular symptoms similar to human ALS (7), 
such as accumulation of insoluble aggregates (8). In addition, expression in mice of 
heterozygous  wild-type/mutant SOD1 augments disease symptoms relative to homozygous 
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mutant animals (7), implying that the wild-type protein produced by the allele carrying the 
normal gene enhances the toxicity of the mutant protein in fALS. It was also shown that 
transgenic mice over-expressing wild-type SOD1 show ALS-like symptoms and  large amounts of 
aggregated SOD1 in the spinal cord and brain (9). These findings suggest that investigating the 
mechanism of aggregation of wild-type and mutant SOD1 may further our understanding of the 
molecular origins of both fALS and sALS. 
SOD1-containing pathological inclusions in ALS may be amyloid-like in structure. First, 
neuronal tissue from a mouse model that expresses the H46R/H48Q mutations can be stained 
with Thioflavin S, a fluorescent dye whose properties change in the presence of amyloid-like 
aggregates (10). Second, in vitro, reduction of the disulfide bond and removal of metals from 
SOD1 and its mutants leads to the formation amyloid-like aggregates (11).  Third, in vitro 
formed SOD1 fibrils share common toxic properties with ALS inclusions, such as the ability to 
induce inflammation (12) and activate microglial cells (13). And fourth amyloid fibril formation 
of recombinant SOD1 can be seeded with tissue extracts of SOD1-containing inclusions from 
ALS transgenic mice (14). All these data suggest the pathologic inclusions share similarities with 
in vitro formed amyloid fibrils.  
It is well established that amyloid fibril formation is driven by the exposure of short 
aggregation prone-segments. Here, we pinpoint the aggregation-prone regions of SOD1 in order 
to clarify the molecular origins of ALS. Using a computational (15), we identified four segments 
in SOD1 with high propensities to form fibrils We experimentally observed that proline 
substitutions in two of these segments block fibril formation of full-length protein, emphasizing 
the importance of these segments in amyloid aggregation. Our studies therefore suggest specific 
segments within the SOD1 sequence that drive the aggregation and perhaps initiate pathology of 
ALS. 
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RESULTS 
Aggregation-prone segments in SOD1 
To find which segments induce aggregation of SOD1, we used the 3D-profile method (15) 
(Figure 3.1B). In SOD1, we find four segments of 7 to 9 residues with energies favorable for fibril 
formation: 14VQGIINFE21, 30KVWGSIKGL38, 101DSVISIS107 and 147GVIGIAQ153.  We confirmed 
our predictions by determining that all four segments form fibril-like or needle-like aggregates 
(Figure 3.2). 
Most in-segment disease mutations are compatible with aggregate formation 
Twenty-four mutations associated with fALS (http://alsod.iop.kcl.ac.uk/Als/) are 
located in the four aggregation-prone segments. We found that only two of the twenty-four 
mutations changed fibril formation propensity of the segments from favorable to unfavorable 
(Supplementary Figure 3.1, Supplementary Table 3.1). To validate the computational predictions 
we synthesized fourteen peptides with disease-related mutations. We found that thirteen of the 
fourteen mutant peptides formed aggregates with fibril morphology (Fig. 2). The only peptide, 
G37R, which did not form fibrils was also predicted to have low fibril-formation propensity.  
101DSVISLS107and 147GVIGIAQ153form steric zipper structures 
The crystal structures of the two fibril-forming segments 101DSVISLS107 and 
147GVIGIAQ153 were solved to 1.4 Å and 1.9 Å resolution, respectively. Each segment forms pairs 
of β-sheets that mate together through complementary surfaces (Figures 3.3A and 3.3B). Such 
structures are typical for amyloid-forming segments, and are known as steric zippers (16) 
(Figures 3.3A and 3.3B). 
The structures revealed that the steric zippers formed by 101DSVISLS107 and 
147GVIGIAQ153 differ in arrangement. β-Sheets in the 101DSVISLS107 structure interact through 
their distinct surfaces in the face-to-back packing of class-2 steric zippers (Figure 3.3A). In 
contrast, the 147GVIGIAQ153 steric zipper is formed by identical β-sheet surfaces in face-to-face 
packing of class-1 steric zippers (Figure 3.3B). In the 147GVIGIAQ153 structure, we observed that 
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β-sheets also interact tightly with their opposite sides in back-to-back packing (Supplementary 
Figure 3.2A). The area buried and shape complementarity of the two steric zipper interfaces are 
comparable (Supplementary Table 3.2).  
Segments with fALS mutations also form steric zipper structures 
To determine how mutations found in fALS change the fibril-forming properties of the 
wild-type segment, we studied the structure of 147GVTGIAQ153 (I149T) and 147GIIGIAQ153 
(V148I). X-ray fiber diffraction of 147GIIGIAQ153 (V148I) showed a cross-β diffraction pattern 
common to amyloid fibrils (Supplementary Figure 3.3), but we could not obtain a high 
resolution structure. The structure of 147GVTGIAQ153 (I149T) was solved to 1.3 Å (Figure 3.3C 
and Supplementary Figure 3.2B). The dry interface of 147GVTGIAQ153 (I149T) compared to the 
wild-type segment is additionally stabilized by two hydrogen bonds formed between Thr and 
Gln (Figures 3.3B and 3.3C). In general the 147GVTGIAQ153 (I149T) structure reveals that 
mutations in the steric zipper can change the spatial arrangement of the β-sheet surfaces 
forming the steric zipper without diminishing its apparent strength. 
The 147GVIGIAQ153 segment accelerates fibril formation of apoSOD1WT 
We tested whether any of the isolated peptide segments accelerate nucleation or growth 
of full-length protein fibrils. We hypothesized that if a segment is critical for fibril formation, the 
presence of that short segment should alter the aggregation kinetics of the full-length protein, 
possibly by providing a template for fibril nucleation (17). Of the four segments, only 
147GVIGIAQ153 from the C-terminus accelerated fibril formation of apoSOD1WT in a dose-
dependent manner (Figure 3.4A and Supplementary Figure 3.6A). This acceleration was 
consistently observed, although the required ratio of segment to full-length protein varied with 
the different preparations of SOD1. These results suggest that 147GVIGIAQ153 might initiate fibril 
formation of full-length protein.  
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147GVIGIAQ153 accelerates the fibril formation of apoSOD1G93A 
To test whether the 147GVIGIAQ153 segment can nucleate the fibril formation of SOD1 
mutants associated with fALS, we followed the aggregation of apoSOD1G93A, one of the best 
characterized mutants of SOD1 (18). Indeed, similar to apoSOD1WT, fibril formation of 
apoSOD1G93A was accelerated in the presence of 147GVIGIAQ153 (Figure 3.4B). Likewise, we 
observed variability in the aggregation kinetics and in the quantity of 147GVIGIAQ153 needed to 
nucleate the fibril formation of the apoSOD1G93A mutant from different protein preparations. In 
electron micrographs of samples collected after the ThT fluorescence signal reached a plateau, 
we observed both thick rigid fibril-like aggregates of 147GVIGIAQ153 together with thin flexible 
thin fibrils of apoSOD1G93A (Figure 3.4B) The fibrils of full-length protein tend to cluster with 
needle-like aggregates of 147GVIGIAQ153, further hinting that the full-length aggregation is 
facilitated by the presence of this C-terminal segment. 
 
DISCUSSION 
SOD1 contains four fibril-forming segments 
Aided by a computational algorithm (15), we identified four segments likely involved in 
SOD1 fibril formation. In isolation from the rest of the protein, all these segments formed 
aggregates with fibril morphology. The existence of several aggregation-prone segments in SOD1 
unifies conflicting studies that find different regions from the protein participate in aggregate 
formation (19, 20).   
fALS-linked mutations modulate but do not disrupt aggregation 
There are roughly 140 mutations in SOD1 that are associated with fALS. Of the fourteen 
we tested, thirteen formed aggregates (Figure 3.2). The ability of the segments to form fibrils 
was unaffected by the mutations that changed their charge, size or hydrophobicity. The 
structure of the mutant segment I149T revealed molecular details of the changes in the steric 
zipper organization caused by the mutation. Although, the steric zippers formed by wild-type 
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and mutant segments have different spatial arrangements, their interaction energies are 
comparable as judged by the area buried and shape complementarity of the interfaces 
(Supplementary Table 3.2). Although, many fALS mutations promote aggregation by 
destabilizing the native protein structure, our results suggest that disease-related mutations 
generally do not inhibit fibril formation of the aggregation-prone segment and may even 
enhance it. 
Two C-terminal segments dominate fibril formation 
Full-length protein with I18P and I35P substitutions formed fibrils similar in 
morphology to the wild-type protein (Supplementary Figure 3.5), leading us to conclude that the 
N-terminal segments 14VQGIINFE21 and 30KVWGSIKGL38 do not form the β-sheet spine of the 
SOD1 fibrils. Pro substitution at position I104 suppressed fibril formation of wild-type protein, 
implying that this segment is involved in fibril nucleation and/or growth. We also observed 
change in fibril morphology of the I149P mutant that blocks the aggregation of 147GVIGIAQ153 
compared to wild-type fibrils. This Pro mutant formed rod-shaped aggregates that were less 
than 100nm in length (Figure 3.5), suggesting that the C-terminus of SOD1 takes part in fibril 
elongation and/or forms the β-sheet spine of the SOD1 fibrils. In the samples of both I104P and 
T149P mutants we observed wild-type fibrils, suggesting that blocking the aggregation of the C-
terminal segments may in turn lead to fibril formation through other segments.  The two peptide 
segments, 14VQGIINFE21 and 30KVWGSIKGL38 formed aggregates with fibril morphology 
(Figure 3.2) and high β-sheet content, suggesting they can also participate in aggregation of the 
full-length protein. Thus for fALS cases in which the fibril-forming segment 147GVIGIAQ153 is 
missing due to early translation termination of SOD1 (21), the remaining three aggregation-
prone segments can participate in aggregate formation.  
C-terminal segment 147GVIGIAQ153 seeds aggregation 
Using fibril formation assays, we find that addition of the C-terminal segment 
147GVIGIAQ153 accelerates the aggregation of wild-type protein (Figure 3.4A). In the native state, 
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the 147GVIGIAQ153 segment is buried in the dimer interface and protected from exposure (Figure 
3.1A).  Reduction of the disulfide bond results in enhanced mobility of the disulfide loop and of 
the adjacent 147GVIGIAQ153 segment. This in turn weakens the interactions across the dimer 
interface and destabilizes the β-barrel fold. Indeed, the conditions used in this study favor the 
monomeric state (22), in which the 147GVIGIAQ153 segment is exposed for interaction.  
147GVIGIAQ153 also accelerated the aggregation of the fALS mutant apoSOD1G93A further 
suggesting the importance of this segment in SOD1 aggregation. In addition, the wild-type and 
the mutant protein can template each other’s aggregation implies structural similarities between 
the aggregates. Preformed nuclei of apoSOD1G93A seed the aggregation of wild-type protein 
(Supplementary Figure 3.8A) and vise-versa (Supplementary Figure 3.8B). Based on this, we 
can infer that the aggregation of the wild-type protein influences the aggregation of mutant 
SOD1. Our experiments show that 147GVIGIAQ153 segment accelerates the aggregation of both 
wild-type and mutant protein suggesting that this segment is a common molecular determinant 
of aggregate formation in sALS and fALS.  
Our experiments suggest that fiber formation of SOD1 appears to be initiated by the 
monomer where the segment 147GVIGIAQ153 is unprotected. Although mature SOD1 is a stable 
dimer, newly translated SOD1 is a copper-free monomer with reduced Cys, in which the 
aggregation-prone C-terminus is exposed and flexible. Dimer formation is a part of the SOD1 
maturation process and facilitated by the copper chaperone for SOD1 (CCS). CCS modifies the 
nascent SOD1 by inserting copper and oxidizing its intra-subunit disulfide bond; this leads to 
spontaneous dimer formation (23). Thus any delay in the posttranslational processing of SOD1 
by CCS, such as slow protein folding, sequence mutations, or changes in the cellular 
environment, lead to increased accumulation of unfolded monomeric intermediates (24). 
Indeed, pathogenic SOD1 proteins derived from either cultured cells or the spinal cords of 
transgenic mice tend to be metal-deficient (25) and/or lack the disulfide bond (26). 
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It is possible that various processes, such as abnormally high expression of SOD1 can 
also result in an increased pool of aggregation susceptible monomers. Normally, the cellular 
concentration of SOD1 is 30-fold more abundant than that of CCS (at both the RNA and protein 
levels) (27), so CCS must cycle through the pool of newly translated molecules to activate them. 
Overexpression of wild type SOD1 in mice caused paralysis (9). The excess SOD1 most likely 
overwhelms the endogenous CCS system, and the pool of immature wild-type SOD1 molecules 
aggregate, leading to paralysis which is similar to symptoms in ALS. In short, exposure of the 
aggregation-prone segments in immature SOD1 could be at the root of both sporadic and 
familial ALS.  
A common pathway for fALS and sALS 
Although SOD1-containing aggregates are seen in only a subset of sALS cases, the 
similarities between SOD1-linked fALS and sALS disease suggest that clarification of the 
molecular origins of SOD1 aggregation will be informative about ALS cases as a whole. Our 
hypothesis is that the exposure of one or more fibril-forming segments of SOD1 can lead to 
aggregation of the full-length protein. Here we identified two segments 101DSVISLS107 (located at 
the Greek Key loop) and 147GVIGIAQ153 (located at the C-terminus) that are likely to participate 
in fibril nucleation and growth of SOD1. fALS mutations located within these segments do not 
prevent fibril formation, but do alter the fibril morphology and the steric zipper packing. We 
speculate that in vivo exposure of these segments could occur prior to chaperone-assisted 
maturation of the protein. Overall our data suggest a common molecular origin of fALS and 
sALS: the exposure and the interaction of aggregation-prone segments at the C-terminus of 
SOD1. 
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MATERIALS AND METHODS 
Peptide synthesis 
GVIGIAQ, VQGIINFE, GSIKGL, and DSVISLS were purchased from CS Bio and Celtek 
Bioscience Peptides. GIIGIAQ (V148I) and GVTGIAQ (I149T) were purchased from GenScript.  
The rest of the peptides were synthesized on HMPB-ChemMatrix resin using standard Fmoc 
solid-phase synthesis conditions (28).  200 µmoles of the first amino acid was coupled to 
50µmoles of HMPB-ChemMatrix resin with 200 µmoles coupling reagent 1-(Mesitylene-2-
sulfonyl)-3-nitro-1H-1,2,4-triazole (MSNT) and 100µl of the base N-methyl-imidazole dissolved 
in 3ml of dichloromethane. The reaction was capped and left at room temperature overnight. 
For a coupling step of the rest of the amino acids, 200 µmoles of Fmoc-protected amino acid (4 
eq) and coupling reagent O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate (HBTU, 4 eq) were weighed into 15ml falcon tube. The amino acid was dissolved in 
3.0 ml of 0.1 M 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HOBT) in N-methylmorpholine and 135µl N,N-diisopropylethylamine (DIEA). This mixture 
was vortexed briefly and allowed to react for at least 1 min. The activated amino acid solution 
was then added to the fritted/washed polypropylene tube containing the resin. The reaction was 
heated to 70°C in the Pierce Reacti-Therm heat block for 15min with stirring. After the coupling 
reaction, the resin was washed three times with dimethyl formamide (DMF). For Fmoc 
deprotection, 3 ml of 20% piperidine in DMF was added to the resin. The mixture was heated to 
70°C in the Pierce Reacti-Therm heat block for 5 min with stirring. After the deprotection 
reaction, the resin was washed three times with DMF. The cycles of coupling and deprotection 
were alternately repeated to give the desired full-length peptide. After the final deprotection, the 
resin was washed three times in DMF followed by three times in dichloromethane and left to dry 
overnight. Acid-labile side-chain protecting groups were globally removed and peptides were 
cleaved from the resin by adding 50 µL triisopropylsilane and 50 µL water followed by adding of 
4ml trifluoroacetic acid (TFA). The reaction was stirred for three hours.  After three hours, the 
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TFA mixture containing the newly synthesized peptides was dripped into a 50ml tube, and the 
TFA was evaporated overnight in the fume hood. 
Peptide purification 
After the synthesis the crude peptides were dissolved in 20% to 30% acetonitrile.   
Peptides were purified on a preparative C18 column (10µm, 250x20mm, Higgins Analytical) 
using Reverse Phase HPLC with 9ml/min flow rate. Solvent A was 0.1% TFA dissolved in water. 
Solvent B was 0.1% TFA dissolved in acetonitrile. The gradient used for peptide purification was 
0% to 50% solvent B over 50 minutes. The purity of the synthesized peptides was assessed by 
C18 analytical column (5µm 250x4.6mm Higgins Analytical) at a flow rate of 1 mL/min and 
gradient 10-60% B solvent over 50 minutes. Masses of the newly synthesized peptides were 
verified by MALDI-TOF-MS.  
Peptide fibril formation 
VQGIINFE, DSVISLS and their corresponding mutants were dissolved in water to a final 
concentration of 2mM. GVIGIAQ and its corresponding mutants except for RVIGIAQ (G147R) 
and GVTGIAQ (I149T) were dissolved in water to a final concentration of 1mM. GVTGIAQ 
(I149T) formed fibril-like aggregates only at 6mM concentration in water. RVIGIAQ (G147R) 
formed fibrils when dissolved to 1mM in 25mM K phosphate pH 7.0 and 1mM EDTA. Due to the 
high peptide solubility, KVWGSIKGL and its mutants were dissolved with 0.1M Tris base (pH 
was not adjusted) to 60 mM. Peptide segments were incubated at 37°C with shaking level 9 in a 
Torrey Pine Scientific shaker. After 7 to 10 days the samples were examined by TEM. 
Crystallization 
GVIGIAQ was crystallized using the hanging drop vapor diffusion method: 1 μL of 0.3 
mg/mL GVIGIAQ was mixed with 1 μL of reservoir solution. The reservoir solution comprised 1 
mL of 1 M sodium acetate pH 4.5 and 1.75 M ammonium sulfate. GVTGIAQ (I149T) was 
crystallized using the hanging drop vapor diffusion method: 1µl of 6mg/ml peptide dissolved in 
water was mixed with 2 µl of reservoir solution. The drop was equilibrated over 1 ml of reservoir 
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solution containing 0.1 M sodium acetate pH 4.5 and 0.7 M hexanediol. DSVISLS was 
crystallized using the hanging drop vapor diffusion method: after filtering with a 0.2µm filter, 
1µL of 3 mg/mL peptide was mixed with 1 µL of reservoir solution, comprising 0.1 M MES pH 
6.0, 20% PEG 6000, and 5 mM ZnCl2. Peptide crystals were mounted directly onto the ends of 
pulled glass capillaries. 
X-ray diffraction and data processing 
X-ray diffraction data were collected at beamline 24-ID-E of the Advanced Photon 
Source, Argonne National Laboratory, Argonne, IL, USA with a wavelength of 0.8954 Å and at 
beamline ID13 at the European Synchrotron Radiation Facility in Grenoble, France with a 
wavelength of 1.0332 Å. Data were collected at 100 K with 5° oscillations. 
Indexing of diffraction images was performed using the programs DENZO (29) or XDS 
(30) Scaling of data was performed using the program SCALEPACK (29). The merged scaled 
data were imported into CCP4 format with programs from the CCP4 program suite organized 
under the “CCP4i” interface (31). Molecular replacement solutions were found using the 
program Phaser (32). In the case of GVIGIAQ the search models consisted of geometrically 
idealized β-strands with side chain conformations modeled as the most frequently observed 
rotamers defined in the graphics program COOT (33). The solution of the GVTGIAQ (I149T) was 
found by Phaser (32) using the structure of GVIGIAQ as a search model. A molecular 
replacement solution for DSVISLS was determined using an extended beta strand of sequence 
DSVISAS after expanding dataset with SFTOOLS in the CCP4 suite (31) from P21 to P1. 
Crystallographic refinements were performed with the programs Refmac (34), Buster, and 
Phenix (35). Model building was performed with COOT (33) and illustrated with PyMOL (36). 
Area buried and shape complementarity were calculated with AREAIMOL (37) and SC (38), 
respectively. 
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X-ray powder diffraction of GIIGIAQ (V148I) 
Aggregates of GIIGIAQ (V148I) grown in 0.1 M sodium phosphate pH 2.5 were pelleted 
by spinning the sample for 5 minutes at 20,000 x g. The pellet was scooped with a crystallization 
loop. Data was collected for 5 minutes with 1° oscillations using an in-house Rigaku RAXIS-4++ 
image plate detector (Rigaku-FRD).  
Protein expression, purification and metal removal 
Human SOD1WT and SOD1G93A were expressed in the EGy118 strain of Saccharomyces 
cerevisiae (S. cerevisiae) which lacks the endogenous yeast sod1 gene. The proteins were purified 
and metals were removed as previously described in (39), except that, in the last step, 25 mM 
potassium phosphate,  pH 7.0, 1 mM EDTA were used as dialysis buffer. After metal removal, 
apoSOD1WT.and apoSOD1G93A were immediately frozen and stored in -80°C. The protein was 
used within two weeks of freezing. In Figure 3.5, Supplementary Figure 3.6, Supplementary 
Figure 3.7 and Supplementary Figure 3.8 are shown assays done with SOD1 purified from S. 
cerevisiae.  
We also used human SOD1 with C6A and C111S substitutions (AS-SOD1) purified from 
Escherichia coli (E. coli). AS-SOD1 has similar properties to the wild-type protein (40), but lacks 
the two surface exposed Cys, which can cross link to form larger oligomers (41). The plasmid 
with AS-SOD1 gene was given by Becky Chan (Prof. Valentine lab). Pro mutations at positions 
I18P, I35P, I104P and I149P in the AS-SOD1 gene were made using QuickChange Site-Directed 
mutagenesis Kit (Stratagene).  
Proteins (wild-type and mutants) were expressed in the E. coli strain BL21(DE3) in the 
following way. Cells transformed with pET 22b vector containing AS-SOD1 gene, were grown in 
LB media containing 100µg/ml ampicillin at 37°C with shaking. Cells were induced at OD600 
~0.6 with 1 mM IPTG. ZnSO4 was added to a final concentration of 0.05mM to aid protein 
folding. Then, cells were grown at 32°C. After 4 hours, the cells were harvested by centrifugation 
for 10-15 min at 4600xg. 
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To release the protein from the periplasm, the cell pellet was resuspended in ice-cold 30 
mM Tris-HCl pH 8, 20% sucrose (20-30ml for 1L growth media). Then, cells were stirred slowly 
at 4°C for 20 min. The cell slurry was spun at 10,000 × g at 4°C for 10 min and the supernatant 
was discarded. The cell pellet was resuspended in ice-cold water (20-30 ml for 1L growth media) 
and stirred slowly at 4°C for 20 min. During this step, the periplasmic proteins together with the 
expressed protein were released into the buffer. The cell suspension was centrifuged at 10,000xg 
for 10min. Ammonium sulfate was added to the supernatant which contained the expressed 
protein released by the double osmotic shock (0.326g ammonium sulfate per ml supernatant) 
and stirred at 4°C for 45min. This solution was centrifuged at 14,000xg for 30min. Then, the 
supernatant which contained the expressed protein was mounted on a HiTrap Phenyl HP 5ml 
column (GE Healthcare). Solvent A was 2.5 M ammonium sulfate, 0.15 M sodium chloride, 0.05 
M sodium phosphate, pH 7.0. Solvent B was 0.15 M sodium chloride, 0.05 M sodium phosphate, 
pH 7.0. Proteins were eluted by running 100ml gradients from 0% to 100% at 5ml/min. Finally 
the protein was loaded on size-exclusion silica G3000 column (Tosoh Bioscience). The column 
buffer was made of 0.1M sodium sulfate, 25mM sodium phosphate 1mM sodium azide pH 6.5.  
To remove metals from AS-SOD1 and its mutants we followed the protocol described in (12), 
except that, in the last step, 25 mM potassium phosphate,  pH 7.0, 1 mM EDTA were used as 
dialysis buffer. Fibril formation assays were done immediately after the metal removal.  
Fluorescence assays 
Concentrated protein was thawed on ice and filtered through a 0.2µm filter prior to the 
fibril formation assay. Fibril formation assays were performed with 17 µM apoSOD1WT and 
apoSOD1G93A in 25 mM potassium phosphate buffer, pH 7.0, 1 mM EDTA, 35 mM Tris(2-
carboxyethyl)phosphine (TCEP) and 10 µM ThioflavinT. Under the conditions used, the SOD1 
dimer is dissociated, so the molar concentrations of wild-type apoSOD1WT and apoSOD1G93A 
were calculated using the molecular weight of the monomer. Stock solutions of 0.4 mM 
GVIGIAQ were made by dissolving the lyophilized peptide in 10mM potassium phosphate pH 
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7.0, 1mM EDTA. Stock solutions of 0.8mM VQGIINFE, GSIKGL, and DSVISLS were made by 
dissolving the lyophilized peptide in 10mM potassium phosphate pH 7.0, 1mM EDTA. Peptides 
were added in the molar ratios indicated in Figure 3.5A and B and Supplementary Figure 3.6 
and 3.7. Aggregation assays of apoAS-SOD and its Pro mutants were performed with 35 µM 
protein in 25mM sodium citrate pH 3.5, 1mM EDTA, 30 mM TCEP and 10 µM ThioflavinT.  
Seeding experiments were done using previously formed fibrils (prepared with 25µM 
protein; see above). 50µl of the pre-formed fibrils were pipetted in a glass NMR tubes and 
sonicated in a water bath for 15minutes. After sonication the fibrils were diluted twice and 2µl 
were added for every 100µl reaction volume to make 2% seed solutions (v/v). 
All assays were performed in black Nunc 96-well optical bottom plates (Thermo 
Scientific). Teflon balls (1/8 inch in diameter) were distributed into each well of the 96-well 
plate. Then, 150-200 μL of solution (four replicates per sample) were pipetted into each. The 
plate was agitated at 300 rpm with a 3-mm rotation diameter in a Varioskan microplate reader 
(Thermo) at 37 °C. Fluorescence measurements were recorded every 10-15 min by using λex = 
444 nm, λem = 482 nm, with an integration time of 200 μs. Description of data normalization 
and plotting can be found in the Supporting Information.  
Normalization of the fluorescence data 
For simplicity, in Figure 3.5 the mean values of ThT fluorescence are displayed. The 
individual values, which were used to calculate the mean signal shown in Figure 3.5, were re-
plotted in Supplementary Figure 6. Similarly, Supplementary Figures 3.7 and 3.8 were made by 
plotting the individual sample replicates. In all figures, the ThT fluorescence signal was 
corrected for the background by subtracting the mean fluorescence signal acquired during the 
first one to two hours of the assay. The fluorescence was also normalized by dividing each 
measurement by the mean signal collected for two to four hours during which the fluorescent 
reading had the largest value. If one of the sample replicates had fluorescence reading close to 
the background, its fluorescence was normalized by dividing it by the mean fluorescence reading 
100 
of the remaining replicates. The data was smoothed by substituting each data point with the 
average value calculated using four data points collected prior and after the point and the point 
itself. This is equivalent to central moving average with sliding nine data points wide window. 
The normalized fluorescence signal of the peptides (14VQGIINFE21, 33GSIKGL38, 101DSVISLS107 
and 147GVIGIAQ153) incubated without the protein was calculated using the averaged 
fluorescence signal of maximum fluorescence acquired over two to three hours from the assays 
done with the largest peptide to protein ratios. 
Transmission Electron Microscopy 
Negatively stained specimens for transmission electron microscopy (TEM) were 
prepared by applying 5 µL of sample on hydrophilic 400 mesh carbon-coated formvar support 
films mounted on copper grids (Ted Pella, Inc.). The samples were allowed to adhere for 3 min, 
rinsed twice with distilled water and stained for 1 min with 1% uranyl acetate. Grids were 
examined on either a JEM1200-EX (JEOL) or T12 (FEI) microscope 
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Figure 3.1: The four SOD1 segments predicted to form fibrils form aggregates with 
fibril morphology.  (A) Ribbon diagram of SOD1 dimer (PDB code: 2C9U) which shows zinc 
(green) and copper (blue) atoms coordinated in the metal binding loop. The intra-subunit 
disulfide bond between Cys57 and Cys146 is shown in gold. The four SOD1 segments predicted 
to form fibrils are shown in red. (B) Diagram of the 3D-profile Rosetta energies (y-axis) 
calculated for each six-residue segment from the SOD1 sequence (x-axis). Segments predicted to 
form fibrils are highlighted in red.  
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Figure 3.2: Mutations associated with fALS preserve the fibril-forming 
propensities of 13VQGIINFE21, 101DSVISLS107 and 147GVIGIAQ153. All predicted segments 
formed fibrils. In addition, thirteen of the fourteen mutated segments that we tested formed 
aggregates with fibril morphology, confirming the robustness of our predictions. Scale bar is 
100nm. 
103 
 
Figure 3.3: Steric zipper structures of (A) 101DSVISLS107, (B) 147GVIGIAQ153 and (C) 
147GVTGIAQ153 (I149T) segments.  Off-axis (right) and down the fibril axis (left) views of the 
dry steric zipper interface of 101DSVISLS107, 147GVIGIAQ153 and147GVIGIAQ153. The dry steric 
zipper of the 147GVTGIAQ153 (I149T) (C) compared to the wild-type (B) is stabilized by two 
hydrogen bonds (dashed lines) formed between the mutated Thr149 and Gln153, showing that 
this mutation is compatible with the steric zipper. The side chains carbon atoms and Cα atoms 
of odd numbered residues are colored burgundy to distinguish the two faces of the sheets. This 
was done to illustrate the face-to-back steric zipper packing of 101DSVISLS107 (A) and the face-
to-face packing of 147GVIGIAQ153 (B) and 147GVTGIAQ153 (I149T) (C). 
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Fig. 3.4: Two C-terminal segment 147GVIGIAQ153 nucleates the fibril formation of 
full-length SOD1. (A) Using a ThT fluorescence assay, we observed that full-length SOD1 co-
incubated with 147GVIGIAQ153 forms fibrils more rapidly than the full-length protein alone. 
Adding 15 molar excess of 147GVIGIAQ153 shortened the lag time of aggregate formation nearly 
50%. To the right are TEM images of the samples taken after the ThT fluorescence signal 
reached a plateau. Above is a micrograph of apoSOD1WT fibrils. The lower micrograph of 
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apoSOD1WT co-incubated with the peptide same shows that wild-type apoSOD1 fibrils (white 
arrows) co-localize with 147GVIGIAQ153 needle-like aggregates (black arrows). (B) 147GVIGIAQ153 
seeded the aggregation of mutant apoSOD1G93A. Twenty times molar excess of 147GVIGIAQ153 
shortened the lag phase of apoSOD1WT aggregation by about one third. ApoSOD1G93A co-
incubated with a 20 molar excess of 147GVIGIAQ153 (bottom right) formed a mixture of full-
length protein fibrils (white arrow) and 147GVIGIAQ153 needle-like aggregates (black arrows). 
Each point in the ThT fluorescence assays is an average of four replicates. 
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Figure 3.5: Pro substitutions in 101DSVISLS107 and 147GVIGIAQ153 inhibited 
aggregation of full-length protein. ApoAS-SOD1I104P formed amorphous aggregates (left), 
with occasional fibers like those of the wild-type protein (middle). Short rods were observed in 
apoAS-SOD1I149P sample (right) together with some wild-type looking fibrils. 
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Supplementary Figure 3.1: Mutations associated with fALS preserve the fibril-
forming propensities with the exception of G37R in 30KVWGSIKGL38 and I104F in 
101DSVISLS107. The Rosetta energies of wild-type segments are shown in blue and the energies 
of segments with fALS mutations are in red.  Nearly all mutant segments are predicted to form 
fibrils with energies below the threshold value of -23 kcal/mol (dashed line). 
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Supplementary Figure 3.2: Wet interfaces of the steric zippers formed of 
147GVIGIAQ153 and 147GVTGIAQ153 (I149T).  (A) Val148 of the wild-type segment is 
intercalated between residues Gly150 and Val151 of the mating β-sheet. The interaction between 
the two β-sheets is mediated by hydrogen bonds between Gly150 from the mating sheet 
interfaces and two water molecules. (B) In contrast, Val148 of I149T is shifted by about 2Å to 
face Gly150 of the mating β-sheet and there are no water molecules between the β-sheets. 
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Supplementary Figure 3.3: The V148I mutation in the 147GVIGIAQ153 segment does 
not perturb the propensity of the mutant peptide to form fibril-like aggregates. The 
fiber x-ray diffraction pattern of 147GIIGIAQ153 (V148I) rod-like aggregates grown at pH 2.5 
displays a cross-β diffraction pattern typical of amyloid fibrils, with a meridional reflection at 
4.7Å and an equatorial reflection at 8.0 Å. 
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Supplementary Figure 3.4: Single Pro mutation is sufficient to inhibit the 
aggregation of SOD1 fibril forming peptides. All SOD1 segments with high propensity to 
form fibrils formed fibril-like aggregates (left panels). Peptides with Pro substitutions in the 
middle of the same segments formed amorphous looking aggregates which lacked the 
morphology typical for the amyloid-like fibrils (right panels). Based on this data, we inferred 
that Pro mutations can block the fibril formation of each SOD1 fibril forming segment in the 
context of the full-length protein. 
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Supplementary Figure 3.5: apoSOD1I18P and apoSOD1 I35P formed aggregates with 
morphology similar to apoSOD1WT. TEM was used to assess whether segments 
14VQGIINFE21 and 30KVWGSIKGL38 are important for fibril formation of the full-length protein. 
Proteins with I18P and I35P substitution that block the aggregation of segments 14VQGIINFE21 
and 30KVWGSIKGL38, formed fibrils similar in  morphology with wild-type protein. Based on 
this, we can conclude that in the conditions tested, 14VQGIINFE21 and 30KVWGSIKGL38 are 
auxiliary rather than the building segments of the fibril core.   
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Supplementary Figure 3.6: The C-terminal segment 147GVIGIAQ153 accelerates the 
fibril formation of full-length apoSOD1. The individual fluorescent curves representing 
each of the four sample replicates, which were used to calculate the average fluorescence shown 
in Fig. 5, are plotted. The C-terminus peptide 147GVIGIAQ153 accelerates the fibril formation of 
both apoSOD1WT (A) and apoSOD1G93A (B).  
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Supplementary Figure 3.7: 14VQGIINFE21, 33GSIKGL38 and 101DSVISLS107 do not 
nucleate apoSOD1WT fibril formation.  (A) 14VQGIINFE21 does not alter apoSOD1 fibril 
formation when added 30 times, 15 times, 2 times more or 2 times less than the full-length 
protein. Similarly, segments 33GSIKGL38 (B) and 101DSVISLS107 (C) do not change the fibril 
formation of the full-length protein. The other segments show no effect on protein aggregation 
(Fig. S7) but it is possible that under different experimental conditions these other segments can 
become accessible for self-association. Each sample was done in triplicates and is represented by 
curves that are same in color. 
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Supplementary Figure 3.8: apoSOD1WT and apoSOD1 G93A can cross-seed their fiber 
formation. (A) The fibril formation of apoSOD1WT is seeded as efficiently with apoSOD1 G93A 
nuclei as with tseeds formed with the wild-type protein. (B) The reverse it also true. The fibril 
formation apoSOD1G93A can be cross seeded with apoSOD1WT nuclei. (C) apoSOD1WT and 
apoSOD1 G93A showed similar rates of aggregation.  
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Peptide name Mutatio
n 
Rosetta Energy 
[kcal/mole] 
Cluster: VQGIINFE 
        VQGIIN 
           QGIINF 
              GIINFE 
Wild-
type 
-24.4: average 
-24.2 
-24.9 
-24.0 
Cluster: GQGIINFE 
        GQGIIN    
           QGIINF 
              GIINFE 
V14G -24.4: average 
-24.4 
-24.9 
-24.0 
 Cluster: MQGIINFE 
        MQGIIN 
           QGIINF 
              GIINFE 
V14M -24.3: average 
-24.0 
-24.9 
-24.0 
 Cluster: VQSIINFE  
        VQSIIN 
           QSIINF 
             SIINFE 
G16S 
 
-25.6: average 
-27.0 
-25.5 
-24.2 
Cluster: VQAIINFE 
        VQAIIN 
           QAIINF 
              AIINFE 
G16A 
 
-25.4: average 
-25.9 
-25.4 
-24.8 
Cluster: VQGIISFE 
        VQGIIS 
           QGIISF 
              GIISFE 
N19S -24.8: average 
-25.3 
-24.4 
-24.8 
Cluster: VQGIINCE 
        VQGIIN 
           QGIINC 
              GIINCE 
F20C -24.6: average 
-24.2 
-24.6 
-24.4 
 Cluster: VQGIINFG  
        VQGIIN  
          QGIINF    
             GIINFG 
E21G -24.5: average 
-24.2 
-24.8 
-24.6 
Cluster: VQGIINFK  
        VQGIIN  
           QGIINF  
              GIINFK 
E21K -24.5:average 
-24.2 
-24.8 
-24.5 
Cluster: KVWGSIKGL 
         KVWGSI 
            VWGSIK 
                  WGSIKG 
                      GSIKGL 
Wild-
type 
-22.9: average 
-24.0 
-21.7 
-20.8 
-25.0 
Segment: KVWGSIKRL 
         KVWGSI 
            VWGSIK 
              WGSIKR 
G37R -20.9: average 
-24.0 
-21.7 
-17.4 
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                  GSIKRL -20.4 
Cluster: DSVISLS 
        DSVISL 
          SVISLS 
Wild 
type 
-25.5 average 
-25.3 
-25.9 
Cluster: GSVISLS       
        GSVISL 
           SVISLS 
D101G -26.5 average 
-27.1 
-25.9 
Cluster: YSVISLS       
        YSVISL 
           SVISLS 
D101Y -25.4 average 
-24.8 
-25.9 
Cluster: HSVISLS       
        HSVISL 
           SVISLS 
D101H -25.6 average 
-25.4 
-25.9 
Cluster: NSVISLS 
         NSVISL 
            SVISLS 
D101N -25.7: average 
-25.5 
-25.9 
Cluster: DSVFSLS 
        DSVFSL 
          SVFSLS 
I104F -22.2: average 
-20.5 
-23.9 
Cluster: DSVILLS 
        DSVILL 
          SVILLS          
S105L -25.2: average 
-23.9 
-26.4 
Cluster: DSVISVS 
        DSVISV 
          SVISVS 
L106V -27.1: average 
-26.4 
-27.8 
Cluster: GVIGIAQ 
        GVIGIA 
          VIGIAQ 
Wild 
type 
-26.1: average 
-27.1 
-25.1 
Cluster: RVIGIAQ  
       RVIGIA 
         VIGIAQ 
G147R -23.4: average 
-21.6 
-25.1 
Cluster: DVIGIAQ  
       DVIGIA 
         VIGIAQ 
G147D -24.7: average 
-24.2 
-25.1 
Cluster: SVIGIAQ  
       SVIGIA 
         VIGIAQ 
G147S 
 
-26.0: average 
-26.9 
-25.1 
Cluster: GGIGIAQ 
        GGIGIA 
         GIGIAQ 
V148G  -24.4: average 
-25.1 
-23.7 
Cluster: GIIGIAQ 
       GIIGIA 
         IIGIAQ 
V148I -25.8: average 
-27.1 
-24.4 
Cluster: GVTGIAQ 
        GVTGIA 
         VTGIAQ 
I149T  -24.5: average 
-24.7 
-24.3 
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Cluster: GVIGTAQ 
        GVIGTA 
         VIGTAQ 
I151T -24.5: average 
-25.5 
-23.5 
Cluster: GVIGIVQ 
        GVIGIV 
         VIGIVQ 
A152V -26.7: average 
-27.8 
-25.5 
 
Supplementary Table 3.1: The effect of fALS-associated mutations on the fibril 
formation propensity of the SOD1 segments predicted to form fibrils: To compare 
the fibril formation propensity between segments longer than six residues, we calculated the 
average Rosetta energy for each cluster (15). The mutated residues are shown in bold and 
underlined. The segments with Rosetta energies larger than the threshold (-23 kcal/mol) are 
shown in italic. 30KVWGSIKGL38, had averaged Rosetta energy slightly larger than the threshold 
energy. This Rosetta energy can be explained with the presence of two six residue segments with 
unfavorable fibril formation energies. We studied this segment because two six residue 
segments that are part of 30KVWGSIKGL38 are predicted to form fibrils.  
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Supplementary Table 3.2: Comparison of the steric zippers formed by 
101DSVISLS107, 147GVIGIAQ153, and fALS mutant 147GVTGIAQ153 (I149T). 
 
Segment 
Sequence 
 
Shape 
complementarity 
of dry interface 
Area 
buried  
Å2 dry 
interface 
Sheet-
to-sheet 
Distance 
dry 
interface 
Å 
Shape 
complementarity 
of wet interface  
Area 
buried 
Å2 wet 
interface 
Sheet-
to-sheet 
Distance 
Wet 
interface 
Å 
GVIGIAQ 0.81 419 11.4 0.74 462 6.7 
GVTGIAQ 0.94 549 9.8 0.85 540 6.7 
DSVISLS 0.77 430 9.5 0.77 430 9.5 
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Supplementary Table 3.3: Statistics for data collection, processing and refinement 
of 147GVIGIAQ153, 147GVTGIAQ153 (I149T) and 101DSVISLS107. 
 
Data Collection  GVIGIAQ GVTGIAQ DSVISLS 
Space Group C2 C2 P21 
Resolution (Å) 1.9 1.3 1.4  
Unit Cell Dimensions 
 a (Å) 50.13 47.79 4.795   
 b (Å) 4.84 4.79 45.51 
 c (Å) 18.14 17.69 11.15  
β () 99.5 109.4 100.4 
Measured Reflections 1001 4551 2644   
Unique Reflections 415 1053 717 
Overall Redundancy 2.4 4.3 3.7 
Last Shell Redundancy 2.4 2.4 1.4 
Overall Completeness (%) 95.2 95.7 73.6 
Last Shell Completeness (%) 89.2 81.6 28.4 
Overall Rsym 14.4 12.8 18.6 
Last Shell Rsym 20.6 26.8 16.6 
Overall I/(I) 6.3 7.3 6.1 
Last shell I/(I) 4.8 3.6 3.7 
Refinement 
Rwork  23.2 20.18 18.7 
Rfree  24.8 23.32 22.8 
r.m.s.d. bond length (Å) 0.010 0.004 0.006 
r.m.s.d. bond angle () 1.32 1.064 0.92 
Number of protein atoms 46 45 50 
Number of solvent atoms 3 4 4 
Average B factor of protein atoms 16.32 6.01 19.07 
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CHAPTER 4 
 
Atomic structure of a toxic, oligomeric segment of SOD1 linked to Amyotrophic 
Lateral Sclerosis (ALS) 
 
INTRODUCTION 
Since Alzheimer’s pioneering report in 1906, fibrillar protein deposits have been linked 
to neurodegenerative diseases. More recently, this link has been challenged by findings that 
transient, soluble oligomers formed by these proteins are cytotoxic (1-3). Whereas atomic- 
resolution structures of the spines of amyloid fibrils have shown tightly packed β-sheets with 
interdigitated side chains(4-9), atomic-level details of toxic oligomers remain elusive. Various 
reports suggest that toxic intermediates formed by amyloid-forming proteins consist of 
antiparallel β-sheet rich structures (10-15). These reports utilized chemical cross-linking, 
analytical size exclusion, electron microscopy and FTIR, but no atomic structure of toxic 
amyloid oligomers has been reported. 
ALS is a debilitating disease, destroying spinal motor neurons and often leading to death 
within a few years of symptom onset. More than 170 different mutations in SOD1, a metal-
binding, homodimeric protein of 153 residues, are found in familial cases of ALS (16). SOD1 
aggregation has also been implicated in sporadic ALS pathogenesis (17,18). Most of these SOD1 
mutants show little change in enzymatic function suggesting that toxicity derives not from a loss 
of native function, but from a gain of toxic function (19-21). Transgenic mouse models of the 
familial mutants show motor neuron degeneration and stain positive for SOD1-containing 
inclusions, suggesting that protein aggregation is a mode of toxicity (22-24). Enrichment of 
oligomers has also been observed in cell culture  (25, 26) and in transgenic mice (27, 28). 
However, a causal relationship between the appearance of aggregates and neuronal death has 
not been conclusively supported, and no atomic structure has been described for toxic oligomers 
124 
of SOD1 or any other neurodegenerative-disease-related protein. Here we propose a structure 
for toxic oligomers formed by SOD1. 
 
RESULTS 
Crystal structure of SOD1 residues 28-38 reveals an antiparallel β-sheet oligomer 
 Based on mutational studies of others  (29-32) and our own (see below), we focused on 
residues 28-38 of SOD1 (with sequence PVKVWGSIKGL) as having the potential to form a toxic 
amyloid oligomer (Supplementary Figures 4.1 and 4.2). To determine the structure of this 
segment we needed to increase its solubility. We achieved this by engineering a single residue 
replacement:  proline to lysine at the N-terminal position 28. Rod-like crystals, 5 μm in the 
shortest dimension appeared overnight and upon further optimization yielded diffraction to 2.0 
Å resolution. We determined the phases by single isomorphous replacement with anomalous 
scattering (SIRAS) from crystals soaked in potassium iodide (Supplementary Table 4.1).  
The crystal structure shows a twisted β-sheet built of antiparallel, out-of-register β-
strands. Describing its shape, we term it the corkscrew (Figure 4.1A). Each b-strand in the sheet 
contains eight residues, from Lys28 to Ile35. The three C-terminal residues, Lys36, Gly37, and 
Leu38, adopt a β-hairpin conformation, positioning the C-terminal carboxylate to hydrogen-
bond with the N-terminal residue of an adjacent strand. The twist of the sheet is left-handed, as 
is commonly observed for β-sheets. The sheet undergoes a full turn every 16 strands, with a 
helical pitch of 71 Å corresponding to the unit cell “c” dimension. Unit cell repeats extend the 
corkscrew throughout the length of the crystal. Examination of Lys28 reveals that the P28K 
substitution made to facilitate crystallization affects only crystal lattice contacts (Supplementary 
Figure 4.4), and suggests that the native sequence would adopt the corkscrew structure seen 
here. Indeed, SOD1 residues 28-38 assembled preferentially into a corkscrew in our MD 
simulations (Figure 4.1F and Supplementary Figure 4.5B).  
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The corkscrew architecture differs markedly from amyloid fibrils. Sheets from adjacent 
corkscrews do not mate together tightly as sheets do in amyloid fibrils, but instead touch lightly 
through sparse contacts involving polar and charged side chains lining the exterior of the 
corkscrew (Lys28, Lys30, Ser34, and Lys36), Trp32 and water-mediated contacts. Hence, unlike 
amyloid fibrils, the corkscrew has no dry interface between sheets to stabilize its assembly. 
Instead, the corkscrew assembly is stabilized by weaker hydrophobic forces arising from the 
concave interior filled with aliphatic side chains of Val29, Val31, Ile35, and Leu38 (Figure 4.1A 
and Supplementary Figure 4.3).  
The absence of a stable amyloid-like dry sheet-sheet interface suggests that 
fragmentation of the corkscrew could be relatively facile and its subsets of various sizes could fit 
the definition of soluble oligomers. Indeed, ion mobility mass spectrometry experiments 
confirm that this SOD1 segment 28-38 forms low molecular weight oligomers in solution similar 
in cross-section to the crystal structure of the corkscrew (Supplementary Figure 4.6), supporting 
our hypothesis that the corkscrew represents the structure of a soluble oligomer. Furthermore, 
the β-sheet rich nature of the corkscrew is a property shared in common with other amyloid-
related oligomers such as α-synuclein, amyloid-β and HET-s (11-13, 33). In fact, several amyloid 
oligomers have been reported to share antiparallel, out-of-register β-strand architecture (13, 34, 
35).  
The corkscrew shares several structural features with another soluble oligomer, 
cylindrin, from the non-pathogenic amyloid-forming protein, aB-crystallin(36). Both oligomers 
are composed of antiparallel β-strands, shifted out-of-register by two residues. Both sheets are 
highly curved and have an antifacial geometry, meaning opposite faces of the sheet display 
different sets of side chains, not related by symmetry (37).  In both oligomers, individual strands 
hydrogen-bond to neighboring strands through alternating weak and strong interfaces 
(Supplementary Figure 4.5A). The strong interface of the corkscrew is composed of 9 inter-chain 
hydrogen bonds and the weak interface is composed of 7 hydrogen bonds - 1 intra-main chain 
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and 6 inter-main chain hydrogen bonds. The β-strands in both oligomers have similar values of 
buried surface area (984 Å2 vs 943 Å2) and shape complementarity (0.79 vs 0.74) 
(Supplementary Table 4.2). The primary difference between the two architectures is that 
cylindrin is a closed barrel of defined stoichiometry (6 strands) whereas the corkscrew, though 
highly curved, is not entirely closed and is likely to exist in a range of oligomeric sizes.   
Before proposing a role for corkscrew in ALS, it is important to show that the corkscrew 
can accommodate full-length SOD1 without steric conflict. We modeled the remainder of SOD1 
around the corkscrew scaffold keeping the tertiary structure of SOD1 intact everywhere except 
near the corkscrew (Figure 4.1B). In our model, strands 2, and 3 detach from the native fold, 
exposing the corkscrew-forming residues 28-38 residing in strand 3. This local unfolding may 
be triggered by dissociation of the SOD1 dimer and metal depletion. Biochemical studies have 
noted that metal-depleted monomer is prevalent in patient tissues (38-40) as well as in mouse 
models (28, 41) and is an intermediate in the conversion of native holo-SOD1 to pathological 
aggregates. While this model is speculative, it agrees with H/D exchange, molecular dynamics 
(MD) and mass spectrometry studies by others showing that most familial SOD1 mutants have 
minimal change in their secondary structure and contain a partially unfolded β-barrel at 
physiological temperature with local unfolding in β-strand 3 (30, 42).  
To probe the role of the corkscrew in SOD1-associated cytotoxicity we took advantage of 
the sensitivity of the corkscrew structure to mutations at Gly33. The absence of a bulky side 
chain at position 33 appears essential to form the concave inner surface of the corkscrew (Figure 
4.1C). Mutation of Gly33 to a larger residue, such as tryptophan (Figure 4.1D) or valine would 
introduce severe steric clashes with Val29 and Val31, destabilizing the corkscrew structure. 
Consistent with this observation, our all-atom MD simulations revealed that the corkscrew was 
less stable for W33 than for G33, regardless of whether the N-terminus was native proline or 
lysine (Figure 4.1E and Supplementary Figure 4.4C). Thus, we set out to infer the role of the 
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corkscrew in cytotoxicity by ascertaining whether G33 mutants (presumably deficient in forming 
corkscrews) alleviated toxicity of SOD1 familial mutants.  
Segment (28-38) is necessary and sufficient for toxicity 
We asked if the segment is cytotoxic and if the corkscrew structure underlies its toxicity. 
To examine cytotoxicity, we used embryonic stem-cell-derived motor neurons expressing green 
fluorescent protein to facilitate visualization of neuron morphology(43). The corkscrew-forming 
segment was aggregated and applied to motor neurons and cellular viability was measured upon 
overnight treatment. We found that viability as measured by MTT (3-(4,5-Dimethylthiazol-2-
yl)-2,5-Diphenyltetrazolium Bromide) reduction assay was reduced by 60% compared to buffer-
treated cells at physiological concentrations of 8-100 μM in a dose-dependent manner (Figure 
4.2A). In contrast, the segment harboring a single point replacement of G33W, which disrupts 
corkscrew formation did not induce any toxicity in cells at any concentration tested (Figure 
4.2B). We also tested replacement of Gly33 with a less bulky residue, valine and found that it 
was also sufficient to alleviate toxicity of the segment (Figure 4.2B). The segment harboring the 
native proline residue is also cytotoxic, and mutation at Gly33 to tryptophan or valine renders 
the peptide segment non-toxic (Supplementary Figure 4.7).  
To further validate our hypothesis that the corkscrew structure is essential for SOD1-
mediated toxicity in ALS, we introduced corkscrew-disrupting mutations at G33 in two familial 
mutants of full-length SOD1 – A4V and G93A (44) and tested for alleviation of toxicity. Proteins 
were recombinantly expressed, purified and aggregated by demetallation and agitation at 37°C 
for 12 hours, which produced a mixture of fibrils and oligomers. Motor neurons were treated 
with aggregated proteins overnight and cellular viability was measured thereafter. A4V and 
G93A mutants were toxic to the cells at 8 μM, which looked drastically degenerated compared to 
buffer-treated cells (Figure 4.2C). In contrast, A4V/G33V, A4V/G33W, G93A/G33V and 
G93A/G33W proteins were non-toxic at the same concentration, and cellular morphologies 
were indistinguishable from those of the buffer-treated cells. We also quantified the cellular 
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viability, confirming that A4V and G93A were toxic to cells (Figure 4.2D) and that the 
introduction of the corkscrew disrupting substitutions at Gly33 alleviates their toxic effects. 
Together, these data suggest that the segment 28-38 is both necessary and sufficient for motor 
neuron toxicity. 
Toxicity of full-length SOD1 derives from soluble oligomers 
We asked if toxicity of full-length SOD1 derives from soluble oligomers or insoluble 
fibrils.  We tested the cytotoxic effects of the non-fibril-forming mutant (I104P) (26). Even 
though it did not form any mature fibrils (Figure 4.3A), it was toxic to motor neurons, and 
addition of the corkscrew-disrupting substitution, G33W, alleviated the cytotoxicity (Figures 
4.3B and 4.3C). These results suggest that fibril formation is not essential for cytotoxicity. 
To identify which species of SOD1 aggregate is toxic, we monitored the toxicity of various 
SOD1 mutants as their aggregates evolved over time. We found that both familial mutants (A4V 
and G93A) were toxic to cultured neurons when aggregated for 12-16 hours but extended 
aggregation for 72 hours rendered the protein non-toxic (Figures 4.3D and 4.3E). A4V/G33W 
and G93A/G33W were non-toxic irrespective of the duration of aggregation. Negative stain 
electron microscopy showed abundant fibrils in the samples aggregated for 72 hours (Figure 
4.3F) and immunoblotting with the conformational oligomer-specific antibody (A11) suggested 
samples aggregated for 72 hours contained no oligomers (Figure 4.3G). These results suggest 
that toxicity of aggregated SOD1 mutants derives from oligomers. 
Several reports suggest that wt-SOD1 (WT) aggregates in sporadic ALS (45-47) 
analogous to mutant SOD1 aggregates in familial ALS; however, it is not clear if WT and mutant 
SOD1 aggregate by the same mechanism or have the same toxicity. We developed assays to 
answer these questions in the absence of established cellular and animal models that 
recapitulate WT toxicity. To monitor the kinetics of fibril formation in these experiments, we 
used Thioflavin T, a dye that fluoresces upon binding to fibrils. The fibril-forming behavior of 
WT, G93A, and G33W constructs were similar, displaying a lag time of 2-4 hours, presumably a 
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period in which small-oligomers form, followed by a short log phase and then a plateau 
indicative of mature-fibrils (Supplementary Figure 4.8). We then performed the motor neuron 
cytotoxicity assay with protein aggregates from several time points. We found that WT or G93A 
protein samples that were allowed to aggregate for up to 12 hours were toxic to the motor 
neurons, whereas the same protein preparations that were aggregated for 16 hours or more 
exhibited no toxicity (Supplementary Figures 4.8A and 4.8B). Electron microscopy showed no 
mature fibrils in samples aggregated up to 12 hours (Supplementary Figure 4.8D). In contrast, 
samples shaken for 16 hours or longer exhibited large fibril loads and were non-toxic to motor 
neurons. G33W, which cannot form the corkscrew, was non-toxic regardless of the extent of 
fibril formation (Supplementary Figure 4.8C). Thus, WT and mutant SOD1 share similar 
mechanisms of cytotoxicity that depend on exposure and self-assembly of residues 28-38; this 
exposure may be enhanced by structural perturbations induced by familial mutations.  
Corkscrew disruption alleviates defects in a Danio rerio (zebrafish) ALS model: 
To determine whether corkscrew-disrupting mutations alleviate axonopathies caused by 
familial SOD1 mutants in vivo, we conducted experiments using a zebrafish model of ALS (48-
51) . We expressed A4V SOD1 with and without the corkscrew-disrupting substitution at Gly33 
in a zebrafish TDL6 line in which the primary motor neurons are labeled with GFP and the 
mitochondria are labeled with dsRed (52). We analyzed the axons at 2 days post fertilization 
(dpf). A4V caused 8% reduction in axon length (Figures 4.4A and 4.4B) as has been previously 
shown 50, but A4V/G33V-injected fish were significantly better (Figures 4.4A and 4.4B). 
Additionally, we observed 30% of A4V-injected fish were severely deformed and could not be 
imaged suggesting that an acute phenotype is lethal (Supplementary Figure 4.9C). In contrast 
the WT and double mutant expressing fish did not display large mortality. We observed a 
similar phenotype upon expression of G93A – G93A-expressing zebrafish have 5% reduction in 
axon lengths while G93A/G33V expressing zebrafish were significantly better (Figures 4.4C and 
4.4D).  
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Defects in mitochondrial assembly and trafficking along with vacuolation (53, 54) and 
abnormal clustering in neuronal processes (55-58) are established pathological phenotypes 
observed in transgenic mice, patient-derived cells and other models. However, they have not 
been reported in any zebrafish model of ALS thus far. Therefore, we analyzed the mitochondrial 
morphology upon expression of SOD1 familial mutants. Expression of A4V mutant protein 
caused remarkable mitochondrial pathology characterized by abnormal diffused clustering at 
the branch points indicative of defective mitochondria (Figure 4.4E) whereas A4V/G33V-
expressing fish had a mitochondrial network similar to WT fish. These defects were quantified 
by measuring the size and fluorescence intensity of the mitochondria confirming that A4V-
expressing fish displayed enlarged mitochondria (Figure 4.4F and Supplementary Figure 4.9), 
which were fewer in number (Figure 4.4G and Supplementary Figure 4.9). We also observed 
similar defects in the G93A-expressing zebrafish (Figures 4.4H and 4.4I and Supplementary 
Figure 4.9). Thus, disrupting the corkscrew segment alleviates ALS-linked axonopathies and 
mitochondrial defects in this in vivo model. 
 
DISCUSSION 
Our experiments suggest that segment 28-38 of SOD1 is important for SOD1-mediated 
toxicity. The crystal structure of this segment revealed an oligomer composed of antiparallel, 
out-of-register β-strands, which assemble into a corkscrew-like structure. G33V and G33W 
point mutants that were designed to disrupt the observed oligomer alleviated toxicity of both the 
isolated peptide and full-length SOD1, which contained toxic familial mutants. In a zebrafish 
model of ALS, G33V prevented axonopathies and mitochondrial defects, two characteristic 
features of ALS-linked pathology. Taken together, these results suggest that the corkscrew 
structure is critical for SOD1-mediated cytotoxicity. 
The corkscrew structure explains its oligomeric state and suggests the identity of its 
potential interacting partners in the cell. The corkscrew is composed of a single twisted sheet 
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rather than pairs of tightly mated sheets, as observed in 88 steric zipper structures published 
thus far. The lack of a tight sheet-sheet interface suggests the corkscrew is labile to 
fragmentation into small, soluble oligomers of varying size, rather than fibers. A clue about the 
identity of the corkscrew’s interacting partners in the cell is offered by examining the functions 
of its structural homologs. A search for corkscrew homologs in the Protein Data Bank using the 
DALI server (59) yielded matches with other highly twisted β-sheet proteins such as membrane 
receptor proteins, enzymes and bactericidal-permeability increasing (BPI) protein (Fig. S10). 
The twisted sheet seen in the crystal structure of BPI has been shown to bind lipids and 
destabilize membranes(60). It is conceivable that the cleft seen in the corkscrew structure is 
important for cytotoxicity potentially as a binding site for lipids. 
Our results demonstrate that toxicity derives from the corkscrew oligomers rather than 
fibrils (Supplementary Figure 4.11). Previously, we have shown that out-of-register oligomers 
are likely off-pathway from in-register fibril formation due to the large energetic cost of 
rearrangement of out-of-register oligomers into in-register fibrils(61). Although we cannot 
ascertain whether the fibrils observed in our experiments are in-register, our results are 
consistent with this hypothesis. The corkscrew-disrupting mutations of G33V/G33W attenuate 
cytotoxicity but do not attenuate fibril formation. Cytotoxicity assays of the non-fibril forming 
mutant (I104P) and the time course assays with the familial mutants, A4V and G93A suggest 
that toxicity is a property of soluble oligomers and not of large insoluble fibrils. These findings 
for SOD1 align with the hypotheses proposed by others for amyloid-β and huntingtin that large 
insoluble aggregates are relatively inert deposits (62-65). 
From a molecular perspective, it would be unlikely to find ALS-linked mutations in the 
28-38 segment of SOD1 given its structural importance for mediating toxicity. Indeed compared 
to other regions of SOD1, this segment contains few familial mutations, and no mutations are 
found in the core of this segment spanning residues 32-36(29). Notably familial mutants 
including G37R and the rare mutants V29A and V31A are found near the ends of this segment. 
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From our crystal structure, we infer that all these mutations are compatible with the corkscrew 
structure, although it is unclear if they actively promote oligomer assembly. 
In summary, we have identified an 11-residue segment in ALS-associated SOD1 that is 
necessary for its cytotoxicity. Our data support the hypothesis that SOD1 forms toxic oligomers 
composed of antiparallel, out-of-register β-sheet structures involving residues 28-38. This 
cytotoxic segment may be a target for developing structure-based ALS therapeutics. 
 
MATERIALS AND METHODS 
SOD1(28-38) structure determination  
Crystals of SOD1(28-38) with P28K substitution were grown by hanging drop vapor 
diffusion using VDX plates (Hampton Research, Aliso, Viejo, CA). Lyophilized peptide at 98% 
purity (Genscript Inc.) was dissolved to 50 mg/ml in 50 mM Tris-base buffer. The reservoir 
solution contained 0.2 M sodium citrate pH 5 and 13% PEG 6000. Crystallization drops were 
prepared by mixing peptide with reservoir in a 2:1 ratio, in a total volume of 2 μL. Thick needle-
like crystals appeared overnight and harvested after 2-3 days growth at ambient temperature. 
For isomorphous replacement, the crystals were soaked for 30 seconds in a solution composed 
of approximately 60% KI stock solution (prepared by dissolving solid KI to 0.5 M in reservoir), 
30% reservoir solution, and 10% glycerol stock for cryoprotection. The crystals were 
subsequently flash frozen in liquid nitrogen. Single crystals were mounted with CrystalCap HT 
Cryoloops (Hampton Research, Aliso Viejo, CA). All data were collected at the Advanced Photon 
Source (Chicago, IL) on beamline 24-ID-E, which has a 5 μm microfocus beam suitable for the 
crystals. All data were processed using DENZO and SCALEPACK or XDS (66). SIRAS phasing 
produced an interpretable map and the structure was built using COOT(67). Model refinement 
was performed using REFMAC (68) and BUSTER(69). Figures were generated using PyMol(70). 
Unless stated otherwise, SOD1(28-38) refers to KVKVWGSIKGL. 
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Molecular Dynamics simulations 
We performed all-atom MD simulations of SOD1 and αB crystallin on Anton(71, 72), a 
special-purpose computer designed to accelerate standard molecular dynamics simulations by 
orders of magnitude. Protein, water, and ions were represented explicitly, using the AMBER 
99SB*-ILDN (73-75) force field and the TIP3P water model(76).  Simulations of the SOD1 
corkscrew were initiated from the crystal structure comprised of an eight-stranded corkscrew 
with either a wild-type (KVKVWGSIKGL and PVKVWGSIKGL) or G33W mutant 
(KVKVWWSIKGL and PVKVWWSIKGL) monomer sequence.  Initial structures were placed in a 
cubic box 76 Å on each side and solvated with approximately 13,000 water molecules and 
150 mM NaCl. The systems were minimized and then equilibrated in the NPT ensemble at 1 bar 
and 300 K for 50 ns with 5 kcal mol−1 Å−2 harmonic position restraints applied to all non-
hydrogen atoms of the protein; these restraints were tapered off linearly over 50 ns.  Production 
runs were initiated from the final snapshot of the equilibration run and performed in the NVT 
ensemble using a 2.5 fs time step.  Non-bonded interactions were truncated at 12 Å. The wild-
type (KVKVWGSIKGL and PVKVWGSIKGL) and G33W mutant (KVKVWWSIKGL and 
PVKVWWSIKGL) corkscrew simulations were run for 16.4 µs, 13.8 µs, 16.6 µs and 15.2 µs, 
respectively. RMSDs in Figure 4.1E and Supplementary Figure 4.4C were calculated on the 
hydrophobic core of the corkscrew (Cα atoms of residues 3 to 9, excluding the chains at the end). 
SOD1 oligomer assembly simulations were initiated from three monomers of a tandem 
repeat structure (KVKVWGSIKGL--GG--KVKVWGSIKGL) built in homology to a monomer of 
the tandem repeat structure of αB crystallin cylindrin (PDB ID 3SGR (36)). These monomers 
were separated in space by at least 30 Å, placed in a box 62 Å on each side, and solvated with 
approximately 7,600 water molecules and 150 mM NaCl.  System preparation and simulations 
then proceeded as described above for the SOD1 corkscrew simulations.  Each monomer was 
weakly restrained such that its Cα root-mean-square deviation (RMSD) was within 
approximately 2 Å of the starting structure. In particular, a flat-bottom harmonic restraint, U, 
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was applied to each monomer such that 𝑈(𝑅) =
1
2
𝑘(𝑅 − 𝑅0)
2 for 𝑅 > 𝑅0, and 𝑈(𝑅) = 0 
otherwise.  Here, 𝑅 is the RMSD from the initial structure, 𝑅0 = 2 Å, and 𝑘 = 50 kcal mol-1 Å−2.  
The flat-bottom RMSD restraints limit the monomers’ sampling of very collapsed structures and 
structures that have significantly reduced β-sheet content, and allow simulations to focus on 
discovering possible amyloid-like oligomers.  We ran 20 assembly simulations beginning from 
the same starting conformation with different initial velocities drawn from a Maxwell-
Boltzmann distribution. Of the twenty simulations, four were run for 4 µs and the rest were run 
for 1 µs. 
The αB crystallin assembly simulations were initiated from three monomers of the 
tandem repeat structure of αB crystallin (GKLKVLGDVIEV--GG--KLKVLGDVIEV, PDB ID 
3SGR).  System preparation and simulation protocol were as above, except that we ran 10 
assembly simulations in this case. Of these 10 simulations, two were run for 5 µs, two were run 
for 2 µs, and the rest were run for 1 µs. 
Expression and purification of SOD1 constructs  
All SOD1 constructs were expressed recombinantly in E. coli. All recombinant proteins 
are based on a SOD1 background strain that carries a C6A, C111S double mutation to simplify 
the purification. The SOD1 gene was inserted into the pET22b vector from Novagen with NcoI 
and SalI restriction enzyme digestion sites (gift from Professor Joan Valentine’s lab at UCLA).  
Mutations in the SOD1 gene were made using the QuickChange Site-Directed mutagenesis Kit 
(Stratagene). The plasmid was transformed into the BL21(DE3)Gold (Agilent Technologies) 
expression strain. For expression, 10 ml LB + Amp (100 μg/mL) was inoculated from frozen 
stock and grown overnight. 10 ml of starting culture was added to a 2 L flask of 1 L LB + Amp 
(100 μg/mL) and grown for 3 hours at 37 °C to OD600 = 0.6. IPTG was then added to 1 mM and 
Zn2+ was added to 0.05 mM to induce protein expression, which continued for an additional 3 
hours. The bacterial pellet was collected by centrifugation at 4000 rpm for 10 mins. 
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To purify SOD1 from the bacteria, osmotic shock was used to release proteins including 
SOD1 from the periplasm. First, the cell pellet was resuspended in 30 mL of 30 mM Tris-HCl pH 
8 with 20% sucrose and stirred slowly for 20 mins. The cells were collected by centrifugation at 
10,000 × g at 4 °C for 10 mins. The pellet was then resuspended in 30 mL of ice-cold water and 
stirred slowly for 20 mins on ice to release periplasmic proteins. Next, cell debris was removed 
by centrifugation at 4 °C for 10 mins at 10,000 × g. The contaminant proteins were then 
removed by precipitation with ammonium sulfate. 0.326 g/ml (NH4)2SO4 was added to the 
supernatant, and the solution was stirred at 4 °C for 45 mins. The protein was purified out of 
ammonium sulfate by separation over a phenyl sepharose column. The column was equilibrated 
with buffer A (2 M (NH4)2SO4, 0.15 M NaCl, 0.05 M NaH2PO4, pH 7.0) and buffer B (0.15 M 
NaCl, 0.05 M NaH2PO4, pH 7.0). The protein eluted at 6-30% buffer B. The protein was then 
concentrated and further purified by size exclusion chromatography on a silica G3000 column 
(Tosoh Bioscience). The column buffer comprised 0.1 M sodium sulfate, 25 mM sodium 
phosphate, and 1 mM sodium azide, pH 6.5. 
SOD1 demetallation (required for aggregation) 
The protein constructs purified by size exclusion chromatography were dialyzed in four 
buffers at 4°C to remove the bound metals. Protein preparations were put in a dialysis cassette 
(10 kDa molecular weight cutoff) and exchanged with buffer 1 twice (100 mM Na Acetate pH 
3.8, 10 mM EDTA pH 8.0), followed by exchange with buffer 2 (100 mM Na Acetate pH 3.8, 100 
mM NaCl, 1 mM EDTA pH 8.0), buffer 3 (100 mM Na Acetate pH 5.5, 100 mM NaCl, 1 mM 
EDTA pH 8.0), and finally buffer 4 (20 mM K Phosphate pH 7.0, 1 mM EDTA pH 8.0). Each 
exchange lasted 12 hours. To avoid metal contamination, all stock solutions (except for EDTA) 
were treated with Chelex 100 resin (Bio-Rad) to remove trace metals and all beakers were rinsed 
with metal-free water. 
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Protein and peptide aggregation 
Full-length SOD1: Following metal removal, proteins were concentrated using a 
centrifugal concentrator (10 kDa molecular weight cutoff) to 800 μM (monomer) stock 
concentration and stored at -80 °C in 50 μL aliquots until further use. Aggregation assays were 
carried out in 1.5 mL microcentrifuge tubes (Fisher Scientific) under acidic conditions with 80 
μM SOD1, 50 mM sodium acetate, 1 mM EDTA and 1 mM TCEP, pH 3.5. Preparations were 
agitated at 900 rpm (in Torrey Pine Shakers) at 37 °C for indicated times. These samples were 
then dialysed with 10 mM potassium phosphate and 1 mM EDTA, pH 7.0 for 4 hours at 4 °C. 
Peptide: Peptide segments were aggregated by incubation at 37 °C for 12 hours with 
agitation in 50 mM tris-base buffer and added to cultured neurons. 
Differentiation of mESCs to motor neurons  
Hb9:eGFP mESCs were maintained and differentiated into motor neurons as previously 
described(43). Briefly, mESCs were first plated on gelatin to remove mouse embryonic 
fibroblasts (MEFs) prior to differentiation, and then plated in 60 mm bacterial petri dishes in 
core motor neuron medium (DMEM/F12, Neurobasal, 10% Knockout Serum Replacement, Pen-
Strep, Glutamax) to induce embryoid body (EB) formation. Two days later, N2 supplement (1x), 
retinoic acid (1 μM; Sigma), and SAG (1 μM; Calbiochem) were added to the EBs. Media was 
changed every two days. After five days post-retinoic acid and SAG addition, Hb9:GFP EBs were 
dissociated using ice-cold 0.25% Trypsin-EDTA for 6 minutes at room temperature, followed by 
trituration in L-15 medium (Hyclone). Dissociated motor neurons were plated in core motor 
neuron medium with GDNF, BDNF, CNTF (all 10 ng/ml; Peprotech) on 96-well plates that were 
previously coated with poly-L-ornithine (0.01%; Sigma) and laminin (5 μg/ml; BD Biosciences) 
and incubated for 12-16 hrs before treatment with the SOD1 peptides or proteins. Approximately 
80,000 cells were plated per well. All reagents are from Invitrogen, unless otherwise noted. 
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Cytotoxicity Assays 
Aggregated protein preparations were added to cultured neurons at the given final 
concentration. Unless stated otherwise, all full-length proteins were aggregated for 12 hours 
before adding to motor neurons at 8 μM final concentration. Motor neurons were incubated for 
12-16 hrs and imaged (Axio Observer.D1 microscope, Zeiss), followed by cell viability assay. Cell 
viability was measured using the commercially available MTT assay (Promega Cat#G4100) 
according to the manufacturer’s protocol with 4 hour incubation with the MTT reagent. All data 
were normalized using buffer as 100% viability and 0.2% SDS as 0% viability. Experiments were 
performed in triplicates and repeated a minimum of three times. 
Electron Microscopy 
Each 3-5 μL sample was spotted directly on freshly glow-discharged carbon-coated 
electron microscopy grids (Ted Pella, Redding, CA). After 4 min incubation, grids were rinsed 
twice with 5 μL distilled water and stained with 5 μl of 2% uranyl acetate for 1 min. Excess 
uranyl acetate was removed by blotting and specimens were examined on a T-12 electron 
microscope at an accelerating voltage of 80 kV. Images were recorded digitally by wide angle 
(top mount) BioScan 600W 1 × 1K digital camera (Gatan, Pleasanton, CA). 
Dot Blot Assay 
3-5 μL sample was spotted on a nitrocellulose membrane (Trans-Blot, Bio-Rad) followed 
by blocking with 10% fat-free milk in 1X TBST buffer (50 mM Tris, 150 mM NaCl, 0.05% 
Tween20) for 30 mins. Membranes were incubated with primary antibody SOD100 (Enzo Life 
Sciences) at 1:1000 dilution, A11 (EMD Millipore) at 1:500 diluted in 5% fat free milk in TBST 
buffer at room temperature for 1 hour. The membranes were washed three times in TBST buffer 
before incubating with HRP-linked secondary antibody - anti-mouse HRP secondary antibody 
(Life Technologies) at 1:10000 dilution, or anti-rabbit HRP secondary antibody (Life 
Technologies) at 1:10000 diluted in 5% fat-free milk in TBST buffer at room temperature for 1 
hour. Pierce ECL Western Blotting Substrate, (Thermo Scientific, #32209), a chemiluminescent 
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substrate was used for the detection of horseradish peroxidase (HRP) on the immunoblots 
following the manufacturer’s instructions. A detailed protocol can be found at the following 
URL, 
https://tools.thermofisher.com/content/sfs/manuals/MAN0011536_Pierce_ECL_West_Blot_
Subs_UG.pdf 
Thioflavin-T (ThT) Assay 
Fibril formation assays were performed with 80 μM protein concentration in 50 mM 
sodium acetate buffer, 1 mM EDTA, 1 mM TCEP, pH 3.5 and 10 μM ThT – conditions identical 
to those used for aggregating proteins for the cytotoxicity assays, but with the addition of ThT. 
All assays were carried out in black Nunc 96-well optical bottom plates (Thermo Scientific). 
Plates were agitated at 300 rpm in 3-mm rotation diameter in a Varioskan microplate reader 
(Thermo) at 37 °C. Fluorescence measurements were recorded every 30 mins using λex = 444 
nm, λem = 482 nm, with an integration time of 200 μs.  
Mass Spectrometry  
Peptide segments were dissolved in 20 mM ammonium acetate buffer (pH = 7) to a final 
concentration of 200 µM and incubated at room temperature without agitation. Experiments 
were carried out at time t0 and every day for a week and ion mobility was used to calculate the 
cross sections of oligomers. The peptide samples were nano-electrosprayed on a home-built, 
high-resolution ion mobility mass spectrometer (77) consisting of a source ion-funnel, a two-
meter long drift cell, an exit funnel, a quadrupole mass analyzer and detectors. The ions were 
stored and focused in the source funnel and subsequently pulsed into the drift cell filled with 
helium gas at high pressure. A drift voltage was applied across the cell to create a weak electrical 
field. The ions moved forward under the influence of the electrical field, and at the same time 
experienced the drag force due to multiple collisions with helium buffer gas. An ion traveled 
with a constant velocity that reflected its size and shape. At the end of the drift cell, the ions 
were collected by an exit funnel where they were steered and focused into a quadrupole mass 
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analyzer and detected as a function of arrival time in the arrival time distributions (ATDs). By 
measuring ATDs at different pressure to voltage (P/V) ratios, the absolute mobility of the ion of 
interest could be measured: 
𝑡𝐴 =
𝑙2
𝐾0
273.16 𝐾
760 𝑡𝑜𝑟𝑟 ∙ 𝑇
∙
𝑃
𝑉
+ 𝑡0 (𝐸𝑞. 1) 
In Eq. 1, 𝑙  is the length of the drift cell, P is the gas pressure in torr, V is the voltage across the 
cell, and t0 is the time the ions spend outside the drift cell before reaching the detector. The 
collision cross section 𝜎 can then be approximated from K0 (78) 
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2 1
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Here, N is the buffer gas density, µ is the reduced mass of the collision system (He+ion) and kB 
is Boltzmann’s constant. The cross section contains information about the three dimensional 
structure of the ion. In the ATDs shown in Fig. S6, underneath each experimental peak is a 
dotted line representing the peak shape expected for a single conformer (79). 
Zebrafish 
All zebrafish (Danio rerio) were maintained in accordance with standard laboratory 
conditions (80). The University of California, Los Angeles (UCLA) Chancellor's Animal Research 
Committee approved all experiments performed on zebrafish. The TDL6 (Tübingen driver line) 
zebrafish used in all experiments were identified in a screen for developmentally regulated 
enhancers that drive tissue-specific expression.  Gal4-driven GFP expression marks primary 
motor neurons. Mitochondria were marked by a TOL2-mediated insertion of a Gal4-UAS-
MLSDsRed construct (52). 
RNA production and injections 
SOD1 constructs used for zebrafish expressions were the full-length sequence with Cys6 
and Cys111 intact. The constructs (WT, G93A, G93A/G33V, A4V, A4V/G33V were subcloned 
into pcGlobin2 vector and the constructs were linearized using XbaI to generate RNA. The 
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Translation efficiency of the RNA of all constructs was tested by TnT® Quick Coupled 
Transcription/Translation System (Promega) using the manufacturer’s instructions. Construct 
G93A/G33V has an additional mutation of I18G designed to prevent steric clashes due to the 
presence of G33V in the native SOD1 barrel. As a control, we also tested the cytotoxicity of this 
construct in cell culture and found that it was non-toxic similar to G33V construct (Fig. S9B). 
RNA was transcribed using the mMessage Machine T7 kit (Ambion) and the mRNA was diluted 
to 500 ng/μL and 1000 ng/μL aliquots and stored at -80°C. 1 μL mRNA at 500 ng/µL (WT, 
G93A, G93A/G33V) and at 1000 ng/ µL (WT, A4V, A4V/G33V) was injected into TDL6 embryos 
from timed mating at the 1-4 cell stage. Embryos were incubated in 1x E3 buffer at 28.5 °C. 
Analysis of axonopathy 
At 2 dpf (days post fertilization) zebrafish larvae microinjected with SOD1 constructs 
were anesthetized in 0.01% tricaine and imaged using a Leica MZ16F fluorescent stereoscope at 
11.5X magnification. Observers were blinded and the length from the exit point of the spinal 
cord to the tip of the motor axon was measured for 5 axons per embryo corresponding to axons 
12-16 - using Fiji Simple Neurite Tracer. Experiments were repeated multiple times and a 
minimum of 72 embryos were assessed for each construct. 
Analysis of mitochondrial defects 
The mitochondrial network from the base of the spinal cord to the tip of the motor axon 
was imaged on a Leica TCS SP8 confocal microscope at 10X magnification with a 1.5X optical 
zoom. Images were processed with the Leica AF software and mitochondria size was measured 
for 5 axons per embryo using Fiji Image J Particle Analysis with the described algorithm (81). 
Before quantification, fluorescence from the spinal cord and regions outside of the larvae body 
were excluded. The program allowed automatic detection of isolated fluorescent spots by 
threshold and watershedding of binary formatted images without introducing user-bias. Spots 
with a circularity of 0.5-1 were selected to have their intensity and area quantified, where 1 is a 
complete circle. Intensity was quantified for each spot via overlapping gray levels.  
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Protein expression in zebrafish 
Protein expression was confirmed by western blotting (Supplementary Figure 4.9). 
Zebrafish embryos were pooled from each group at 2 dpf and washed twice in Ringer’s buffer 
(NaCl 13 5 mM, KCl 5 mM, MgSO4 1mM, K2HPO4 0.4 mM, Glucose 5.5 mM, HEPES 20 mM pH 
7.4). They were subsequently deyolked and dechorionated and lysed in RIPA buffer (Sigma) 
(volume equals twice the number of embryos in μL) with Halt protease inhibitor cocktail EDTA-
free (Thermo Scientific) added. Lysates were homogenized by sonication and protein 
concentration was determined using the BCA protein assay kit (Thermo Fisher Cat #23252). 
Equal amounts of protein were loaded on 12% Tris-glycine PAGE gels and transferred onto a 
PVDF membrane using an iBlot dry blotting system (Thermo Fisher) at 20 V for 6 mins. 
Membranes were washed with methanol followed by water and then blocked with 10% fat free 
milk in TBST for 1 hr at room temperature and washed three times with TBST buffer. 
Membranes were incubated with primary antibodies – SOD100 (Enzo Life sciences) at 1:500 
dilution in 5% milk in TBST and incubated for 1hr at room temperature or anti β-actin (Abcam) 
at 1:1000 diluted in 5% milk in TBST and incubated overnight at 4°C. Membranes were first 
probed with SOD100 and then stripped using Restore PLUS Western Blot stripping buffer 
(Thermo Scientific) and subsequently probed with anti β-actin. Blots were washed thrice with 
1X TBST and subsequently incubated with the secondary anti-rabbit HRP secondary antibody 
(Sigma) at a 1:10000 dilution in 5% milk in TBST for 1hr at room temperature. Pierce ECL 
Western Blotting Substrate, (Thermo Scientific, #32209), a chemiluminescent substrate was 
used for the detection of horseradish peroxidase (HRP) on the immunoblots following the 
manufacturer’s instructions. 
Statistical Significance 
All statistical analyses were done using GraphPad Prism 7.0.  
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Antibodies used 
The following antibodies were used in this study. SOD100 (EnzoLife sciences) at 1:1000 
dilution, A11 (EMD Millipore) at 1:500 dilution, anti β-actin (Abcam) at 1:1000, anti-mouse 
HRP secondary antibody (Life technologies) 1:10000 dilution, anti-rabbit HRP secondary 
antibody (Life technologies) 1:10000 dilution. 
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Figure 4.1. Structure of an 11-residue segment derived from SOD1 in its oligomeric 
state. (A) 2.0 Å resolution crystal structure of the SOD1 segment with sequence 
KVKVWGSIKGL shows antiparallel, out-of-register β-strands forming a continuous left-handed 
helix. Sixteen strands form one complete turn of the helix, with 25 Å outer diameter and 71 Å 
pitch. The hydrophobic interior lined with valine, isoleucine, and leucine side chains (shown in 
spheres) excludes water molecules, as shown in side and top views. (B) Model of a full-length 
SOD1 toxic oligomer. This model contains 16 protomers. Strands 2 and 3 of each protomer 
detach from the native fold to form the corkscrew spine (green interior, blue exterior) as 
observed in the crystal structure of residues 28-38. The remaining protein decorates the exterior 
of corkscrew retaining much of the SOD1 native structure. The model is illustrated in the same 
two orientations as (A). One monomer is colored brown for clarity. Note that the segment 28-38 
is buried in the core but it is exposed at the ends. (C) Gly33 is essential for creating the concave 
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inner surface of the corkscrew. The lack of side chain on Gly33 permits the close approach of 
hydrophobic side chains of Val29 and Val31 located on β-strands bordering opposite sides of 
Gly33. (D) Unavoidable steric clash results from mutating Gly33 to tryptophan. (E) All-atom 
MD simulations of the corkscrew-forming segment suggest that introduction of the G33W 
substitution destabilizes the structure. Blue and red curves correspond to Cα root-mean-square 
deviations (RMSD) from the corkscrew crystal structure in MD simulations of 8 chains of the 
corkscrew segment (KVKVWGSIKGL) and G33W mutant segment (KVKVWWSIKGL), 
respectively. The structure of the corkscrew segment remained stable throughout the length of 
the simulation, whereas the G33W mutant deviated from the corkscrew structure. (F) The SOD1 
segment 28-38 preferentially assembled into a corkscrew-like structure in MD simulation. MD 
simulations of weakly restrained monomers of SOD1 spontaneously assembled into a corkscrew-
like structure. A snapshot of an assembled corkscrew-like structure from the MD simulations 
(green) is overlaid onto the crystal structure (blue). As a control, we found that monomers of the 
cylindrin-forming segment of αB crystallin spontaneously assembled into a cylindrin structure 
using the same simulation protocol. 
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Figure 4.2. Corkscrew forming segment 28-38 is necessary and sufficient for 
cytotoxicity. (A) Cell viability of motor neurons measured by MTT reduction assay shows that 
the corkscrew segment (KVKVWGSIKGL) is toxic to primary motor neurons in a dose-
dependent manner. Results shown as Mean+SD (n=3). Symbols represent individual values of 
triplicates and bars represent average values. Statistical significance was analyzed using two 
tailed T-tests with Welch’s correction. (B) Corkscrew-forming segment (28-38) harboring single 
point substitutions at Gly33 (G33V and G33W) is non-toxic to motor neurons. All peptide 
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segments were prepared identically and motor neurons were treated with different final 
concentrations. Statistical significance of G33V and G33W mutants was compared to the 28-38 
segment by two-way ANOVA. (C) Hb9-GFP-labeled motor neurons treated with 8 μM 
aggregated full-length familial mutants (A4V and G93A) lose neurites but the corresponding 
corkscrew-disrupting mutants (G93A/G33V, G93A/G33W, A4V/G33V and A4V/G33W) are 
non-toxic and neurons look healthy. (Scale bar = 20 μm) (D) Cell viability measured by MTT 
reduction assay confirming that the familial mutants A4V and G93A are toxic and substitution 
of Gly33 with valine or tryptophan renders the protein non-toxic. Results shown as Mean+SD 
(n=3). Symbols represent individual values of triplicates and bars represent average values. 
Statistical significance was analyzed by one-way ANOVA. (*p < 0.05,**p < 0.01,***p < 
0.001,****p < 0.0001). 
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Figure 4.3. Toxicity of full-length SOD1 derives from soluble oligomers. (A) Electron 
micrographs of a non-fibril forming SOD1 mutant (I104P) and the corresponding double mutant 
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(I104P/G33W) show some aggregates but no large fibrils. (B) Motor neurons treated with I104P 
lose neurites and have shrunken cell bodies (left) but I104P/G33W treated cells look healthy. (C) 
Cell viability measured by MTT reduction assay confirmed that I104P is toxic and I104P/G33W 
is non-toxic. Statistical significance was analyzed using a two-tailed T-test with Welch’s 
correction. (D,E) The toxic properties of SOD1 mutants depend on the duration of aggregation. 
A4V and G93A mutants aggregated for 12-16 hours are toxic to motor neurons while extended 
agitation for 72 hours renders the proteins non-toxic. The corkscrew-disrupted proteins 
(A4V/G33W and G93A/G33W) are non-toxic irrespective of the duration of aggregation. Results 
shown as Mean+SD (n=3). Symbols represent individual values of triplicates and bars represent 
average values. Statistical significance was analyzed by two-tailed T-tests with Welch’s 
correction. (*p < 0.05,**p < 0.01,***p < 0.001,****p < 0.0001). (F) Representative electron 
micrographs of various preparations of the familial mutants, A4V and G93A and the double 
mutants, A4V/G33W and G93A/G33W. Some large aggregates can be seen at 2-16 hour time 
points but no fibrils, whereas at 72 hours all constructs show large fibril loads. (G) Immunoblots 
of the familial mutants aggregated for different time points. Samples aggregated for 12-16 hours 
are A11 positive and both proteins when aggregated for 72 hours lose A11 reactivity. SOD100 was 
used as loading control. 
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Figure 4.4. Corkscrew-disrupting substitution of G33V alleviates axonopathies in a 
Danio rerio (zebrafish) ALS model. (A) Micrographs of zebrafish embryos at 2 dpf show 
reduction in axon lengths of A4V–expressing embryos, whereas corkscrew-disrupted 
A4V/G33V–expressing embryos have significantly better axon lengths. The first axon is 
highlighted in pink for clarity and axons measured for quantification are marked by an asterisk. 
Scale bar 100 μm. (B) Quantification of axon lengths show that A4V-expressing embryos have 
shorter axons than WT-expressing embryos. The corkscrew-disrupting substitution G33V 
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alleviates the defect. Results shown as Mean+SEM relative to WT for at least 72 embryos. 
Statistical significance was analyzed by one-way ANOVA. (C) Micrographs of zebrafish embryos 
at 2 dpf show reduction in axon lengths of G93A–expressing embryos, whereas corkscrew-
disrupted G93A/G33V–expressing embryos have significantly better axons. The first axon is 
highlighted in pink for clarity, and axons measured for length are marked by an asterisk. Scale 
bar 100 μm. (D) Quantifications of axon lengths show that G93A-expressing fish have shorter 
axons than WT-expressing fish. The corkscrew-disrupting substitution, G33V alleviates the 
defect. Results shown as Mean+SEM relative to WT for axons 12-16 of at least 73 embryos. 
Statistical significance was analyzed by one-way ANOVA. (E) Micrographs show A4V-expressing 
zebrafish have impaired mitochondria which are clustered at the branch points (encircled) as 
compared to WT. The mitochondrial network of A4V/G33V-expressing fish is similar to WT. 
(F,G) Quantitative analysis of the mitochondrial network shows A4V-expressing fish have larger 
mitochondrial size (30.17 a.u.) and diffused clustering (fluorescence intensity 32 a.u.) in the 
axons indicative of defective fission, whereas A4V/G33V-expressing fish have healthy 
mitochondria (10.57 a.u. size and 54 a.u. fluorescence intensity) similar to WT (14.08 a.u. size 
and 58 a.u. fluorescence intensity). Symbols represent individual measurements made for each 
group. Statistical significance was analyzed by one-way ANOVA. (H,I) Quantitative analysis of 
the mitochondria network show G93A-expressing fish have larger, more diffusely clustered 
mitochondria (14.68 a.u. size and 39 a.u. fluorescence intensity) indicative of defective fission. 
Mitochondrial network of G93A/G33V (11.68 a.u. size and 59 a.u. fluorescence intensity) 
expressing fish is similar to WT (10.78 a.u. size and 78 a.u. fluorescence intensity). Statistical 
significance was analyzed by one-way ANOVA. Symbols represent individual measurements for 
each group. (*p < 0.05,**p < 0.01,***p < 0.001,****p < 0.0001). 
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Supplementary Figure 4.1. Prediction of cylindrin-compatible segments. (A) 3D 
profile method for predicting cylindrin-compatible segments in amyloid proteins.  An example 
of threading with the amyloid-β peptide is shown. (B,C) Visual analysis of the cylindrin structure 
revealed a layering of side chains in the core (b; backbone trace with even-numbered, ‘inward-
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facing’ side chains shown as sticks, and glycine Cα shown as a small sphere), and a 'knob in hole' 
packing of valine and glycine residues (c; surface rendering) that allows for the small 
circumference of the barrel. (D-H) Structures resulting from the 3D profile predictions were 
analyzed for packing in the barrel core. Representation is similar to panel B, but side-chain 
atoms are shown as spheres with van der Waals radii. The protein of origin and segment 
sequence are given, with even-numbered, ‘inward-facing’ residues in bold, and the critical 
position 4 residue underlined. (D) The original cylindrin structure, after Rosetta-based side-
chain repacking and energy minimization. Notice the packing of valine 4, cyan, near the center. 
Although there is a gap between the two layers (arrowhead), it is small. (E) In this model of a 
segment from the human prion protein, methionine (cyan) occupies the central position 4, 
filling the space more completely than valine of the cylindrin sequence. (F) A histidine side 
chain at position 4 can also fill the central space, but is not able to satisfy hydrogen bonding 
groups. (G) Alanine at position 4 does not fill the core as well, leaving gaps (arrowheads). (H) 
Adjacent alanine and glycine, at positions 2 and 8 respectively, leave large gaps in outer layers of 
the cylindrin model core (arrowheads), in spite of a native valine packing in the middle at 
position 4. (I) Manual selection of cylindrin-compatible segments. First, three sequence-based 
criteria, which define the glycine position and the position of an adjacent, appropriate side chain 
(with cylindrin-compatible size and charge) in the core, were used in the initial selection of 
segments.  The resulting sequences were further culled based on the presence of undesirable 
amino acids in specific positions.  Prolines were avoided because of their tendency to disrupt 
β-structure.  Charged and bulky inward-facing residues were avoided because of likely 
disruption to the packing. Small inward-facing residues were avoided because of gaps in 
packing, e.g. as in panel H. Large numbers of glycines were avoided because of the tendency for 
these sequences to be flexible rather than adopt a fixed conformation. Cysteines were avoided 
for experimental purposes. Four overlapping segments of SOD1 resulted from this manual 
selection. 
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Supplementary Figure 4.2. Frequency distribution of ALS-related mutations in 
SOD1. (A) Histogram representation of the number of familial-disease mutations found at each 
residue position. Gray connected line refers to the total number of patients known to carry 
mutations at that residue. The segment 28-38 is expanded. Val29 and Val31 each have one 
known familial mutation and Gly37 and Leu38 have two known familial mutations. Notice that 
the segment 28-38 has low frequency of individuals with ALS linked mutations with none in 
residues 32-36. A total of 4 individuals are known to carry mutations in this region. Data were 
obtained from http://alsod.iop.kcl.ac.uk (B) Ribbon diagram of dimeric SOD1 (PDB ID: 2C9S) 
with the segment 28-38 highlighted in blue. Zinc and copper atoms are shown as magenta 
spheres, and the familial mutation residues, A4V and G93A are colored red. 
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Supplementary Figure 4.3. Hydrophobicity mapped on the surface of the 
corkscrew crystal structure (left), and a lengthwise cross-section (right). The cleft interior is 
strongly hydrophobic (red) made up of valine and isoleucine side chains of Val29, Val31, and 
Ile35, whereas the exterior is strongly hydrophilic (blue) arising from Lys28, Lys30, Ser34, and 
Lys36. 
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Supplementary Figure 4.4. Lysine substitution at position 28 contributes weakly to 
the crystal packing and not to the stability of the corkscrew structure. (A) Crystal 
packing of the corkscrew structure. Two asymmetric units forming crystal contacts are shown in 
blue and yellow from neighboring corkscrews and N-terminal lysines are shown in sphere 
representation. Among the eight N-terminal lysines in each asymmetric unit, 5 form weak van 
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der Waals interactions with a lysine residue and a tryptophan residue of the neighboring 
corkscrew. These interactions contribute weakly (~9%) of the total buried surface area in the 
crystal contacts. Buried surface area in the crystal contacts was calculated by AREAIMOL. (B) 
Lysine at position 28 is not essential for corkscrew formation and replacing it with the native 
proline residue does not disrupt the potential for hydrogen bonding. The N-terminal lysine 
forms a hydrogen bond with the carbonyl oxygen of Ser34 in an adjacent β-strand (left). 
Substituting the N-terminal lysine with the native proline residue (gray) maintains the hydrogen 
bond (right). (C) The blue and red curves correspond to Cα root-mean-square deviations 
(RMSD) from the corkscrew crystal structure in MD simulations of the 8-chain wild-type 
(PVKVWGSIKGL) and G33W mutant (PVKVWWSIKGL) corkscrews, respectively. The G33W 
mutant deviates from the corkscrew structure, whereas the wild-type structure remains stable 
throughout the length of the simulation. The simulations suggest that the dynamics of the 
backbone at residue 33 may contribute to the instability of the G33W mutant. The G33 residue 
in the corkscrew structure occupies a region of Ramachandran space different from the 
allowable region for tryptophan and other non-glycine amino acids. In the wild-type 
simulations, the backbone dihedral angles of G33 tend to remain in the lower right quadrant of a 
Ramachandran plot, whereas those of W33 in the mutant quickly relax to the β-sheet/α-helix 
regions, leading to deviations from the corkscrew structure. The extra hydrophobicity of G33W 
may also have an effect, making the mutant corkscrew more likely to collapse.  
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Supplementary Figure 4.5. Structural comparison of corkscrew and cylindrin. (A) 
Hydrogen bonding network of the corkscrew structure (left). Shown here the orange -strand 
has a strong interface with the -strand below composed of 9 hydrogen bonds and a weak 
interface with the -strand above composed of 7 hydrogen bonds. Hydrogen bonding network in 
the cylindrin structure (Right, PDB ID: 3SGO) shares a similar architecture where the orange 
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strand has a stronger interface with the -strand below composed of 12 hydrogen bonds and a 
weak interface with the -strand above composed of 8 hydrogen bonds. Br2 refers to the non-
natural amino acid 2-bromoallyl-glycine that was used for phasing. (B) MD simulations of 
weakly restrained monomers of SOD1 spontaneously assembled into a corkscrew-like structure.  
A snapshot of an assembled corkscrew-like structure from the MD simulations (red) is overlaid 
onto the crystal structure (blue). Out of 20 simulations, three successfully assembled to a 
corkscrew-like structure. Interestingly, in trajectories where a corkscrew did not form, 
individual monomers often formed interfaces composed of out-of-register β-sheets. As a control, 
we found that monomers of αB crystallin spontaneously assembled into a cylindrin structure 
using the same simulation protocol. A snapshot of an assembled cylindrin from the MD 
simulation (red) is overlaid onto the crystal structure (blue, PDB ID 3SGR). Out of 10 
simulations, one successful assembly to cylindrin was obtained. As in the SOD1 assembly runs, 
in αB crystallin assembly trajectories where a cylindrin did not form, we often observed dimers 
composed of out-of-register β-sheet interfaces. 
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Supplementary Figure 4.6. The corkscrew-forming segment, SOD1(28-38) forms 
oligomers in solution with cross section similar to the crystal structure. (A, B) n-
ESI-q mass spectrum of 200 µM cylindrin and corkscrew peptides in 20 mM ammonium acetate 
buffer (pH = 7.0), respectively. Each mass spectral peak is annotated with n/z where n is the 
oligomer number and z is the charge. (C-F) Representative ATDs of n/z = 1/1 peaks of the 
cylindrin and corkscrew peptides incubated for t = 0 and 24 hours. Each ATD feature is 
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annotated with n/z and an experimental collision cross section (M = monomer, D = dimer, Tr = 
trimer, Hex = hexamer). The narrow dashed lines are the peak shapes predicted for a single 
conformer of the cross sections given. 
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Supplementary Figure 4.7. Segment (28-38) with native proline is toxic and 
substitution at Gly33 renders it non-toxic. (A) Peptides were prepared identically by 
solubilizing in 50 mM tris-base buffer and overnight incubation at 37 °C with agitation and ES-
derived motor neurons were treated with 100 μM final concentration. P28(28-38) is toxic while 
the peptides with substitutions G33V and G33W are non-toxic. Symbols represent individual 
values and bars represent average values. Statistical significance was measured by ANOVA. (**p 
< 0.01, ***p < 0.001). (B) Electron micrographs of all three peptides showed similar fibrils 
suggesting that substitution at Gly33 does not change the fibrillation propensity. 
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Supplementary Figure 4.8. WT and mutant SOD1 show similar kinetics of 
aggregation and cytotoxicity. (A) Thioflavin T assay of 80 μM WT protein shows a lag time 
of 2-4 hours before fibrils first appear (left). Cell viability (right) of ES-derived primary motor 
neurons incubated with protein aggregated for indicated times shows WT is only toxic when 
shaken up to 12 hours, when abundant fibrils first appear. (B) Similar to WT, the mutant G93A 
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shows a lag time of 2-4 hours in a thioflavin T assay (left).  Cell viability (right) of ES-derived 
primary motor neurons incubated with protein aggregated for indicated times shows G93A is 
also toxic when shaken up to 12 hours, when abundant fibrils first appear. (C) Thioflavin T assay 
(left) shows G33W, the corkscrew-disrupted mutant protein behaves similar to WT and G93A 
with a lag phase of 2-4 hours. However, it is non-toxic at all time points (right). Results shown 
as Mean+SD (n=3). Statistical significance was analyzed using a two-tailed T-test with Welch’s 
correction (*p < 0.05, ***p < 0.001, ns not significant). (D) Electron micrographs of SOD1 
constructs aggregated for different lengths of time. Samples aggregated up to 12 hours tend to 
show some aggregates and sparse fibrils while samples aggregated for 16 hours or more show a 
large fibril load. Scale bar 200 nm.  
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Supplementary Figure 4.9. Expression of A4V and G93A mutant proteins causes 
axon shortening and abnormal mitochondrial clustering in zebrafish model. (A) 
Western blotting of zebrafish embryos to confirm expression of the mRNA injected. SOD100 
was used to detect SOD1 and β-actin was used as loading control. UI refers to uninjected 
zebrafish. (B) Construct G93A/G33V/I18G is non-toxic in cell culture model similar to the 
G93A/G33V mutant. (C) Zebrafish at 2 dpf were imaged and higher percentage of A4V (30%) 
and G93A (10%) injected zebrafish displayed significant deformation compared to WT and the 
G33V expressing fish. (D) Average axon length (normalized to WT construct) and mitochondrial 
size of the different constructs. n refers to the total number of measurements made for each 
construct. 
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Supplementary Figure 4.10. Structural comparison of corkscrew with other β-
sheet proteins. The DALI server was used to search the Protein Data Bank for proteins with a 
similar structural fold. Three main categories of proteins were found – big barrel proteins, small 
β-sheet proteins that bind ligands and open twisted β-sheet proteins that bind ligands. (A) 
Overlay of corkscrew (purple) with the structure of BamA (PDB: 4K3C), a β-barrel membrane 
protein (gray). (B) Overlay of corkscrew (purple) with the structure of AbyU (PDB: 5DYV), a 
diels alderase (gray) with HEPES (red) bound in the barrel. (C) Overlay of corkscrew (purple) 
with BPI (PDB: 1BP1), bactericidal protein with phosphocholine bound. Notice that the twisted 
sheet creates a groove for binding phosphocholine (red). RMSD – root mean square deviation of 
Cα, LALI – length of aligned residues. 
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Supplementary Figure 4.11. Model of SOD1 aggregation pathway. SOD1 forms a stable 
dimer that is resistant to aggregation. Its destabilization into monomers renders it prone to 
aggregation into β-sheet rich fibrils. The corkscrew structure of segment 28-38 (purple) 
determined here, suggests that there is an off-pathway for oligomer formation independent of 
the in-register fibrils. The mutations, G33W/G33V specifically prevent corkscrew formation, an 
out-of-register oligomer. Fibril formation assays suggest that G33W/G33V do not affect the in-
register fibril formation pathway and large fibrils are non-toxic.  
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Supplementary Table 4.1. X-Ray Data Collection and Refinement Statistics 
 KVKVWGSIKGL KVKVWGSIKGL (iodide) 
Beamline APS 24-ID-E APS 24-ID-E 
Resolution Å 1.9 2.1 
Total unique reflections  8378 11489 
Total reflections observed 47323 43500 
Unit cell dimensions 
a, b, c (Å) 
α, β, γ  (°) 
  
33.2, 44.4, 71.2   
90.0, 90.0, 90.0 
 
33.1, 44.4, 71.4  
90.0, 90.0, 90.0 
Space group P212121 P212121 
Rmerge 16.5% (48.4%) 9.5% (41.8%) 
I/σ 8.4 (4.3) 11.1 (3.6) 
Completeness 95.5 % 96.7% 
Wavelength (Å) 0.9791 0.9791 
Refinement 
Resolution (Å) 35.5-2.0 19.3-2.0 
Reflections for refinement  
(after merging Friedel Pairs) 
6690 6249 
Rfree/Rwork (%) 25.08/21.09 26.2/21.2 
Molecules per asymmetric 
unit 
8 8 
Solvent content (%) 54.6 54.6 
Matthews coefficient (Å3/Da) 2.71 2.71 
Total water molecules 34 52 
Total iodide atoms 0 2 
Glycerol molecule 0 1 
Rmsd bond length (Å) 0.010 0.010 
Rmsd angles (°) 1.022 0.88 
Ramachandran plot 
Allowed 
Generous 
Disallowed 
 
100 
0 
0 
 
100 
0 
0 
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Supplementary Table 4.2. Comparison of shape complementarity (Sc) and buried 
surface area (Ab) of corkscrew with cylindrin and steric zippers. 
 Corkscrew Cylindrin* Steric Zipper** 
Sc 0.79 0.74 0.68 
Ab (Å2) 984  943 1034 
Ab/Residue 89 86 94 
 
* PDB ID:  3SGO 
** PDB ID: 4RIL 
For the Sc calculation, we examined the interface between one chain and the remaining chains 
of the assembly. 
Ab values were calculated using AREAIMOL. The area buried was calculated by subtracting the 
solvent accessible surface area of one chain of the assembly from the total solvent accessible 
surface area of an isolated chain. 
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CHAPTER 5 
 
Structure of the toxic core of α-synuclein from invisible crystals 
 
INTRODUCTION 
 The presynaptic protein α-synuclein (α-syn), found in both soluble and membrane-
associated fractions of the brain, aggregates in Parkinson’s Disease (PD).  These aggregates are 
the main component of Lewy bodies, the defining histological feature of this neurodegenerative 
disease, and have been shown to accompany neuronal damage (1).  Two other observations 
point to aggregated α-syn as a molecular cause of Parkinson’s disease (2).  The first is that 
families with inherited forms of PD carry mutations in α-syn, such as A53T, and abundant Lewy 
bodies (3-5). The second is that families with duplicated or triplicated genes encoding α-syn 
develop early onset PD, presumably because at high local concentrations α-syn is forced into 
amyloid (6,7).    
 Our focus is on a central segment of α-syn, residues 68-78, that we call NACore (Figure 
5.1), because of its critical role in both the aggregation and cytotoxicity of α-syn.  NACore lies 
within a 35 residue domain of α-syn termed NAC (Non Amyloid-β Component, originally 
reported to be deposited with amyloid b in the brains of Alzheimer’s disease patients), which the 
studies of others have established as necessary and sufficient for aggregation and toxicity of α-
syn (8-12) (Supplementary Figure 5.1). For example, deletion of residues 71-82 prevents 
aggregation of α-syn in vitro, and abolishes both its aggregation and neurotoxicity in a 
drosophila model of PD (12). Yet this segment in isolation from the rest of α-syn readily forms 
amyloid fibrils and is highly cytotoxic (13, 14). Also, β-synuclein, the close homolog of α-syn, 
which does not aggregate and is not found in Lewy bodies, differs in sequence from α-syn 
principally by the lack of residues 74-84 that are part of NACore (9).  
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 Segments outside NAC also influence the aggregation of α-syn and have been associated 
with fibril structure (15-17). In brain extracts from patients with multiple system atrophy, the 
core of α-syn fibrils extends approximately from residue 30 to 100 (18). Also the A53T mutation 
of α-syn can accelerate its transition into the amyloid state, and hence accelerate PD (19). This 
mutation was found to induce the onset of PD at an early age (20), and consistent with this, α-
syn containing this A53T mutation forms fibrils in vitro more rapidly than wild type (3). Thus 
we carried out screens for crystals of peptide segments within the NAC domain and adjacent 
regions, seeking structural information on the molecular basis of aggregation and toxicity of α-
syn. 
 
RESULTS 
Structure determination byMicroED 
 Extensive crystal screens of two segments, NACore, residues 68GAVVTGVTAVA78, and 
PreNAC, 47GVVHGVTTVA56, seemingly produced non-crystalline, amorphous aggregates.  But 
on examination by electron microscopy, we found the aggregates to be clusters of elongated 
nanocrystals only 50-300 nm in cross section and thus invisible by conventional light microcopy 
(Figure 5.1).  We confirmed well-ordered crystallinity of NACore at both the SACLA and LCLS 
free electron lasers. We also found that a 9-residue fragment within the NACore, which we term 
SubNACore, 69AVVTGVTAV77, yielded crystals 1,000 – 10,000 times larger in volume than the 
NACore nanocrystals (Figure 5.1). We were therefore able to apply synchrotron methods(21, 22) 
to these larger crystals to determine the structure of their amyloid-like fibrils. Although this 9-
residue fragment is missing only two residues compared with NACore, it is not as toxic (23), 
offering insight described below, into the toxicity of α-syn.  
 To determine the structure of the invisible crystals of NACore and PreNAC, we turned to 
Micro-Electron Diffraction (MicroED) (24-26).  In MicroED, an extremely low dose electron 
beam is directed on a nanocrystal within a transmission electron microscope under cryogenic 
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conditions, yielding diffraction patterns such as that in Figure 5.2. As the wavelength used in our 
experiments at 200keV is very small (0.025Å), the Ewald sphere is essentially flat yielding 
diffraction patterns that closely resemble a 2D slice through 3D reciprocal space. As the crystal 
is continuously rotated in the beam, a series of such diffraction patterns is collected (25). Scaling 
together diffraction data collected from multiple crystals produces a full 3D diffraction dataset. 
MicroED has been successfully applied to the well-known structures of hen egg-white lysozyme 
(25, 26), bovine liver catalase (27) and Ca2+-ATPase (28).  But NACore and PreNAC are the first 
previously unknown structures determined by MicroED. 
 For NACore and PreNAC, we collected microED patterns from nano-crystals that lay 
preferentially oriented, flat on the surface of a holey carbon Quantifoil grid, in a frozen-hydrated 
state. Grids were first screened for appropriately sized crystals, and candidate crystals screened 
for diffraction. We used crystals showing strong diffraction for data collection by continuous 
unidirectional rotation about a fixed axis, acquiring a series of diffraction frames at fixed time 
intervals (25).  The needle-shaped crystals typically exceeded the length needed for MicroED; 
those that were unbent and 100 to 300 nm wide produced the best diffraction patterns. Data 
from multiple crystals were integrated, scaled and merged together (Supplementary Table 5.1).   
 The multi-crystal NACore and PreNAC datasets were phased by molecular replacement, 
using the atomic model of SubNACore and an ideal beta strand model, respectively, as probes.  
As shown in Supplementary Figure 5.2, diffraction phases calculated from the SubNACore probe 
structure and NACore structure factors yielded a difference density map (Supplementary Figure 
5.2), which clearly reveals the positions of the missing residues, after subsequent refinement, 
two water molecules, and several hydrogen atoms (Figure 5.3e).  Full models of NACore and 
PreNAC were refined against the MicroED data, producing structures at 1.4Å resolution with 
acceptable R-factors (Supplementary Table 5.1). Electron scattering factors were used in the 
refinement calculations (29). 
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NACore Structure 
 The structure of the NACore peptide chain is a nearly fully extended β-strand (Figure 5.3 
and Supplementary Figure 5.3). These NACore strands stack in-register into β-sheets, as had 
been predicted by site-directed spin labeling (16, 17).  The sheets are paired (Figure 5.3b), as is 
usual in amyloid spines, and the pairs of sheets form typical steric-zipper protofilaments (Figure 
5.3c), previously seen as the spines in many amyloid-like fibrils formed from short segments of 
fibril-forming proteins (21).  The unusual features of this steric zipper are that the 11-residue 
width of the zipper is longer than has been previously observed (22), and each pair of sheets 
contains two water molecules, each associated with a threonine sidechain, within the interface 
instead of being completely dry.  Also, in our crystals of NACore, each sheet forms two snug 
interfaces: Interface A with 268 Å2 of buried accessible surface area per chain, is more extensive 
and presumably stronger than Interface B (167 Å2), because the terminal residues of the chains 
in opposing sheets bend towards each other (Figure 5.3 and Supplementary Figure 5.4).  The 
structure of PreNAC reveals a peptide chain that forms a β-strand kinked at residue glycine 51. 
These strands are arranged into pairs of β-sheets that like the NACore structure interdigitate to 
form steric zipper protofilaments (Figure 5.3). Of special note, a five residue segment of PreNAC 
(51GVTTV55) differs in only one residue from a five residue segment of NACore (73GVTAV77) and 
their backbones and identical sidechains superimpose closely with an alpha carbon RMS 
deviation of 1.5Å (Supplementary Figure 5.4).  This means that weaker interface B of NACore 
mimics a hypothetical interface between NACore and PreNAC (Figure 5.3d). 
Relevance of NACore to Parkinson Disease 
 The relevance of the structure of NACore to fibrils of full length α-syn is established by 
the resemblance of their diffraction patterns. Specifically, the fiber diffraction pattern of aligned 
fibrils of full-length and N-terminally acetylated (30) α-syn protein display the same principal 
peaks as the diffraction of aligned NACore nanocrystals (Figure 5.2). All three fibrils display the 
strong reflection at 2.4Å in their diffraction patterns. As seen in Figure 5.3 and Supplementary 
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Figure 5.5 this reflection arises in NACore because one β-sheet of the steric zipper is translated 
along the fiber axis with respect to the other β-sheet by 2.4Å, one half the 4.8Å spacing between 
β-strands, permitting the two sheets to interdigitate tightly together. All three share a strong 
4.6Å reflection, which in NACore results from both the stacking of β-strands and the staggering 
between adjacent β-sheets of the steric zipper, while a shared reflection at near 8.2Å likely arises 
from the distance between the adjacent pairs of β-sheets that make up the α-syn fibril (Figure 
5.2 and Supplementry Figure 5.5). This comparison of fiber diffraction patterns (Supplementary 
Table 5.2) strongly suggests that the structure of NACore is similar to the spine of our toxic 
fibrils of full α-syn.  
 The combined structures of NACore and PreNAC allow us to construct a speculative 
model for much of the ordered segments of the A53T early onset mutant α-syn (Figure 5.3d). 
Experimental support of this model comes from the agreement of its simulated fiber diffraction 
with the measured diffraction patterns of α-syn and N-acetyl α-syn fibrils as well as aligned 
NACore nanocrystals (Supplementary Table 5.2). Above we hypothesized that the weaker 
Interface B of NACore might mimic an intramolecular interaction of PreNAC with NACore 
(Figure 5.3).  In fact, the interacting sidechains in the weaker NACore Interface B (G73, T75, and 
V77) are identical to the sidechains (G51, T53, V55) interacting in the hypothetical interface of 
PreNAC with NACore. Assuming that this interface actually forms in fibrils of the early onset 
mutant A53T, we have built the model shown in Figure 5.3d. The hypothetical interface of this 
model offers a possible reason for a greater propensity of the A53T mutant to aggregate than the 
wild type sequence, conceivably leading to early onset of PD.   
 The identity and structure of the cytotoxic amyloid formed by α-syn remains a subject of 
intensive research (19, 31-35).  The weight of evidence over the past decade has tilted scientific 
opinion from the fully developed amyloid fibrils found in Lewy bodies as the toxic entities to 
smaller, transient amyloid oligomers. Yet recently, quantitative arguments have been put 
forward in favor of fibrils (36).  Our experiments of the cytotoxicity of NACore on 
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neuroblastoma cells (Figure 5.4) are consistent with the view that fibrils are toxic:  we find that 
NACore shaken and aggregated for 72 hours displays abundant fibrils, is more toxic than freshly 
dissolved NACore (Figure 5.4) and is comparably toxic to similarly aggregated full α-syn. We 
also find greater cytotoxicity of NACore than SubNACore, which is shorter by two residues.  This 
is consistent with the more rapid fibril formation of NACore than of SubNACore (Figure 5.4d). 
These observations do not rule out the formation of a non-fibrillar, oligomeric assembly, 
present, but undetected, in our aggregated samples of NACore and α-syn. Of course, NACore is 
merely a fragment of full length α-syn, and lacks most of the membrane-binding motifs of the N-
terminus of the protein, which have been implicated in membrane disruption (37, 38). Yet it is 
clear that NACore is the minimum entity that recapitulates all the features of full length a-syn 
aggregation and toxicity.   
 
DISCUSSION 
 The miniscule size of NACore crystals is typical of amyloid and also of various other 
biological crystals of interest. For amyloid crystals, our speculation is that the tiny size is a 
consequence of the natural twist of β-sheets that form the protofilaments of the fibrils.  The 
crystal lattice restrains the twist, creating a strain in these crystals, which increases as crystals 
grow.  Eventually this strain prevents further addition of β-strands, limiting the thickness of the 
needle crystals.  In our experience, longer segments (for example, 11 residues compared to 9 
residues) limit crystal growth even more; in the case of 11-residue NACore and 10-residue 
PreNAC, the strain produces nanocrystals, invisible by optical microscopy.  These crystals are 
too small for mounting and conventional synchrotron data collection, but are ideally suited for 
analysis by MicroED. Our structures of NACore and PreNAC demonstrate that MicroED is 
capable of determining new and accurate structures of biological material at atomic resolution. 
This finding paves the path for applications of MicroED to other biological substances of 
importance, for which only nanocrystals can be grown. In our particular application, we have 
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been able to learn the atomic arrangement of the core of the crucial NAC domain.  This opens 
opportunities for structure-based design of inhibitors of amyloid formation of α–syn (39). 
 
MATERIALS AND METHODS 
Crystallization 
 Microcrystals of SubNACore, 69AVVTGVTAV77, were grown from synthetic peptide 
purchased from CS Bio. Crystals were grown at room temperature by hanging drop vaporization. 
Lyophilized peptide was dissolved in water at 2.9 mg/ml concentration in 48 mM lithium 
hydroxide. Peptide was mixed in a 2:1 ratio with reservoir containing 0.9 M ammonium 
phosphate, and 0.1M sodium acetate pH 4.6.  
 Nanocrystals of NACore, 68GAVVTGVTAV78, were grown from synthetic peptide 
purchased from CS Bio. Ten batches of synthesized peptide (CSBio) at a concentration of 1 
mg/ml in sterile water were shaken at 37°C on a Torrey Pines orbital mixing plate at speed 
setting 9, overnight. The insoluble material was washed in 30% (w/v) glycerol then stored in 
water at room temperature before diffraction. The sample contained a mixture of fibrils and 
crystals.  
 Nanocrystals of PreNAC, 47GVVHGVTTVA56, were grown from synthetic peptide 
purchased from InnoPep. Crystallization trials of synthesized peptide were prepared in batch. 
Peptide was weighed and dissolved in sterile-filtered 50mM phosphate buffer pH 7.0 with 0.1% 
DMSO at a concentration of 5mg/ml. This solution was shaken at 37°C on a Torrey Pines orbital 
mixing plate at speed setting 9, overnight. 
Data Collection and Processing 
 X-ray diffraction data from microcrystals of SubNACore were collected using 
synchrotron radiation at the Advanced Photon Source, Northeast Collaborative Access Team 
micro focus beam line 24-ID-E. The beam line was equipped with an ADSC Quantum 315 CCD 
detector. Data from a single crystal were collected in 5° wedges at a wavelength of 0.9791 Å 
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using a 5 μm beam diameter. We used data from three different sections along the needle axis. 
The crystals were cryo-cooled (100 K) for data collection. Data were processed and reduced 
using Denzo/Scalepack from the HKL suite of programs (43). 
 Electron diffraction data from nanocrystals of NACore and PreNAC were collected using 
MicroED techniques (25, 26). These nanocrystals typically clump together. To break up the 
clumps, an approximately 100μL volume of nanocrystals was placed in a sonication bath for 30 
minutes. Nanocrystals were deposited onto a Quantifoil holey-carbon EM grid in a 2-3μl drop 
after appropriate dilution, which optimized for crystal density on the grid. All grids were then 
blotted and vitrified by plunging into liquid ethane using a Vitrobot Mark IV (FEI), then 
transferring to liquid nitrogen for storage. Frozen hydrated grids were transferred to a cryo-
TEM using a Gatan 626 cryo-holder. Diffraction patterns and crystal images were collected 
using an FEG-equipped FEI Tecnai F20 TEM operating at 200 kV and recorded using a bottom 
mount TVIPS F416 CMOS camera with a sensor size of 4000 squared pixels, each 15.6 μm in 
size per square dimension. Diffraction patterns were recorded by operating the detector in 
rolling shutter mode with 2 x 2 pixel binning, producing a final image 2000 squared pixels in 
size. Individual image frames were taken with exposure times of 3-4 seconds per image, using a 
selected area aperture with an illuminating spot size of approximately one micron. This 
geometry equates to an electron dose of less than 0.1 e−/Å2 per second. During each exposure, 
crystals were continuously rotated within the beam at a rate of 0.3° per second, corresponding 
to 1.2° wedge per frame. Diffraction data were collected from several crystals each oriented 
differently with respect to the rotation axis. These data sets each spanned wedges of reciprocal 
space ranging from 40° to 80°. 
 X-ray diffraction data from nanocrystals of NACore were collected using XFEL radiation 
at the CXI instrument (Coherent X-ray Imaging) at the Linear Coherent Light Source (LCLS)-
SLAC . The photon energy of the X-ray pulses was 8.52 keV (1.45 Å). Each 40 fs pulse contained 
up to 6 x 1011 photons at the sample position taking into account a beam line transmission of 
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60%. The diameter of the beam was approximately 1 μm. We used a concentration of 
approximately 25 μl of pelleted material suspended in 1 mL water. The sample was injected into 
the XFEL beam using a liquid jet injector and a gas dynamic virtual nozzle (44). The micro jet 
width was approximately 4 µm and the flow rate was 40 μl/min. The sample caused noticeable 
sputtering of the liquid jet. XFEL data were processed using cctbx.xfel (45, 46).  
 Calibration of the sample to detector distance in microED was accomplished using a 
polycrystalline gold standard and by referencing the prominent reflections in the electron 
diffraction experiment with the corresponding reflections in the XFEL data. Calibration of the 
x/y locations of the 64-tile CSPAD detector was performed by cctbx.xfel by refining the optically 
measured tile positions against a thermolysin data set (45). 
 To gain compatibility with conventional X-ray data processing programs, the microED 
diffraction images were converted from tiff or TVIPS format to the SMV crystallographic format. 
We used XDS to index the diffraction images (47), and XSCALE for merging and scaling 
together data sets originating from different crystals. For NACore, data from four crystals were 
merged, while for PreNAC, data from three crystals were merged to assemble the final data sets 
(see Supplementary Table 5.1). 
Structure Determination  
 The molecular replacement solution for SubNACore was obtained using the program 
Phaser (48). The search model consisted of a geometrically ideal β-strand composed of nine 
alanine residues.  Crystallographic refinements were performed with the program Refmac (49).  
The molecular replacement solution for NACore was obtained using the program Phaser (48). 
The search model consisted of the SubNACore structure determined previously.  
Crystallographic refinements were performed with the program Phenix (50) and Buster (51).  
The molecular replacement solution for PreNAC was obtained using the program Phaser (48). 
The search model consisted of a geometrically ideal β-strand composed of six residues with 
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sequence GVTTVA. Crystallographic refinements were performed with the program Phenix (50) 
and Refmac (49).  
 Model building for all segments was performed using COOT (52). Data processing and 
refinement statistics are reported in Supplementary Table 5.1. The coordinates of the final 
models and the structure factors have been deposited in the Protein Data Bank with PDB code 
4RIK for SubNACore, 4RIL for NACore, and 4ZNN for PreNAC. The structures were illustrated 
using Pymol (53). 
Protein expression and purification 
 The human wild type α-syn construct was previously characterized (54) (pRK172, 
ampicillin, T7 promoter) with sequence: 
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHG 
VATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILE
DMPVDPDNEAYEMPSEEGYQDYEPEA.   
 Full length α-syn was purified according to published protocols (34). The α-syn construct 
was transformed into E.coli expression cell line BL21 (DE3) gold (Agilent Technologies, Santa 
Clara, CA) for wild type α-syn protein expression. A single colony was incubated into 100 mL LB 
Miller broth (Fisher Scientific, Pittsburgh, PA) supplemented with 100 mg/mL ampicillin 
(Fisher Scientific, Pittsburgh, PA) and grown overnight at 37C. One liter of LB (Miller) 
supplemented with 100 mg/mL ampicillin in 2 L shaker flasks was incubated with 10 mL of 
overnight culture and grown at 37C until the culture reached an OD600 ~0.6-0.8 as measured 
by a BioPhotometer UV/VIS Photometer (Eppendorf, Westbury, NY). IPTG (Isopropyl b-D-1-
thiogalactopyranoside) was added to a final concentration of 0.5 mM, and grown for 4-6 hours 
at 30C. Cells were harvested by centrifugation at 5,500 x g for 10 minutes at 4C. The cell pellet 
was frozen and stored at -80C.  
 The cell pellet was thawed on ice and resuspended in lysis buffer (100 mM Tris-HCl pH 
8.0, 500 mM NaCl, 1 mM EDTA pH 8.0) and lysed by sonication. Crude cell lysate was clarified 
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by centrifugation at 15,000 x g for 30 minutes at 4°C. The clarified cell lysate was boiled and cell 
debris was removed by centrifugation. Protein in the supernatant was precipitated in acid at pH 
3.5 through addition of HCl by titration to protein solution on ice while stirring then centrifuged 
for an additional 15,000 x g for 30 minutes at 4 °C. Supernatant was dialyzed against buffer A 
(20 mM Tris-HCl, pH 8.0). After dialysis the solution was filtered through a 0.45 μm syringe 
(Corning, NY 14831) before loading onto a 20 mL HiPrep Q HP 16/10 column (GE Healthcare, 
Piscataway, NJ). The Q-HP column was washed with five column volumes of buffer A and 
protein eluted using a linear gradient to 100% in five column volumes of buffer B (20 mM Tris-
HCl, 1M NaCl, pH 8.0). Protein eluted at around 50-70% buffer B; peak fractions were pooled. 
Pooled samples were concentrated approximately tenfold using Amicon Ultra-15 centrifugal 
filters. Approximately 5 ml of the concentrated sample was loaded onto a HiPrep 26/60 
Sephacryl S-75 HR column equilibrated with filtration buffer (25 mM sodium phosphate, 100 
mM NaCl, pH 7.5). Peak fractions were pooled from the gel filtration column and dialyzed 
against 5 mM Tris-HCl, pH 7.5, concentrated to 3 mg/ml. These were filtered through a 0.2 μm 
pore size filter (Corning, NY 14831) and stored at 4 °C. 
 Recombinantly expressed full-length α-syn with an N-terminal acetylation was prepared 
and purified in the following way based on a protocol by Der-Sarkissian et al. (16)The α-syn 
plasmid was co-expressed with a heterodimeric protein acetylation complex from S. pombe to 
acetylate the N-terminus (pACYC-DUET, chloramphenicol, T7 promoter) (55). The two vectors 
were co-transformed into E. coli BL21 (DE3) using media containing both ampicillin and 
chloramphenicol. Cell cultures were grown in TB media containing ampicillin and 
chloramphenicol and induced to express α-syn with 0.5 mM IPTG overnight at 25C. Cells were 
harvested by centrifugation, the cell pellet then resuspended in lysis buffer (100 mM Tris-HCl 
pH 8.0, 500 mM NaCl, 1 mM EDTA pH 8.0, and 1 mM phenylmethylsulfonyl fluoride) and cells 
lysed using an Emulsiflex homogenizer (Avestin). The lysate was boiled and debris removed by 
centrifugation. A protein fraction was also removed by precipitation at low pH on ice followed by 
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centrifugation. The remaining supernatant was pH adjusted by titration and dialyzed against 
Buffer A (20 mM Tris-HCl, pH 8.0, 1 mM DTT, 1 mM EDTA, pH 8.0). The resulting protein 
solution was loaded onto a 5 mL Q-Sepharose FF column (GE Healthcare) equilibrated with 
Buffer A and eluted against a linear gradient of Buffer B (1M NaCl, 20 mM Tris-HCl, pH 8.0, 1 
mM DTT, 1 mM EDTA, pH 8.0). Fractions containing α-syn were identified using SDS-PAGE, 
collected, concentrated and further purified by size exclusion (Sephacryl S-100 16/60, GE 
Healthcare) in 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM DTT, 1 mM EDTA. Purity of fractions 
was assessed by SDS-PAGE.  
 Acetylated protein was characterized by LC-MS (30, 56). Expected average mass: 14460.1 
Da for alpha-synuclein and 14502.1 for acetylated alpha-synuclein. Observed average mass: 
14464.0 Da for alpha-synuclein and 14506.0 for acetylated alpha-synuclein (Extended Data 
Figure 6). The shift of 4 Da between observed and expected average masses is due to 
instrumental error. 
Fibril formation and detection 
 Purified α-syn in 50mM Tris, 150 mM KCl pH 7.5 was shaken at a concentration of 500 
μM at 37°C in Torey Pine shaker. To form the fibrillar samples of SubNACore and NACore, 
lyophilized peptides were dissolved to a final concentration of 500 μM in 5 mM lithium 
hydroxide, 20 mM sodium phosphate pH 7.5 and 0.1 M NaCl. All samples were shaken at 37°C 
in a Torey Pine shaker for 72 hours. Freshly dissolved samples were prepared by dissolving 
lyophilized peptides immediately prior to addition to cells for assays.  
 Turbidity measurements were used to compare NACore and SubNACore aggregation. 
Peptide samples were freshly dissolved to 1.6mM in a sample buffer with 5mM LiOH and 1% 
DMSO and then filtered through a PVDF filter (Millipore, 0.1µm). Measurements were 
performed using a black NUNC 96 well plate with 200µL of sample/well (3-4 replicates per 
sample). The plate was agitated at 37°C, with a 3mm rotation diameter, at 300rpm in a 
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Varioskan microplate reader (Thermo). Absorbance readings were recorded every 3-15 minutes 
at 340nm. 
Negative Stain Transmission Electron Microscopy 
 Cytotoxicity samples were evaluated for presence of fibrils by electron microscopy. 
Briefly, 5 μL samples were spotted directly on freshly glow-discharged carbon-coated electron 
microscopy grids (Ted Pella, Redding, CA). After 4 min incubation, grids were rinsed twice with 
5-μL distilled water and stained with 2% uranyl acetate for 1 min. Specimens were examined on 
an FEI T12 electron microscope. 
Fibril Diffraction 
 Fibrils formed from purified α-syn with and without N-terminal acetylation were 
concentrated by centrifugation, washed, and oriented while drying between two glass capillaries. 
Likewise, NACore nanocrystals were also concentrated, washed with nanopure water, and 
allowed to orient while drying between two glass capillaries. The glass capillaries holding the 
aligned fibrils or nanocrystals were mounted on a brass pin for diffraction at room temperature 
using 1.54Å x-rays produced by a Rigaku FRE+ rotating anode generator equipped with an HTC 
imaging plate. All patterns were collected at a distance of 180 mm and analyzed using the Adxv 
software package (57). A simulated pattern from the full length α-syn model presented in Figure 
3 was obtained by calculating structure factors from the model using the sfall module from 
CCP4, assigning the model a unit cell of 200 x 4.74 x 200 angstroms. Cylindrical averaging of 
these structure factors about the fiber axis (y axis) direction produced a set of simulated fibril 
diffraction intensities. 
Cytotoxicity assays 
 Adherent PC12 cells were cultured in ATCC-formulated RPMI 1640 medium (ATCC; 
cat.# 30-2001) supplemented with 10% horse serum and 5% fetal bovine serum and plated at 
10,000 per well to a final volume of 90 μl. All MTT assays were performed with Cell Titer 96 
aqueous non-radioactive cell proliferation kit (MTT, Promega cat #4100). Cells were cultured in 
188 
96-well plates for 20h at 37°C in 5% CO2 prior to addition of samples (Costar cat. # 3596). 10 μL 
of sample was added to each well containing 90 μL medium and incubated for 24h at 37°C in 5% 
CO2. Then, 15 μL dye solution (Promega cat #4102) was added into each well, followed by 
incubation for 4h at 37°C in 5% CO2. This was followed by the addition of 100μl solubilization 
Solution/Stop Mix (Promega cat #4101) to each well. After 12h incubation at room temperature, 
the absorbance was measured at 570nm. Background absorbance was recorded at 700nm. The 
data was normalized with cells treated with 1% (w/v) SDS to 0% reduction, and cells treated 
with sample buffer to 100% reduction. 
 Lactose dehydrogenase assays were done using CytoTox-ONE™ Homogeneous 
Membrane Integrity, (Promega, cat #G7890) as per manufacturers instructions. Briefly, cells 
were plated in 96 well black-wall, clear bottom (Fisher Cat #07-200-588) tissue culture plates at 
10,000 cells per well to a final volume of 90μL. Cells were incubated for an additional 20h at 
37°C in 5% CO2 prior to addition of samples. Next, 10μl of sample was added to each well 
following which the cells were incubated for another 24 hours. 100μl of reagent was added to 
each well and incubated for 15mins at room temperature. The addition of 50μL of stop solution 
stopped the reaction. Fluorescence was measured in a Spectramax M5 (Molecular Devices) 
using excitation and emission wavelengths of 560 nm and 590 nm, respectively. Data was 
normalized using cells treated with buffer as 0% release and 0.1% triton X-100 as 100% release. 
Construction of α-syn A53T fibril model 
 A model for full-length α-syn A53T mutant fibrils that are involved in the early onset of 
PD was constructed using a section of the NACore crystal packing as a scaffold. Figure 5.3 
illustrates the four copies of the NACore segment used for the scaffold. The crystal structure of 
the two inner strands was adapted with minimal changes as the analogous segments 68-78. The 
structure of PreNAC was matched onto the weak interface of the NACore structure. Only four of 
the eleven sidechains in the segment 46-56 differ from those in the NACore segment 68-78 and 
residues V51-V55 can be closely matched to V71-V75. Hence the model for both the homotypic 
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interface and heterotypic interface in the full-length fiber model closely resemble those observed 
in the NACore structure. The regions outside these segments were adapted from the structure of 
the native α-syn fold, PDB ID 2KKW (58). These segments were spliced in manually using 
COOT. The models were energy minimized and temperature annealed using the program CNS  
(59) with hydrogen bonding potential (60). The simulated fiber diffraction pattern calculated 
from this model shows prominent reflections that agree with those observed in fiber diffraction 
patterns of NACore, α-syn, and N-acetyl α-syn (Supplementary Table 5.2). 
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Figure 5.1. NACore (residues 68-78) is the fibril-forming core of the NAC domain 
of full-length α-syn.  Top: beta strands indicated byNMR and EPR (17, 40, 41). Center: red 6-
residue segments are predicted to form amyloid fibrils (42).  The A53T early-onset  Parkinson 
mutation is indicated by a red arrow and red letter T.  Bottom: the miniscule size of the preNAC 
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and NACore crystals used for MicroED  is illustrated by this comparison to SubNACore 
microcrystals (middle. Scale comparisons are illustrated on two  magnifications using phase 
contrast light microscope images  and electron micrographs , in which individual NACore and 
PreNAC nanocrystals are indistinguishable by light microscopy. 
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Figure 5.2. Diffraction from NACore nano crystals is similar to that from full 
length α-syn fibrils. (A) Single crystal electron diffraction pattern obtained duringMicroED 
data collection (see text). Equally spaced concentric rings denote resolution shells. An arrow 
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points to The highest resolution spot is at 1.52 Å (arrow). The inset shows the overfocused image 
of the diffracting  crystal (arrow),  which is  ~1480 x 200 x 200 nm. (B) Composite of fibril 
diffraction patterns from α-syn preparations and NACore. Full-length α-syn reveals reflections 
that match those from NACore and N-terminally acetylated α-syn. The two patterns of full-
length α-syn share with NACore three major peaks denoted by arrows:  8.2 Å (orange), 4.6 Å 
(blue), and 2.4 Å (green). The origin of these peaks can be traced to the (0 0 2), [(1,1,1),(-1 1 1)], 
and (0 2 0) planes in the NACore structure, respectively. The reflection at 8.2Å likely arises from 
adjacent pairs of β-sheets. 
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Figure 5.3. Structure of the amyloid core of α-syn. (A) The crystal structure of NACore 
(orange) reveals pairs of sheets as in the spines of amyloid fibrils. The A53T mutation in PreNAC 
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is shown in black. The sheets in both structures are related by the 21 fibril axes shown in black. 
The gaps left by the interface are filled with water molcules which hydrogen-bond to the 
threonine residues (partly showing aqua spheres). (B) and (C), are orthogonal views of the 
fibrillar assemblies. (D) A speculative model of an α-syn protofibril containing the A53T 
mutation (black), where the strong interface of NACore (orange) forms the core of the fibril and 
its weaker interface interacts with PreNAC (blue). (E) The locations of 5 out of a possible 73 
protons are suggested by small, positive Fo-Fc density (green contoured at 2.8s, shown by 
arrows. The blue mesh is 2Fo-Fc density contoured at 1.4 s. 
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Figure 5.4. NACore aggregates faster than SubNACore and is more cytotoxic to 
cultured cells. Cytotoxicity of NACore, SubNACore and α-syn measured on PC12 cells using 
(A) MTT assay and (B) LDH release assay. In both assays NACore is more toxic than 
SubNACore. Also, shaken fibrils are more toxic than an equal concentration of freshly dissolved 
sample. Results shown as mean ± standard error of the mean from triplicate samples. A t-test 
was used to measure statistical significance * <0.05, **<0.01,***<0.001. (C) Representative 
electron micrographs of NACore, SubNACore and α-syn samples tested for cytotoxicity. NACore 
and α-syn show abundant fibrils but SubNACore few. NACore also forms fibrils immediately 
upon dissolving whereas SubNACore shows no fibers, but instead amorphous aggregates. Scale 
500nm. (D) NACore and SubNACore were aggregated in identical conditions and monitored by 
turbidity. NACore begins to aggregate in 15 hours while SubNACore forms no aggregates for up 
to 50 hours. Electron microscopy of the samples at 50 hours confirmed the turbidity readings 
(insets, scale 2 μm), with error bars denoting standard deviation from triplicates. 
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Supplementary Figure 5.1. A schematic representation of α-syn, highlighting the 
NAC region (residues 61-95) and within it the NACore sequence (residues 68-78). A 
series of bars span regions of α-syn that are of interest to this work. Among the three synuclein 
paralogs (α, β, and γ), the region whose sequence is unique to α-syn is shown as a blue bar 
(residues 72-83) that overlaps with a large portion of NACore. Segments investigated by Bodles 
et al.23 are also shown. These span a variety of regions within NACore. Two of the segments we 
now investigate, SubNACore and NACore, are shown in this context. Only one of the segments 
studied by Bodles et al. is an exact match to our NACore sequence, and only this segment is both 
toxic and fibrillar. The sequences of α-synuclein, β-synuclein, and γ-synuclein are shown as a 
reference with conserved residues in bold and the NACore sequence in red.  
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Supplementary Figure 5.2. Difference density maps calculated after successful 
molecular replacement using the SubNACore search model clearly revealed the positions of the 
missing residues (positive Fo-Fc density at N and C termini corresponding to G68 and A78) and 
one water molecule near a threonine side chain (red circle); a second water was located during 
the refinement process. The blue mesh represents 2Fo-Fc density contoured at 1.2 s level. The 
green and red mesh represent Fo-Fc density contoured at 3.0 and -3.0 s, respectively. All maps 
were sa-weighted (61). 
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Supplementary Figure 5.3. The crystal structure of NACore reveals pairs of sheets 
as in the spines of amyloid fibrils. (A) NACore’s two types of sheet-sheet interfaces: a 
larger interface (orange, 268 Å2 of buried accessible surface area per chain) we call interface A, 
and a weaker interface (blue, 167 Å2) we call interface B. The crystal is viewed along the 
hydrogen-bonding direction (crystal “b” dimension). The red lines outline the unit cell. (B) The 
van der Waals packing between sheets.The sheets are related by a 21 screw axis denoted in black. 
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The only gaps left by the interface are filled with water molcules which hydrogen-bond to the 
threonine residues (partly showing aqua spheres). The shape complementarity of both interfaces 
is 0.7. The viewing direction is the same as in (A, C) Orthogonal view of the fibrillar assembly. 
The protofibril axis, coinciding with the 21 screw axis designated by the arrow, runs vertically 
between the pairs of sheets. 
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Supplementary Figure 5.4. (A) Comparison of the crystal packing for NACore 
(orange chain) and SubNACore (white chain). The face-to-face interactions are virtually 
the same for the pairs of NACore peptides in its crystal structure and the SubNACore peptides in 
its structure (A and B shown in gold and blue, respectively). The table below shows a pairwise 
the RMSD comparing the nine residues shared in common between the structures. RMSD_res is 
an all-atom comparison between residue pairs, while RMSD_ca compares only alpha carbon 
pairs. (B) PreNAC (blue) is compared with NACore (orange). Five residues from each strand are 
shown in darker color and the RMS deviations between their alpha carbon pairs compared in 
the table below. Therefore the PreNAC-NACore interaction mimics weaker Interface B in the 
NACore structure. 
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Supplementary Figure 5.5. Intense reflections common among the NACore and the 
two polymorphs of full length α-syn suggest common structural features. These 
features are illustrated here on the crystal packing diagrams of NACore. The (0,0,2) planes 
approximate the separation between sheets in interface A (orange). The (0,2,0), (-1,1,1), and 
(1,1,1) reflections are intense because the corresponding Bragg planes recapitulate the staggering 
of strands from opposing sheets. The red lines correspond to the unit cell boundaries and all 
planes are shown in black. 
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Supplementary Figure 5.6. Mass spectrometry analysis of recombinantly 
expressed, full length α-syn, with and without N-terminal acetylation The mass profile of 
wild-type full length α-syn (left) is compared to that of an N-terminally acetylated form of the 
protein (right). The mass shift for the N-terminally acetylated form is appropriately shifted with 
respect to the native form of the protein (14464.0 Da for alpha-synuclein and 14506.0 for 
acetylated alpha-synuclein), within a margin of error of 4 Da. 
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Supplementary Table 5.1. Statistics of data collection and atomic refinement for 
NACore, its fragment SubNACore, and PreNAC. *Highest resolution shell is shown in 
parenthesis. 
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Supplementary Table 5.2. Comparison of reflections observed in powder 
diffraction of fibrils of full-length α-syn, N-acetyl α-syn, and a synthetic pattern calculated 
from our α-syn model, to aligned nanocrystals of NACore. Bold reflections are strong and 
common to all three samples. 
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